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SUMMARY
This project has involved the in ve s t i g a t i o n  of the 
p ol yp eptide  products of gene Ugll, and their inv ol vemen t 
in D N A - pr otein  inter actions occu rring within the ' a 1 
se que nc e of HSV-1. The work stems from the ob se r v a t i o n  of 
Dal zie l and Mars den  (1984), that p o l y pe pt ides of apparent 
m o l e cular  weight 21,000 and 22,000 (21K, 22K) spec ificall y 
i nt er acted with the HSV-1 'a' sequence - a sequen ce involved 
in a number of functions, in clu din g ci r c u l a r i s a t i o n  of the 
virus genome, inv ersion between the L and S segmen ts of the 
genome, and cleavage and pac kaging of viral DNA.
To characte ri se the 21K/22K polypepti des, an tisera  
were raised against synthetic o l i g o p eptid es  co r r e s p o n d i n g 
to five different regions of the predicted Ugll gene product, 
since earlier evidence suggested that the 21K and 22K 
p o l y p ep tides were the products of this gene. All five o l i g o ­
pep ti des were immunogenic, and four induced ant is era which 
app ear ed to recognise virus -sp ecifi c pol ypeptides. The p o l y ­
pe pti des recognised included species with appar en t molec ul ar 
w e i gh ts of 22K, 21K, 17.5K, 15K, 14K and 11K, and these 
were shown, by tryptic peptide analysis, to share common 
amino acid sequences. Ti mecourse  experiments, and the use 
of phos phonoac etic acid, an inh ibitor of viral DNA replication, 
e st ab lis hed that the 21K and 22K polype ptides are true late 
gene products, and immuno blottin g of proteins eluted from 
DNA cel lulose demonstrated that they are also DN A- b i n d i n g 
proteins. Immune electron microsco py studies, however, 
dem ons trat ed  that the Ugll gene products localise strongly 
to nucleoli of infected cells - an unexpected location for 
an ’a ’ sequence binding protein, since viral DNA is absent
from nucleoli (Rixon et a l . , 1983).
Attempts to purify the 21K polypeptide, with a view to 
studying in more detail its i ntera ct ion with the 'a* sequence, 
met with little success. Therefore, DNase I f ootpr in ting 
experimen ts  on the HSV-1 'a' sequence were car ried out, using 
crude whole cell extracts. The ex pe r i m e n t s  re vealed DNA- 
protein int era ction s occurring within two regions of the 
’a ’ sequence - the DR£ repeat element s and the region.
These intera ct ions were specific for v i r u s - i n f e c t e d  cell 
extracts. Withi n the DR^ repeat region a repe titive  pattern 
was seen, cons ist ing of an area of prot e c t i o n  (spanning 
seven nucle ot ides - GGGGAGG), flanked on either side by two 
nucleotid es (AG and GG) at which cl ea vage was enhanced, and 
separated by one unaffected n u c l eoti de  (C). Within the 
region there was no apparent protection, however, there was 
a very marked increase in cleavage betw een a number of 
nucleotides. The crude whole cell ex tracts  pos sessed both 
a 5 * — 3 * exonuclea se and a DNase I-like activi ty  which 
limited the usefulnes s of the f o o t p r i n t i n g  assay : it was 
therefore not possible to det ermine whether specific cleavage 
events were generating the enhanced cl ea vages observed.
Use of an HSV-2 deletion mutant lacking gene Ugll 
demonstrated that the products of this gene are not involved 
in these interactions. Timecours e and drug inhibition  
experiments suggested that early polyp e p t i d e s  are involved, 
while exp er iments involving a te mperatu re  sensitive mutant 
tsK showed that imm ediate-early pol ype ptides, with the 
possible exception of Vmwl75, are not suffici ent alone to 
produce the observed interactions.
The HSV-1 and HSV-2 * a f seque nces are heterog eneous
and share only limited st retches of hom ology (Davison and 
Wilkie, 1981). The most ext ensiv e region of homology lies 
within U^, and overlaps the region of enhancement. The use 
of a cloned synthetic ol i g o n u c l e o t i d e  re pre s e n t i n g  this 
ho molog y region, and an intact HSV-2 ’a 1 sequence, suggested 
that the homology region is involved in the i nter ac tions 
ob serve d .
Enh an ce ment was only obs er ve d on 3 ’ en d- l a b e l l e d  DNA 
fragments. For technical reasons, it was only possible to 
3' end-l abe l one strand of the intact HSV-1 'a' sequence 
close to the region, and one strand (the opposite strand) 
of the cloned synthetic o l i g o n u c l e o t i d e  r e p r e sen ti ng the
homology region. Comparison of the patterns of enh ancemen t 
ob se rv ed on these two sub strates led to the con cl usion that 
the enhanced  cleavages could reflect the 5' bounda ries of 
pr ote in binding sites, revealed by an endo ge nous 5 ’-3' 
e x o n u c l e a s e  activity. Two putative U^-b i n d i n g  sites are 
proposed, one contained entirely within, and the other
overlappi ng,  the homology region. These have the sequence
r  A f  A
5 f - C C ^ A A A A C ^ C C C C C C - 3  1 .
NON-STANDARD AB B R E V I A T I O N S
It is assumed that the reader is familiar with t 
more standar d abbreviations, such as DNA, RNA, h, min 
c e t e r a , and these are therefore not listed below.
BHI brain heart infusion
BHK baby hamster kidney
bp base pairs
BPB bromophenol blue
BSA bovine serum albumin
CMV cytomegalovirus
cpe cytopathic effect
CT calf thymus
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HSV herpes simplex virus
HSV-1 herpes simplex virus type 1
HSV-2 herpes simplex virus type 2
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normal rabbit serum
any d eo xy ribonu cl eoside t r i p h o s p h a t e  
New Zealand White (rabbit)
optical density
origin of DNA replication
ph osphonoa cetic acid
po lyacry lamide gel e l e c t r o p h o r e s i s
post column
plaque forming units
post infection
pre-immune
par tia lly-p ur ified 21K p o l y p e p t i d e  
pse udo rabies virus
ra dioimmu noassay 
radial immunod iff usion 
ri bonucleas e
large subunit of rib on u c l e o t i d e  reductase 
small subunit of ri b o n u c l e o t i d e  reductase 
room temperature
thymidine kinase 
terminal repeat 
t emp erature  sensitive
unique
d e o x y u r i d i n e - 5 1- tr ip hosphat e n u c l e o t i d o h y d r o l a s e  
ultra violet
virus-sp ecific polype ptide  of ap pa rent molec ular 
weight
va ric el la-zos te r virus 
Watt
The three-letter amino acid code
amino acid
alanine
arginine
asparagine
aspartic acid
cysteine
glutamine
glutamic acid
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isoleucine
leucine
lysine
methionine
phenylalanine
proline
serine
threonine
tryptophan
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valine
any amino acid
t hr ee - l e t t e r  code
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Cy s 
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H e  
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Ly s 
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INTRODUCTION
-1-
INTRODUCTI ON  
SECTION I : INTROD UCTORY COMMENTS
Herpes simplex virus (HSV) is inte resti ng  not only 
as a human pathogen but also as a useful model for euka ryotic 
gen eti cs and molecular biology. For these reasons herpes 
simp lex  virology is a rapidly advancing field. The isol ation 
and c h a r a c t er is ation of con ditional lethal virus mutants 
has been inv aluable in eluc idating a number of viral gene 
functions. More recently, this approa ch has been augmented 
by the development of plasm id-based systems for the study 
of both HSV tra nscription and DNA replication. In addition, 
the entire HSV type 1 genome is now almost comp letely 
seq uenced (Duncan J McGeoch, personal co mmu nicat ion) and 
this should allow a more detailed ana ly si s of individual 
viral genes. Despite these advances, however, many questions 
still remain unresolved. For example, little is known about 
the precise me cha nis m of viral DNA replication, or the 
m ec h a n i s m  by which the viral DNA is cleaved and packaged 
into virus particles.
This project has involved the further c h a racter is ation 
of an HSV type 1-encoded polype ptide known as V m w 2 1 . This 
po lyp eptide has the interesting property of being a strong 
DN A- bind in g protein which appears to specific all y interact 
with a sequence of viral DNA termed the ’a* sequence. The 
’a ’ sequence is involved in a number of important functions, 
inc luding the cleavage and packaging of viral DNA. This 
project has also involved the investigati on of other 
apparen tly  se que nce -specif ic interaction s occurring within
-2-
the 'a' sequence of HSV type 1.
The aim of this introduction is to pro vid e a general 
ov erv iew of HSV biology with particular em p h a s i s  on virus- 
induced DN A- bi ndi ng proteins and the i n v o l v e m e n t  of DNA- 
protein int era ction s in various aspects of the virus life 
cycle (for example, transcription, DNA r e p l i c a t i o n  and 
packaging). A quite extensive account of the possible 
functi ona l roles of the ’a ’ sequence is also provided. For 
this reason it is not possible to do justice to all aspects 
of herpes virology, and several important  areas, such as 
latency, pathogenesis  and carc inoge nesis, are dealt with 
only briefly, if at all.
-3-
SECTION H  : GENERAL INTRODUCTION
H .1 The human herpes vi ruses
Man is the natural host of the five hu ma n h erpesv ir uses - 
herpes simplex virus type 1 and type 2 (HSV-1, HSV-2), 
v a r i c e l la-zo st er virus (VZV), Ep ste i n - B a r r  virus (EBV) and 
c yt om e g a l o v i r u s  (CMV). In addition, a novel herp e s v i r u s  has 
recently been isolated from i m m u n o c o m p r o m i s e d  patients 
(Josephs et a l . , 1986; Salahuddin et a l . , 1986), but this 
work remains to be confirmed and the e x p e r i m e n t s  extended 
to determine whether this is genuin ely a sixth human h e r p e s ­
virus. Herpes simplex virus is ubiq uitous and infects a 
large percentage of the population. W h i tley  (1985) has 
recently reviewed the epidemiology of HSV. The primary 
infection is frequently asymptomatic or mild, ass ociated  
with m u co cu taneo us  lesions around the mou th or genital 
mucosae. More serious, however, is the o c c a si onal occurrence 
of ke r a t o c o n j u n c t i v i t i s  (which can lead to corneal blindness) 
or, more rarely, acute necrotising encephali ti s, while
infection of the newbo rn^ca n result in severe disseminat ed 
(more usually by HSV-2)
disease.
A ch aracteri stic feature of h e r p e s v i r u s e s  is their 
potential to establish a latent infection, peri odical ly  
reactivatin g to produce recurrent disease. For example, VZV - 
the causative agent of chicken pox in chi ld ren - can 
reactivate later in life to cause shingles, while CMV, which 
usually produces an asymp tom atic primary infection, is a 
severe problem in imm un ocompr om ised hosts both as a primary 
and a recurrent disease. Similarly, HSV can rea ctivate to 
produce severe, usually localised, lesions in imm unosup presse d
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patients. In contrast, in normal i ndivi du als rea ctiv ation  
of HSV is usually asym ptomatic or mild, leading  in the 
latter case to the app earance of 'cold sores' or genital 
lesions.
Ad ditional clinical interest in these viruses stems 
from their a ssocia ti on with tumours. E p s t e i n - B a r r  virus 
is strongly ass oci ated with both Burkitt 's  lymph oma and 
na so ph arynge al  carcinoma (Epstein et a l . , 1964; zur Hausen 
et a l ., 1970; de-The et a l . , 1978; rev ie wed in de-The, 
1982), while CMV appears to be ass oci ated with the European 
form of Kaposi's sarcoma (Giraldo et a l ., 1975). Herpes 
simplex virus type 2 has been implicated in the aetiology 
of at least a proport ion of cases of cervica l carc ino ma 
(Naib et a l . , 1966; Aurelian, 1973; M c D o u g a l l  et a l . , 1980; 
Eglin et a l . , 1981; Park et a l ., 1983) but its precise role 
is unc ertain (zur Hausen, 1982; Galloway and McDougall, 
1983; Rawls, 1985).
H  . 2 The family H er pe svirida e
The human he rp esvir uses belong to the family Herpes- 
viridae, which includes over eighty dis tinct her pesviruses, 
described in a wide range of animals from fish to man 
(reviewed in Roizman, 1982) and even in a fungus (Kazama 
and Schornstein, 1972). Members of the family H e r p e s v i r idae 
share a number of charac teristics  (reviewed in Roizman 
and Furlong, 1974). They : replicate withi n the nucleus 
of infected cells; possess a do ub le-stra nd ed DNA genome 
of approximate molecular weight 80-150 x 10^. have an 
icosahedral capsid, consisting of 162 capsomeres; have a 
rather ill-defined layer known as the tegument between the
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capsid and the envelope; and have a lipid envelope, usually 
acquired by budding through the inner nuclear membrane.
Thus, her pesv iruses cannot be d i ff erentia te d by their 
morphology. Instead, they have been divided into sub families 
on the basis of their biological prop ert ies (Roizman et a l . , 
1981) .
Herpes simplex virus type 1 belongs to the Alpha-
he rp e s v i r i n a e  subfamily, as do HSV-2, VZV and pse udor abies
virus (PRV), among others. This subfamily is cha ra cterise d
cell
by a variable ho sit/range both in vivo and in v i t r o , a 
rela ti vely short reproductive cycle (<24 hours), and the 
frequent establishment of latency in v i v o , usually in 
ganglia. In contrast, the Be ta h e r p e s v i r i n a e  subfamily, 
which includes both human and murine cyt o m e g a l o v i r u s  (HCMV, 
MCMV) showsa narrow in vivo and in vitro host range, a 
rel at ivel y long reproductive cycle which often results in 
en large me nt  of infected cells (c y t o m e g a l i a ) , and can 
e st ab lish latency in secretory glands and ly mphore ti cular 
cells, as well as in other tissues. The G a m m a h e r p e s v i r inae 
subfamily, which includesEBV and M a r e k ’s disease virus (MDV), 
also has a narrow host range in v i v o , and in vitro infects 
1 ym ph obl ast oid cell lines, being either T or B cell specific. 
Their reproductive  cycle is variable, often leading to a 
persistent, rather than a lytic, infection, and latency 
is establ ished in lymphoid tissues.
IE. 3 The herpes simplex virus genome
Herpes simplex virus type 1 has a d o u ble -s tranded  DNA 
genome of appro ximately 155,000 base pairs (Becker et al . , 
1968; Kieff et a l ., 1971). The genome consists of a Long 
(L) and a Short (S) region, each comprising a unique
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sequence (U^, Ug) flanked by inverted repeats (TR^/IR^, 
TRg/IRg) (Sheldrick and Berthelot, 1974). This is represented 
schemati ca lly in Figure 1. A direct repeat sequence, known 
as the ’a ’ sequence, is present at the genomic termini and 
in inverted orientation at the L-S ju nction (Sheldrick and 
Berthelot, 1974; Grafstro m et a l . , 1974, 1975; Wads worth  
et a l . , 1976; Wilkie and Cortini, 1976). One to several 
copies of the ’a* sequence may be present at the L terminus 
and the L-S junction, but only one copy is usually found at 
the S terminus (Wagner and Summers, 1978; Locker and Frenkel, 
1979a). Inversion of the L and S segments can occur between 
inverted copies of the 'a' sequence to gener at e four 
isomeric forms of viral DNA which are found in equimolar 
amounts (Sheldrick and Berthelot, 1974; Ha yward et a l . , 1975; 
Clements et al . , 1976; Delius and Clements, 1976; Skare and 
Summers, 1977). These are shown in Figur e 1.
SECTION in : INFECTION WITH HERPES SI MP LE X VIRUS
HI . 1 Ad sorption and penetration
Herpes simplex virus rapidly adsorbs to cells in 
tissue culture (Hochberg and Becker, 1968; Hummeler e t a 1. , 
1969; Vahlne et a l . , 1978) by a process that is not well 
characterised, but presumably involves at tachment to 
specific cell surface receptors. Interestingly, it appears 
that HSV-1 and HSV-2 do not use the same cell surface 
receptor, in that they interfere with ad so rption  of virus 
strains of the homologous, but not the heterologous, 
serotype (Vahlne et a l ., 1979; Addison et al ♦ , 1984).
Following adsorption, virus enters the cell either
FIGURE 1
Schem ati c represen tat ion of the HSV genome. The genome 
consists of a Long (L) and a Short (S) region, each 
comprising  a unique sequence (U^,Ug) flanked by inverted 
repeats (TR^/IR^; TRg/IRg). The ’a ’ sequence is present 
as a direct repeat at the genomic termini, and in inverted 
or ie nt ati on at the L-S junction. Inversion of the L and S 
segments occurs between inverted copies of the ’a' sequence 
to generate four isomeric forms of viral DNA found in 
equimolar amounts. These are designated P (prototype), Ig 
(inversion of the short segment), 1^ (inversion of the long 
segment) and I^g (inversion of the long and short segments).
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by a process of endocytosis (Hummeler et a l . , 1969) or 
by fusion of the virus envelope with the cell membrane 
(Morgan et a 1. , 1968), and the virus DNA is then rapidly 
transported to the nucleus (Hummeler et al . , 1969) where 
tr an scripti on  of the viral DNA takes place (Wagner and 
R o i z m a n , 1969).
Rosenthal et a l . (1984) dem ons trate d changes in the 
mobility of cell surface proteins during adso rptio n and 
penetration. Initially the membrane became less mobile, 
suggesting a multiv alent attachment bet ween the virus and 
cell receptors. In contrast, there was an increase in 
mobility above control levels during penetration, which 
would be compati ble with either extensive  endocyto sis or 
the fusion of viral and cell membranes.
HI . 2 The effect of HSV infection on host cell m e t a bo lism
Virus infection has a profound effect on host cell 
metabolism, cell DNA, RNA and protein sy nth esis all being 
sig ni fi cantly  impaired (Roizman and Roane, 1964; Roizman 
et a l . , 1965; Spear et a l ., 1970). The re ducti on in host 
protein synthesis is contributed to by a number of factors. 
Host pol yr ibosome s disaggregate rapidly following infection 
(Sydiskis and Roizman, 1966) and later re as sembl e to form 
new polyriboso me s with an altered s e diment at ion rate 
(Sydiskis and Roizman, 1968) which appear to preferentially  
associate with virus-specified mRNA (Stringer et a l . , 1977;
Silverstein and Engelhardt, 1979). Host RNA synthesis is 
decreased fol lowing infection (Roizman et a l . , 1965; Pizer 
and Beard, 1976) and the mRNA released from the po l y ­
ribosomes is degraded (Nishioka and Silverstein, 1977;
Schek and B a c h e n h e i m e r , 1985). Although some cell mRNA does
a ss ociate with polys omes late in infection (Stringer et al . ,
1977) the transl ation of these mRNAs appears to be suppressed 
(Silverstein and Engelhardt, 1979). This may be due to 
m odifi ca ti ons to the mRNA itself, since cell proteins were 
transl ate d in vitro less well than viral prote ins from 
purified, depr ot einised  infected cell RNA (Inglis and 
Newton, 1981; Fenwick and McMenamin, 1984), althoug h Schek 
and Bache nheimer (1985) suggested that this could simply 
be explained by the exten sive degradation of cellular mRNA.
At least two factors appear to be involv ed in the 
inh ibi tion of host polype ptide synthesis - a virion 
c o m p o n e n t (s ), and a protein(s) synthesised later in infection 
(Honess and Roizman, 1975; Fenwick and Walker, 1978; Fenwick 
and Clark, 1982; Read and Frenkel, 1983). The virion- 
ass oci ated component is non-essential in tissue culture 
(Fenwick and Clark, 1982; Read and Frenkel, 1983), while 
the delayed com ponent can function in the abse nce of a 
fu nctional virion component (Fenwick and Clark, 1982;
Read and Frenkel, 1983), and is required for the full 
inhibi tor y effect on host protein synthesis.
The di sa ggregat io n of host polyribosomes, decrease 
in RNA synthesis and degr ad ation  of cellular mRNA all 
appear to involve a component of the virion (Fenwick and 
Walker, 1978; Nishio ka and Silverstein, 1978; Schek and 
Bachenheimer, 1985), although in some cell types protein 
synthesis is required for the degra dation of cellular mRNA 
(Nishioka and Silverstein, 1978). Whether one or more 
virion components are involved, and whether it/they are 
the same as those involved in inhibition of host pol ypeptide 
synthesis, is unclear.
Fenwick and Walker (1979) and Kennedy et a l . (1981)
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reported the phosph or ylati on of cellul ar protei ns as sociated 
with the small ribosomal subunit during infection. This 
p ho s p h o r y l a t i o n  was dependent on vi r u s - s p e c i f i e d  protein 
syn thesis (Fenwick and Walker, 1979), and therefore may 
not play a major role in alter ing ribosomal  function, at 
least early in infection.
It was observed that HSV-2 shut off host protein 
s yn thesis more rapidly and e f f i cient ly  than HSV-1 (Powell 
and Courtney, 1975; Pereira et a l . , 1977). Al thoug h this 
g e n e r a l i s a t i o n  does not hold true for all strains of HSV-1 
and HSV-2, and in particular strain HG52 (Marsden et a l . ,
1978), the HSV-2 strain used in these studies, the 
diff erent ia l shut-off has been used to map this virion 
func tio n to between 0.52 and 0.59 map units on the viral 
genome (Morse et a l ., 1978). A similar locatio n was found
using strain 17syn+ x strain HG52 int erty pi c rec ombi nants  
(Howard S Marsden, unpublished ob servations). The inhi bition 
of host cell DNA synthesis also appears to involve a virion 
c om ponent (Fenwick and Walker, 1978) and to be greater 
follo win g HSV-2 infection than follow in g HSV-1 infection 
(Fenwick et a l . , 1979). The latter authors have similarly 
mapped this function to between 0.52 and 0.59 map units 
on the viral genome. However, the nature of the product, 
or products, involved in these funct ions is, as yet, unknown.
A number of morp hol ogica l cha nges occur within cells 
foll owi ng viral infection, inc lu di ng redupl ic ation and 
th ickening  of nuclear mem br an es and the appe arance of 
fil am en tous or tubular structu res within nuclei (Nii et a 1. , 
1968; Schwartz and Roizman, 1969; At kinson et a l . , 1978).
In addition, margination of host cell chromatin and
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dis aggre ga ti on of nucleoli occur early in infe ction  (Nii 
et a l . , 1968; Schwartz and Roizman, 1969; Cabral and 
Schaffer, 1976), coinciding with the i n h i b i t i o n  of host 
cell DNA synthesis and ribosomal RNA s y n t hesis and processing 
(Wagner and Roizman, 1969).
SECTION IV : HERPES SIMPLEX VIRUS T R A N S C R I P T I O N
I V .1 General features of HSV transc riptio n
The tra nscrip ti on and processing of H S V - s p e c i f i c  RNAs 
is very similar to that of cellular RNA. The viral transcripts 
are synthe sised in the nucleus (Wagner and Roizman, 1969), 
a process which appears to involve the host cell RNA 
polyme ras e H  at all stages of virus in f e c t i o n  (Alwine et a 1 . , 
1974; Ben-ze ev and Becker, 1977; C o s ta nzo et a l . , 1977).
They are capped at their 5 ’ ends and int e r n a l l y  methylated 
in a similar manner to host cell mRNA (Bartk oski and 
Roizman, 1976; Moss et a l . , 1977), and most transcripts 
are polya den ylate d at their 3 ’ ends ( Ba ch enheime r and 
Roizman, 1972; Silverstein et a l . , 1973, 1976).
Thus, it is hardly surprising that viral genes have 
been found to possess 5 f and 3 ’ r e g u la tory sequences 
similar to those of cellular genes (McKnight, 1980; Frink 
e t a 1 . , 1981; Everett, 1983; Preston et a l . , 1984; Rixon 
et a l . , 1984; Rixon and McGeoch, 1985; Bzik and Preston,
1986), including 5' promoter elements such as the ' T A T A ’ 
box and 'CAAT' box sequences (Gannon et a l . , 1979; Wasylyk 
et a l . , 1980; Benoist et a l ., 1980; E f s t r a t i a d i s  et a l . ,
1980), and the 3' sequence AATAAA important for cleavage 
and po ly ad enylation  of pre-mRNAs (Proudfoot and Brownlee,
1974, 1976; Fit zge rald and Shenk, 1981; Zar ko we r et al .
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1986). In addition, a consensus sequence 'YGTGTTYY' has 
been found which occurs about 10 base pairs (bp) d o w n ­
stream from the polyade nyl ation  site in a numbe r of 
eukaryotic genes (Taya et a 1 . , 1982; M c L a u c h l a n  and Clements,
1983; M c L a uc hlan et a l . , 1985), and this seq uen ce has been 
shown to be required for the efficient f o r m ation of mRNA 
3' termini (McLauchlan et a l . , 1985).
However, in contrast to the si tuati on for cellular 
genes, splicing is a relatively rare event in HSV t r a n s ­
cription (Wagner, 1985), and only a few spliced transc ripts 
known to code for viral polypeptides have been described 
(Watson et a l . , 1981; Rixon and Clements, 1982; Frink et al . , 
1983; Costa et a l ., 1985; Perry et a l ♦ , 1986).
I V .2 Temporal regulat ion of HSV gene expressi on
The synthesis of viral proteins is tempora ll y regulated 
and can be broadly divided into three main phases : 
immediate- ea rly (IE), early and late. This closely parallels 
the temporal regulation of viral RNA tr a n s c r i p t i o n  (reviewed 
in Wagner, 1985). Immedia te-early (ore*) polypeptides, as 
the name suggests, are synthesised i mm ediate ly  following 
viral infection and their synthesis is not dep endent on 
the de novo synthesis of other viral p ol yp eptides  (Honess 
and Roizman, 1974). Thus, infection under con ditio ns  which 
inhibit protein synthesis allows the specific a c c u m ulatio n 
of IE mRNAs. These mRNAs are transcribed from only a 
limited portion of the virus genome (Clements et a l . , 1977; 
Jones et a l . , 1977). The locations and o r i e n ta ti ons of 
the major IE tra nscripts are shown later (see section VUE). 
There are five IE polypeptides : Vmwl75 (or ICP4), VmwllO
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(ICPO), Vmw68 (I C P 2 2 ), Vmw63 (ICP27) and Vmwl2 (ICP47); 
these cor res pond to IE genes 3, 1, 4, 2 and 5, resp ect ively 
(Preston et a l . , 1978; Clements et a l . , 1979; Watson et al . , 
1979; Ma rsd en et a 1. , 1982). With the exception of Vmwl2, 
these are all p h o s p h o p r o t e i n s , found predom inantl y within 
the nucleus of infected cells, and are capable of binding 
to calf thymus DNA, at least within crude whole cell 
ex tra cts (Pereira et a l ., 1977; Preston, 1979a; Hay and 
Hay, 1980; Marsden et a l . , 1982).
The precise function of the IE gene products is not 
clear. At least one of these (Vmwl75) plays an essential role 
in HSV tr an scrip tion (Preston, 1979a; Dixon and Schaffer, 1980; 
W a t s o n  and Clements, 1980), while another (VmwllO) plays a 
very significant, if perhaps not a b s o lu te ly essential, role in 
virus re plicat ion (Stow and Stow, 1986; Sacks and Schaffer, 
1987). A virus mutant with a deletion in the gene for Vmw68 is 
impair ed for growth in some cell types, but not others (Sears 
et a l . , 1985), suggesting that a cellul ar pol ypeptide may
co mp le ment this function. Sacks et al . (1985) described a
c o n d i ti onal lethal virus mutant co nt aining a tempe rat ure- 
sens it iv e (t_s) lesion within Vmw63, sugg est ing that this p o l y ­
peptide is essential for virus rep lication. A virus mutant which 
fails to synthesise detectable levels of Vmw63 under IE c o n ­
ditions was recently described (MacLean and Brown, 1987), but 
the ex pr ess ion of this po lypep tide under early or late c o n ­
ditions remains to be investigated. Finally, virus mutants 
which lack the gene for Vmwl2 appear to grow normally in 
a number of cell types (Ma vr om ara-Na zo s et a l . , 1986a; U m e n e , 
1986; Brown and Harland, 1987), suggesting that this p o l y ­
peptide is not essential for virus growth, at least
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in tissue culture.
In contras t to the IE gene products, the syn thesis 
of early (or p ) p ol yp eptides  is a b s o l u t e l y  de penden t upon 
the prior syn th esis of IE p ol yp eptide s (Honess and Roizman, 
1974). Early po ly p e p t i d e s  are s y n t hesis ed  prior to, and 
often play a role in, viral DNA r e p l i cation . These include 
enzy mes  such as thym idine  kinas e and r i b o n u c l e o t i d e  reductase, 
and protein s more directly involved in replica ti on, such 
as DNA pol yme ra se and the major D N A - b i n d i n g  protein (see 
section V).
The late (or # ) pol yp eptide s re qu ir e not only both 
IE and early p o l y p eptide  synt hesis  but also viral DNA 
r e p l i c a t i o n  for their effi cie nt e x p r e s s i o n  (Honess and 
Watson, 1977; Jones and Roizman, 1979; H o l l a n d  et a l . ,
1980). This class include a number of s t r u c t u r a l  proteins, 
such as the major capsid protein (Vmwl55, VP5), g l y c o ­
pro tei n C (gC) and the U^ll gene product, Vmw21 (Honess 
and Roizman, 1973; Ma rsden et a l . , 1976; Cost a et a l . ,
1981; Frink et a l . , 1983).
This cla ssific at ion, however, is not absolute, and 
several p o l y p e p t i d e s  display kinetics of s y n thesi s which 
are in te r m e d i a t e  between these phases. For example, the 
large subunit of r i bo nu cleotid e red u c t a s e  (rr^), alt ho ugh  
clas si fi ed as an early gene, often a p p ea rs under IE 
conditions; anot her early protein, g l y c o p r o t e i n  D, alt ho ug h 
s yn th esised  in significan t levels in the a b sen ce  of DNA 
replica tio n, req uires DNA r e p l i cation for optimal exp re ss ion  
(Gibson and Spear, 1983; Johnson et a l . , 1986), and hence 
gD is some ti mes termed an early-late, or ptf gene; in 
addition, late genes appear to be d i v i s i b l e  into two groups, 
l ea ky -late (^j) and tru e-late ( ^ ) »  w hich differ in their
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degree of d e p e nde nc e on DNA re pl i c a t i o n  for e x p r e s s i o n  
(Powell et a l . , 1975; Holl and et a l . , 1980; Wagner, 1985).
I V .3 Contro l of HSV t r a n s c r i p t i o n
The r e g u la tion of HSV t r a n s c r i p t i o n  is a co mp lex  
pr ocess and, at best, is poorly unde rstood . However , some 
of the factors invo lved have been eluci da ted, ma in l y  through 
stu dies in volving _ts mu tants and, more recen tly, through 
the use of short term tr an s f e c t i o n  assays, or b i o c h e m i c a l l y -  
t ra ns formed  cell lines, to examin e the a b i l i t y  of cloned 
viral gene products to tr a n s a e t i v a t e  p l a s m i d - b o r n e  promoters. 
In general, t r a n s f e c t i o n  exp eriment s i n v o l v i n g  wil d - t y p e 
and ts_ viral gene pr odu cts as t r a n s a c t i v a t o r s  have produced 
res ult s very co m p a t i b l e  with their p h e n o t y p e s  in situ 
(DeLuca and Schaffer, 1985), although  some a p p a r e n t  d i s c r e p ­
anci es have arise n (see below). These va rious  studies 
have suggested that there are a number of both positive 
and negati ve re gu l a t o r y  factors i n f l u e n c i n g  the different 
temporal phases of HSV transcriptio n. A su m m a r y  is shown 
in Figure 2.
Althoug h IE tr a n s c r i p t i o n  appears to i n v o l v e  the 
cellu lar  RNA po ly mer ase H  ( C o s t a n z o et a l . , 1977) and does 
not require prior sy nth esis of viral p o l y p eptid es , it is 
sig nific an tl y enh anc ed by a compo nent of the virus particle 
(Post et a l . , 1981; Batt er so n and Roizman, 1983). The trans- 
a ct iv ating virion component  has been i d e n t i f i e d  as the 
major tegument protein, Vmw65 (Campbell et a l . , 1984). In 
addition, Read and Frenkel (1983), on the basis of studies 
in volving ts_ mutants, suggested that facto r(s) present in 
their virus stocks had a negative i n f lu ence on IE gene 
expression, reduci ng the stability of IE mRNA. However,
FIGURE 2
Re gu la tion of HSV transcription. A summary of the viral 
pol ypept id es  believed to influence viral gene expression. 
These are discussed fully in the text. Factors shown above
the horizon, and indicated by a solid line (----), have a
positive influence in the direction shown, while those 
shown below the horizon, and indicated by the dashed line
(---- ) , have a negative influence. The role of Vmwl2 in
early gene express ion remains to be established.
MDB : major DN A-b inding protein
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these authors did not attempt to establish whether this 
factor was also a virion component.
The IE gene products themselves regulate transcription. 
Both transfection assays and studies involving t_s mutants 
suggest that Vmwl75 has a strong suppressive effect on IE 
gene transcription (Dixon and Schaffer, 1980; Watson and 
Clements, 1980; DeLuca et a l . , 1985; O'Hare and Hayward,
1985a; Gelman and Silverstein, 1986), although at very 
low levels it may serve to activate IE promoters (DeLuca 
and Schaffer, 1985; O ’Hare and Hayward, 1985a; Gelman and 
Silverstein, 1986). In contrast, VmwllO appears to stimulate 
IE transcription, at least in transfection assays ( O ’Hare 
and Hayward, 1985a; Gelman and Silverstein, 1986). Despite 
this difference in behaviour with respect to IE transcription, 
Vmwl75 and VmwllO can both independently stimulate early 
gene transcription, while in combination they appear to 
act synergistically on early promoters (Everett, 1984a, 1986; 
Gelman and Silverstein, 1985, 1986; O'Hare and Hayward, 1985b; 
Quinlan and Knipe, 1985). One report suggests that the 
presence of Vmwl2 may augment this synergistic effect (O'Hare 
and Hayward, 1985b). However, this remains to be confirmed.
The ability of VmwllO to transactivate early gene 
promoters in transient expression assays contrasts with 
the observation that most t_s mutants in Vmwl75 fail to 
induce early gene expression (Watson and Clements, 1978,
1980; Dixon and Schaffer, 1980). Although it is possible 
that early gene expression is inhibited by the altered 
polypeptide (DeLuca and Schaffer, 1985; Gelman and 
Silverstein, 1986), two deletion mutants in Vmwl75 also 
fail to induce early polypeptides, and their deleted gene 
products have neither positive nor negative regulatory
-16-
activity in transfection assays, either alone or in combination 
with other IE polypeptides (DeLuca et a l . , 1985). Thus, it 
would appear that during normal infection VmwllO cannot 
functionally substitute for Vmwl75.
Recently, virus mutants with deletions in both copies 
of the gene for VmwllO have been isolated (Stow and Stow,
1986; Sacks and Schaffer, 1987). Although the deleted genes 
were inactive in transfection assays (Perry et a l ., 1986;
Sacks and Schaffer, 1987) the viruses were capable of 
replication in tissue culture, in a number of different 
cell lines, producing yields 10-100 fold reduced compared 
to wild-type virus (Stow and Stow, 1986; Sacks and Schaffer,
1987). The effects of deletion were most apparent at low 
multiplicities of infection (Stow and Stow, 1986), and the 
plating efficiency of the mutants was increased 15-50-fold 
when titrated on cell lines biochemically transformed 
with the functional gene for VmwllO (Sacks and Schaffer,
1987) - i.e. a major defect of these viruses would appear 
to be at the level of initiation of plaque formation. Thus, 
although there would appear to be no absolute requirement 
for VmwllO, at least in tissue culture, this polypeptide 
would appear to be essential for normal virus growth, 
particularly at low multiplicities of infection.
Although Vmwl75 is clearly essential for early gene 
expression, it may not necessarily be sufficient. Additional 
factors appear to be required for efficient expression from 
at least some early promoters. Persson et a l . (1985) found
that of seven early genes examined only two were almost 
fully expressed in response to Vmwl75 alone, whereas the 
others varied in expression from intermediate to very low 
levels. Therefore, normal viral replication in vivo probably
-17-
requires a balanced interaction between a number of IE, 
and possibly other, viral gene products.
Studies involving _t_s and deletion mutants have suggested 
that both Vmwl75 (Preston, 1979a; Watson and Clements, 1980; 
DeLuca et a l . , 1984, 1985) and Vmw63 (Sacks et a l . , 1985) 
are involved in the activation of late gene expression.
This is supported by the recent finding, in transfection 
assays, that a combination of Vmwl75, VmwllO and Vmw63 was 
required for significant activation of a late promoter 
(E v e r e t t , 1986 ) .
Factors other than IE gene products may also be 
involved in the regulation of HSV gene expression : DNA 
replication is required for the efficient expression of 
late genes; Godowski and Knipe (1985, 1986) have shown, 
using t_s mutants, that the major DNA-binding protein, an 
early protein, may have a negative regulatory role in IE, 
early and late gene expression - an effect independent of 
its role in DNA replication; and an unknown late gene 
function also appears to be involved in the negative regulation 
of IE gene transcription (DeLuca et a l . , 1984).
I V .4 cis-acting sequences required for the regulation of 
HSV transcription
The mechanism by which these various factors regulate 
HSV gene expression is unknown. It is well established 
that control is primarily, although not exclusively, at 
the level of transcription (Preston, 1979b; Everett, 1984a; 
Johnson and Spear, 1984; O'Hare and Hayward, 1985a, 1985b;
Coen et a l . , 1986; Gelman and Silverstein, 1986). Therefore, 
one possible mechanism for control would be specific
-18-
interactions between the transcription factors and specific 
DNA sequences present in the promoter or 5' upstream 
regulatory regions which are characteristic of and possibly 
unique to each temporal class of gene. The features believed 
to be important for IE, early and late promoter activity, 
respectively, can be seen in Figure 3.
A consensus sequence 'TAATGARATTC' is found in the 
far upstream region of all IE genes, but no early or late 
genes (Mackem and Roizman, 1982; Whitton et a l ., 1983;
Whitton and Clements, 1984a) - i.e. this sequence is 
characteristic of, and apparently unique to, IE genes. The 
'TAATGARATTC' element has been shown to mediate responsiveness 
to the virion transactivating factor, Vmw65 (Preston et al . , 
1984; Gaffney et a l ., 1985) although full responsiveness 
required the presence of a GA-rich element itself poorly 
active alone (Bzik and Preston, 1986). Could Vmw65 therefore 
interact directly with the 'TAATGARATTC' sequence? Probably 
not, since Vmw65 neither binds to calf thymus DNA nor to 
DNA containing a 'TAATGARATTC' element (Muller, 1987;
Marsden et a l ., 1987; C M Preston, M C Frame and M E M 
Campbell, submitted for publication). Kristie and Roizman 
(1987) have shown that cellular polypeptides interact with 
DNA containing the 'TAATGARATTC' element, while, more 
recently, Preston and coworkers, using both a gel retardation 
assay in conjunction with specific antibodies or with 
immuno-affinity purified Vmw65, and DNase I protection/ 
methylation inhibition experiments, have demonstrated an 
interaction between Vmw65 and the 'TAATGARATTC' element 
via a cellular p ol ypepti de (s ) (Preston et a l . , submitted 
for publication). Since the complexes containing Vmw65 
bound the 'TAATGARATTC' elements with a much higher affinity
FIGURE 3
- c i s -acting signals required for the regulat ion of HSV 
transcription. Taken from Johnson and Everett (1986a). 
Promoter element requirements  appear to decrease, the 
later the temporal expression of a gene. Thus, late 
promoters consist of only a 'T A T A - b o x ’-capsite region 
(CAP), although they require an active origin of DNA 
replication (ORI) in cis for efficient expression; early 
genes also require a distal promoter element, containing  
at least one of either a ’C A A T - b o x ’ , GC-rich motifs, or 
GA-rich motifs; while immediate-early genes require, in 
addition, a far ups tr eam element, including the consensus 
sequence, TAATGARATTC, as well as flanking modu la tory  
sequences, for response to the virion transactivator, 
Vmw65. This diagram is not drawn to scale.
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than cellular polypeptides alone, these authors concluded 
that Vmw65 must interact with DNA by modifying a cellular 
f a c t o r (s ).
Cellular transcription factors, not surprisingly, 
do appear to play a role in HSV transcription. For example, 
the transcription factor Spl appears to bind to GC-rich 
sequences within the distal promoter region of IE genes 
and stimulates transcription from these genes in vitro 
(Jones and Tjian, 1985). In addition, the sequences required 
both for cis- and trans-activation of an early HSV gene 
(the gene for thymidine kinase) encompass binding sites 
for Spl, CAAT-binding protein and TATA-box-binding protein 
(McKnight and Kingsbury, 1982; Coen et a l . , 1986). Since 
no additional sequences appear to be specifically required 
for transactivation of early genes (Everett, 1983, 1984b;
Smiley et a l . , 1983; Coen et a l ., 1986) it has been 
suggested that IE genes may also act indirectly, by altering 
the specificities of cellular transcription factors. As 
mentioned earlier, IE polypeptides, with the exception of 
Vmwl2, can bind to calf thymus DNA (Hay and Hay, 1980). 
However, whether they interact directly or indirectly with 
DNA remains to be established. Indeed, one report suggests 
that purified Vmwl75 fails to bind to DNA in the absence 
of cellular polypeptides (Freeman and Powell, 1982). Using 
a gel retardation assay, Kristie and Roizman (1986a) recently 
demonstrated the presence of Vmwl75 in complexes formed 
between infected cell polypeptides and the promoter- 
regulatory domains of three IE genes, a true late gene 
and , to a lesser extent, the early thymidine kinase gene.
A number of binding sites appeared to be present in some 
of these promoter elements. Muller (1987) demonstrated an
-20-
interaction between Vmwl75 and its own transcription start 
site, and suggested that this could be involved in the 
repression of IE gene transcription. In addition, Beard 
et a l . (1986) showed that Vmwl75 interacted with DNA 
sequences adjacent to the gD gene promoter, appearing to 
interact with at least three separate domains within this 
region. More interestingly, purified Vmwl75 appeared to 
stimulate in vitro transcription from this promoter, acting 
at the level of initiation of transcription. Subsequently, 
these authors also demonstrated that partial ly-purified 
Vmwl75 could stimulate in vitro transcription from late 
genes (gC and VP5), while it inhibited transcription from 
an IE gene, that for Vmw68 (Pizer et a l . , 1986). Again,
whether these are direct or indirect effects remains to 
be determined.
Therefore, at present the general consensus of opinion 
appears to favour an indirect role for IE polypeptides, 
in altering the specificity of cellular transcription 
factors. However, the IE polypeptide Vmwl2 differs from 
the others in that it is n o n - p h o s p h o r y l a t e d , does not 
appear to bind to DNA, and is located predominantly in the 
cytoplasm of infected cells (Preston, 1979a; Marsden et al . , 
1982; Palfreyman et a l ., 1984). Thus, if Vmwl2 does play 
a role in augmenting the effects of Vmwl75 and VmwllO on 
early gene transcription, then it is more likely to do so 
at a post-transcriptional level, for example, by influencing 
mRNA stability or translational efficiency.
Efficient transcription from a true late promoter 
requires even fewer regulatory sequences. Only the 1 T A T A f- 
box /capsite region appears to be required (Homa et a l . , 
1986; Johnson and Everett, 1986a). Studying the Ugll gene
-21-
promoter, Johnson and Everett (1986a) have shown that an 
active origin of replication is required in cis for efficient 
expression from this true late promoter, and that the DNA 
sequences required for the fully efficient, regulated 
expression of Ugll lie within 31 bp of the RNA capsites.
In addition, by deleting the distal promoter region from 
the gD promoter this classical early gene was converted 
to a late gene phenotype. In agreement with these findings 
Homa et a 1. (1986) have shown a similar sequence requirement
for the gC gene promoter, another true late gene.
The requirement for DNA replication for the efficient 
expression of late genes may reflect more than an increase 
in copy number compensating for a weak promoter. Johnson 
and Everett (1986b) have shown that in the early stages 
following replication the increase in expression from the 
Ugll gene promoter was greater than the increase in plasmid 
copy number, whereas in later stages these increased more 
or less in parallel. Thus, replication per se may account 
for an increase in late promoter activity. An alteration 
in the genome structure or in the factors binding to viral 
DNA during replication may influence late gene expression 
(Silver and Roizman, 1985; Tack and Beard, 1985; Johnson 
and Everett, 1986b).
The mechanisms discussed above for the activation of 
viral genes could equally well apply to the suppression 
of viral gene expression. Thus, for example, factors binding 
to the distal promoter region of early genes could serve 
to inhibit early gene expression late in infection, while 
factors binding to the ’T A A T G A R A T T C ’ element of IE genes 
could specifically inhibit expression from this class of 
genes .
-22-
In summary, a combination of viral proteins, cellular 
factors and regulatory DNA sequences control the sequential 
activation of HSV genes, but the precise interactions 
between these factors remains to be determined.
SECTION V : HSV-INDUCED ENZYME ACTIVITIES
V . 1 Nomenclature for HSV-induced polypeptides
Following infection of cells with HSV a large number 
of polypeptides are induced. These include the IE polypeptides 
which appear to function primarily in HSV transcription, 
virus-induced enzymes and DNA-binding proteins involved in 
various aspects of viral replication, structural polypeptides 
which compose the virus particles, and glycoproteins which 
play important roles in the adsorption and penetration of 
virus particles into cells, and in the induction of immune 
responses following infection in v i v o . Nomenclature used 
in the literature for these polypeptides is confusing, since 
a number of different systems co-exist. In this thesis I 
intend mainly to adopt the system of Marsden et a l . (1976),
whereby polypeptides were originally named according to 
their apparent molecular weight in SDS-polyacry lamide gels. 
Thus, for example, a polypeptide with an apparent molecular 
weight of 21,000 was designated Vmw21. However, reference 
will be made to other systems, particularly that of Honess 
and Roizman (1973) in which polypeptides have been designated 
infected cell polypeptide (ICP) numbers, according to their 
relative position on SDS-polyacrylamide gels. Where possible, 
when using the ICP system, the most probable corresponding 
polypeptide identified in the system of Marsden et a l . is 
provided. For glycoproteins, I have used the system proposed
-23-
at the eighth International Herpesvirus Workshop, held in 
Oxford 1983, which has now been universally accepted. In 
this system, glycoproteins arising from different genes 
are given a unique letter : presently seven glycoproteins 
have been identified, and are designated gB, gC, g D , g E , 
g G , gH and gl, respectively (see section V H . 2 ) .
As already mentioned, virus-specific protein synthesis 
can be divided into IE, early and late temporal stages.
Among the early polypeptides are a number of virus-induced 
enzyme activities, many of which play a direct or indirect 
role in viral DNA replication.
V .2 HSV-induced enzymes involved in nucleic acid metabolism
(a ) Thymidine kinase
Virus-induced enzymes indirectly influence viral DNA 
replication by modifying nucleic acid metabolism, most 
notably pyrimidine metabolism (see Figure 4). Herpes simplex 
virus encodes an enzyme, thymidine kinase (TK), (Dubbs and 
Kit, 1964; Munyon et a l ., 1971) which p h o s p h o r y l a t e s , in 
addition to thymidine, deoxycytidine (Jamieson and Subak- 
Sharpe, 1974; Jamieson et a l . , 1974) and thymidylate (Chen 
and Prusoff, 1978), using nucleoside triphosphate, usually 
ATP, as a phosphate donor. Thus, it possesses both deoxy- 
pyrimidine kinase and thymidylate kinase activities. However, 
exogenously added d e o x y cytid in e, unlike thymidine, fails 
to be incorporated into DNA, suggesting that reduction of 
CDP, rather than phosphorylation of dCMP, is the major route 
of dCDP, and hence dCTP, synthesis following infection 
(Jamieson and S u b a k - S h a r p e , 1976).
The HSV TK has also been associated with a nucleoside
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FIGURE 4
Vi ru s- induc ed  enzymes involved in pyr imi dine metabolism.
A simplif ied  diagram of pyrimidine m e t a b o l i s m  is provided, 
with the possible sites of action of a number of virus- 
induced enzyme activities. A thy midylate synthetase 
activi ty (<4) does not appear to be encoded by HSV, but 
is encoded by other herpesviruses, including VZV and HVS 
(see text). The virus-encoded enzyme thymidine kinase is 
asso cia ted with a number of different enzyme act ivities - 
these are indicated (*).
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phosphotransferase activity (Jamieson et al . , 1976; Falke 
et al . , 1981) which is capable of utilising AMP, and possibly
A D P , as a phosphate donor to convert thymidine to thymidylate 
(dTMP). This activity, however, also appears to require a 
component of the cellular thymidine kinase system (Jamieson 
et a l . , 1976).
(b ) D e o x y u r i d i n e - 5 t-triphosphate nucleotidohydrolase
D e o x y u r i d i n e - 5 '-triphosphate nucleotidohydrolase, or 
dUTPase, is an enzyme which catalyses the conversion of 
dUTP to dUMP and pyrophosphate. The host cell dUTPase, by 
reducing intracellular levels of dUTP, acts to minimise 
incorporation of this nucleotide into DNA. Deoxy-UMP can 
be methylated by the enzyme thymidylate synthetase to dTMP, 
providing additional substrate for thymidylate synthesis.
The HSV-induced dUTPase has been shown to be virus-encoded 
(Preston and Fisher, 1984). Although H S V , H C M V , PRV and EBV 
appear not to encode a thymidylate synthetase enzyme, two 
other herpesviruses do - herpesvirus saimiri (HVS) and VZV 
(Davison and Scott, 1986; Honess et a l . , 1986; Thompson 
et a l . , 1987). In contrast to HSV, both HVS and VZV possess 
an A+T rich genome, possibly suggesting a greater requirement 
by these viruses for thymidylate synthesis.
(c ) Uracil-DNA glycosylase
Virus infection also appears to induce a virus-specific 
uracil-DNA glycosylase (Caradonna and Cheng, 1981). Host 
cell uracil-DNA glycosylase functions to remove deaminated 
cytosine residues from DNA, thus reducing the probability 
of G:C to A:T transitions occurring during replication 
(deaminated dCMP forms stable G:U base pairs). However,
-25-
although the virus-induced enzyme differs biochemically 
from the host cell enzyme (Caradonna and Cheng, 1981) 
it has yet to be shown to be virus encoded.
The function of these viral enzymes is thought to be 
analogous to their cellular counterparts. Virus mutants 
lacking TK (Dubbs and Kit, 1964; Jamieson et a l . , 1974) 
and/or dUTPase (Fisher and Preston, 1986) are unimpaired 
for growth in growing tissue culture cells. However, T K , 
but not dUTPase, is essential for growth in serum-starved 
resting cells (Jamieson et a l . , 1974; Fisher and Preston,
1986), suggesting the importance of the former enzyme in 
cells with a low level of de novo pyrimidine synthesis. 
Thus, it is possibly not surprising that TK-negative virus 
mutants are less pathogenic and less able to undergo latent 
infections in vivo than wild-type virus (Field and Wildy, 
1978) .
(d ) Ribonucleotide reductase
Recently, interest has focussed on another viral 
enzyme involved in nucleotide metabolism. Ribonucleotide 
reductase is an enzyme which catalyses the reduction of 
all four ribonucleoside diphosphates to their corresponding 
deoxyribonucleoside diphosphates, and is essential for 
DNA replication in both prokaryotic and eukaryotic cells 
(Thelander and Reichard, 1979). A ribonucleotide reductase 
activity which differs biochemically and immunologically 
from the cellular enzyme is induced following HSV infection 
(Cohen, 1972; Ponce de Leon et a l . , 1977; Averett et al . ,
1983; Huszar et a l . , 1983). Using a t_s mutant, Dutia ( 1983)
demonstrated that the virus-induced enzyme is at least in
-26-
part virus encoded. This mutation resulted in a 100-fold 
reduction in virus growth over 24 hours at the non-permissive 
temperature, suggesting that this enzyme is essential for 
viral replication (Preston et a l . , 1984). Like its cellular 
counterpart, it appears to be composed of two subunits 
(Cohen et a l ., 1985; Frame et a l ., 1985; Bacchetti et a 1 . , 
1986), a large subunit (rr^) and a small subunit ( r ^ ) ,  
whose interaction is believed to be essential for enzyme 
activity (Frame et a l ., 1985). Synthetic oligopeptides 
corresponding to the carboxy-terminus of Vmw38 ( r ^ )  
specifically inhibit the viral enzyme, and are thought to 
do so by inhibiting this interaction (Cohen et a l . , 1986; 
Dutia et a l . , 1986). This finding has initiated an exciting
new approach to anti-viral therapy - the use of synthetic 
oligopeptides, or their analogues, to inhibit specific 
protein-protein interactions essential for viral replication. 
Furthermore, since antisera raised against the carboxy- 
terminal peptide from the HSV-1 Vmw38 recognised analogous 
polypeptides from HSV-2, VZV, PRV and equine herpesvirus 
type 1 (Dutia et a l ., 1986), it may be possible to derive 
an anti-viral agent effective against a number of members 
of the herpesvirus family.
V .3 HSV-induced enzymes involved or potentially involved in 
virus DNA replication
(a ) DNA polymerase
The enzymes described above all indirectly influence 
viral DNA replication. Other virus-induced enzymes may have 
a more direct effect. The H S V - 1-induced DNA polymerase 
activity is associated with a polypeptide of apparent
-27-
molecular weight (mol. w t .) 150K (Powell and Purifoy, 1977). 
This enzyme differs both biochemically and immunologically 
from the host cell DNA polymerase (Keir et al. , 1966a, 1966b), 
contains both a DNA polymerase and a 3 f — 5 ’ exonuclease 
activity (Weissbach et a l ., 1973; Knopf, 1979) and has been 
shown to be virus-encoded and essential for viral replication 
(Purifoy et a l . , 1977). Although apparently active as a 
monomer in vitro (Knopf, 1979; Ostrander and Cheng, 1980) 
the viral polymerase may form a functional complex in vivo 
with other viral proteins, including the major DNA-binding 
protein and the alkaline exonuclease (Purifoy and Powell,
1981; Littler et a l . , 1983; Chiou et a l . , 1985) and a 
protein known as ICSP34/35 (Vaughan et a l . , 1985) or 65K^gp 
(H S Marsden, M Murphy, R G Hope, D J M Purifoy, P J Vaughan 
and K L Powell, manuscript in preparation). This putative 
complex will be discussed in more detail later (section
VI.4)
(b ) Alkaline exonuclease
An alkaline exonuclease activity, with properties 
distinct from those of cellular nucleases, is induced 
following HSV infection (Keir and Gold, 1963; Morrison and 
Keir, 1968; Hay et a l ., 1971; Hoffmann and Cheng, 1978).
This enzyme has been shown to possess an endonuclease 
activity in addition to its 5 ’ and 3 ’ exonuclease activities 
(Hoffmann and Cheng, 1979; Hoffmann, 1981). Marker rescue 
of t_s lesions (Moss et a l . , 1979) and in vitro translation
experiments (Preston and C o r d i n g l e y , 1982) suggest that
it is v i ru s— e n c o d e d , corresponding to the vir us— specific 
polypeptide Vmw85 (Marsden et a l . , 1978). It appears to
be essential for viral replication (Moss, 1986), but its
-28-
function in vivo is poorly understood. Its possible 
association with the DNA polymerase (Francke and Garrett,
1982) may suggest a direct role in viral DNA replication. 
Alternatively, it may be involved in the degradation of 
host cell DNA thought to occur during viral infection 
(Wildy et a l . , 1961; Hoffmann and Cheng, 1978).
(c ) Topoisomerase
An HSV-induced topoisomerase activity has also been 
reported (Biswal et a l ., 1983; Leary and Francke, 1984;
Muller et a l . , 1985). Topoisomerases are enzymes which 
interconvert topological isomers of DNA by transient breakage 
and rejoining of DNA strands. They produce either transient 
single-strand breaks (type I topoisomerases) or d o uble­
strand breaks (type H  to p o i s o m e r a s e s ). Thus, for closed 
circular DNA, a type I topoisomerase will change the linkage 
number of a given topoisomer in steps of one, whereas a 
type H  topoisomerase will do so in steps of two. T o p o ­
isomerases, or proteins with top ois omerase-l ike activity, 
have been implicated in DNA replication, transcription 
and recombination. (Reviewed in Gellert, 1981).
Biswal and coworkers (1983) described an HSV-1 induced 
topoisomerase activity which copurified with the viral DNA 
polymerase through several chromatographic steps, while 
Muller et a l . (1985) suggested that a type I topoisomerase
activity was a component of the virion envelope or tegument 
structure. Whether these activities belong to the same 
protein, and whether they are virus-encoded, remains to 
be determined, as does their role in virus replication.
-29-
V .4 Other HSV-induced enzyme activities
Protein kinase
In addition to these enzymes, virus-induced protein 
kinase activities have also been described. It has been 
predicted, from DNA sequence analysis, that HSV-1 gene 
Ug3 encodes a protein kinase (McGeoch and Davison, 1986). 
Following infection at least one, and possibly several, 
protein kinase activities are induced (Blue and Stobbs,
1981) and one of these has been shown to differ biochemically 
from known cellular enzymes (Purves et al . , 1986). This
latter enzyme has been extensively purified and shown to 
react with an anti-peptide antiserum directed against the 
carboxy-t erm inus of the predicted product of gene Ug3, 
suggesting that gene Ug3 indeed encodes a functional protein 
kinase activity (M C Frame, F C Purves, H S Marsden,
D J McGeoch and D P Leader, submitted for publication).
A virion-associated protein kinase activity has also been 
described (Rubenstein et a l ., 1972; Lemaster and Roizman,
1980) although it now appears possible that this represents 
the cellular enzyme, casein kinase H  (Stevely et a l . , 1985).
SECTION VI : HSV-INDUCED DNA-BINDING PROTEINS
V I .1 DNA-binding proteins in HSV-infected cell extracts
Infection with HSV induces at least seventeen pol y­
peptides with the ability to bind to DNA (Bayliss et a l . , 
1975; Purifoy and Powell, 1976). Among these are the IE 
polypeptides and the DNA polymerase and alkaline exonuclease 
activities described earlier (Bayliss et a l . , 1975; Purifoy
and Powell, 1976; Hay and Hay, 1980), some polypeptides
-30-
which comigrate with virion components, and a predominant 
polypeptide of apparent mol. w t . 21,000 (Bayliss et a l . ,
1975; Powell and Purifoy, 1976). These early studies 
identified HSV-induced DNA-binding proteins by DNA cellulose 
chromatography, employing calf thymus or salmon sperm DNA. 
This approach identifies non-specific DNA-binding proteins, 
and does not distinguish between the ability of a protein 
to interact directly with the DNA itself, or to bind DNA 
indirectly via protein-protein interactions.
Figure 5 shows an example of HSV-induced polypeptides 
eluted by high salt from a native DNA cellulose column.
Some polypeptides are obviously present in high abundance, 
for example, those labelled MDB, 87, 65 and 21. The protein 
designated MDB, also known as the major DNA-binding protein 
(see below, section V I. 2), has been purified to homogeneity 
and shown to bind directly to DNA (Powell et a l . , 1981),
as has the polypeptide designated 65 (Vaughan et a l ., 1985;
see below, section V I. 3). The 87K polypeptide probably 
represents the alkaline exonuclease. Purification procedures 
used to obtain apparently pure preparations of both the 
alkaline exonuclease and the DNA polymerase involved as 
the final step DNA cellulose chromatography (Powell and 
Purifoy, 1977; Banks et a l . , 1983), suggesting that these
two enzymes probably interact directly with the DNA.
Although the polypeptide designated 21 (Vmw21) is obviously 
one of the more abundant DNA-binding proteins in this 
example, it is often seen at even higher levels, similar 
in intensity to the MDB and 65K polypeptide (compare, for 
example, Bayliss et a l . (1975), Figure 6). Vmw21 has yet 
to be shown to bind directly to DNA.
FIGURE 5
Herpes simplex virus-induc ed DNA-binding proteins. DNA 
cel lulose c h ro ma to graph y was carried out as described in 
method section V.3. HSV-l-infected cell extracts, harvested 
by the high salt extraction procedure (method section I.7b) 
were applied to a dou ble-stranded calf thymus DNA cellulose 
column in B2 buffer, and the flow-through material collected. 
Following extensive washing of the column, bound proteins 
were eluted using 2M N a C l .
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V I . 2 The major DNA-bi nding protein
Until recently the only HSV-induced DNA-binding protein 
studied in any detail was the so-called major DNA-binding 
protein (MDB, Vmwl30, ICP8). The major DNA-bin ding protein 
has been implicated not only in the regulation of viral 
gene expression (see section IV.3) but also in viral DNA 
replication. The purified protein has been shown to bind 
prefere nti ally to single-stranded DNA (Ruyechan and Weir, 
1984; Lee and Knipe, 1985), to bind co-operatively to 
si ngle-stranded DNA, holding it in an extended configuration 
(Ruyechan, 1983; Lee and Knipe, 1985), to denature poly- 
deoxyadenylic acid-polydeoxythymidyli c acid duplexes at 
40°C (Powell et a l ., 1981), and to stimulate the activity 
of the HSV DNA polymerase in vitro (Ruyechan and Weir,
1984). These are properties shared by helix destabilising 
proteins, some of which, such as the bacteriophage T4 gene 
32 product, and the bacteriophage T7 helix destabilising 
protein, have also been implicated in DNA replication 
(Champoux, 1978). In addition, antibody specific for the 
major DNA-binding protein will inhibit DNA replication in 
isolated infected cell chromatin (Powell et a l . , 1981), 
and t_s mutants whose lesions map within or near this gene 
fail to synthesiseHSV DNA at the non-permissive temperature 
(Conley et a l . , 1981; Littler et a l . , 1983; Weller et a l . ,
1983).
Although the major DNA-binding protein exhibits no 
preference for HSV DNA in vitro (Powell et a l . , 1981; Lee 
and Knipe, 1985), it is thought to do so in vivo (Knipe 
and Spang, 1982; Lee and Knipe, 1983; Leinbach and Casto, 
1983; Quinlan et a l . , 1984). Localisation studies have
demonstrated that the protein rapidly migrates to the
-32-
nucleus, where its precise location depends on the presence 
or absence of viral DNA replication. In the presence of 
viral DNA synthesis it localised to large globular areas 
within the nucleus (Quinlan et a l . , 1984) a pattern
resembling that seen for pulse-labelled viral DNA (Rixon 
et a l . , 1983). A DNase-sensitive nuclear association was 
described under these conditions for this protein (Knipe 
and Spang, 1982). In contrast, in the absence of viral DNA 
synthesis the protein localised to small discrete foci 
throughout the nucleus, corresponding to a high salt labile 
a sso ciation  with the nuclear matrix (Quinlan et a l ., 1984).
These different nuclear locations were termed ’replicative' 
and 'p r e - r e p l i c a t i v e ' sites, respectively, by these authors. 
Temp era ture shift experiments involving mutants containing 
ts lesions within the major DNA-binding protein, suggest 
that this protein can move freely between these different 
structures. Thus, inhibition of viral DNA replication by 
shifting to the non-permissive temperature resulted in 
redistrib uti on of the major DNA-binding protein to the 
pr e-r eplicative sites, whereas re-initiation of DNA synthesis 
by shifting down to the permissive temperature resulted 
in localisation of the protein to the replicative compartment 
(Quinlan et a l ., 1984). This occurred both in the presence
and absence of continued protein synthesis. The major DNA- 
binding protein is also present in deoxyribonucleoprotein 
complexes isolated from infected cell nuclei, and immuno- 
precipitation using a monoclonal antibody against this 
protein demonstrated that both intact viral DNA and cell 
DNA were present in these complexes (Leinbach and Casto,
1983) .
In conclusion, therefore, the major DNA-binding protein
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would appear to be both involved in, and essential for, 
viral DNA replication. This may, however, not be its only 
function. The PRV major DNA-binding protein has been shown 
to be important in stabilising progeny viral DNA molecules 
in infected cells, possibly by providing protection against 
nuclease attack (Ben-Porat et a l ., 1983), while Ruyechan 
and Weir (1984) demonstrated that the HSV-1 major DNA- 
binding protein could bind polyriboadenylie acid with an 
affinity intermediate between that for single-str anded and 
double-stranded DNA, suggesting that it may also bind to 
pol yA+ mRNA. This latter observation raises the possibility 
that the major DNA-binding protein could act to regulate 
gene expression at a post-transcriptional level. Although 
Godowski and Knipe (1986) demonstrated that the major DNA- 
binding protein could influence gene expression at the 
level of transcription, they did not exclude the possibility 
of an additional effect at a post-transcriptional level.
V I .3 The 65K DNA-binding protein
The polypeptide ICSP34,35 has been shown to be strongly 
associated with the DNA polymerase (Vaughan et a l . , 1984,1985). 
It is the HSV-2 counterpart of the HSV-1 polypeptide 65K DNA- 
binding protein (65K^gp)(Marsden et a l . , manuscript in pre p­
aration) and is distinct from the 65K transactivating factor 
(Marsden et a l . , 1987). It is a strong DNA-binding protein 
(Bayliss et a l . , 1975; Powell and Purifoy, 1976; Figure 5), and 
can bind to DNA in the absence of other proteins, with the 
possible exception of the HSV DNA polymerase (Vaughan et al . ,
1985). The function of this polypeptide is at present unknown, 
but it has recently been shown to be one of seven genes 
essential for the replication in vivo of plasmid molecules
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containing an HSV-1 origin of DNA replication (Challberg, 
1986; McGeoch, 1987)
V I . 4 Protein complexes involving HSV-induced DNA-bi nding  proteins 
Multiprotein complexes are believed to be involved 
in a number of DNA replication systems (Alberts et a l . ,
1983) and there is now a growing body of evidence to 
suggest that similar complexes may function in HSV DNA 
replication. There is both genetic and biochemical evidence 
for a functional complex involving at least four virus- 
specific polypeptides - the major DNA-binding protein, 
the alkaline exonuclease, the DNA polymerase and ICSP34,35 
(65Kpgp). Purification of the DNA polymerase through a 
series of chromatographic stages was often found to result 
in the purification of a major 150K polypeptide apparently 
contaminated with a lower mol. w t . protein later identified 
as ICSP34,35 (Powell and Purifoy, 1977; Knopf, 1979; 
Ostrander and Cheng, 1980; Vaughan et a l . , 1985). That 
this polypeptide was strongly associated with the DNA 
polymerase was confirmed by Vaughan et a l . (1984) who
used monoclonal antibodies against the major DNA-binding 
protein, alkaline exonuclease and ICSP34,35 for immuno- 
affinity chromatography of infected cell extracts. These 
authors demonstrated (i) that a monoclonal antibody against 
the alkaline exonuclease would purify not only the alkaline 
exonuclease but also the major DNA-binding protein, and 
to a lesser extent the DNA polymerase and ICSP34,35;
(ii) that a monoclonal antibody against the major DNA- 
binding protein purified, in addition to the major DNA- 
binding protein, the alkaline exonuclease and ICSP34,35; 
and (iii) that a monoclonal antibody against ICSP34,35
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resulted in the purification of the DNA polymerase and 
major DNA-binding protein, as well as ICSP34,35, with a 
low level also of the alkaline exonuclease. Thus, these 
authors suggested that there was a very strong association 
between the major DNA-binding protein and the alkaline 
exonuclease, and between the DNA polymerase and ICSP34,35 
while there was an association of intermediate strength 
between the major DNA-binding protein and ICSP34,35.
That this putative complex is functional in vivo is 
suggested by studies involving t_s^ mutants. A mutant of HSV-2 
containing a t_s lesion within the alkaline exonuclease 
gene was found to induce a DNA polymerase activity which 
was also temperature-sensitive in vivo (Francke and Garrett,
1982). In addition, t_s lesions within the major DNA -binding 
protein have been shown to destabilise both the alkaline 
exonuclease and DNA polymerase activities (Purifoy and 
Powell, 1981; Littler et a l ., 1983), and to induce secondary 
mutations within the DNA polymerase gene, resulting in 
altered sensitivity to the DNA polymerase inhibitors, 
phosphonoacetic acid and aphidicolin (Chiou et a l ., 1985).
These secondary mutations may be compensatory, perhaps 
restoring a functional interaction between the DNA polymerase 
and the altered major DNA-binding protein.
V I . 5 Interactions between HSV DNA and virus-induced polypeptides
The association of virus-induced polypeptides with 
HSV DNA in vivo has not been extensively studied. Herpes 
simplex virus DNA does not show a predominantly nucleo- 
somal structure and is therefore sensitive to nuclease 
attack on isolated nuclei (Leinbach and Summers, 1980). 
Pignatti et a l . ( 1979) have purified what they term
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’replication c o m p l e x e s ’ from HSV infected cells, and shown 
that these contain viral, but not cellular, DNA polymerase 
activity, and intact viral DNA. Isolated, non-deproteinised 
HSV DNA was found to be relatively resistant to 3 ’, but 
not 5 ’ , exonuclease attack, leading to the suggestion that 
protein(s) might be bound at the 3 ’ hydroxyl terminus of 
HSV DNA (Kudler and Hyman, 1979). This suggestion was 
supported by the electron microscopy observations of Wu 
et a l . (1979) who found evidence for protein association
with the direct terminal repeat regions of HSV DNA (the 
’a ’ sequence), and the corresponding internal repeat 
regions. The sensitivity of this association to alkaline 
denaturation of the DNA led these authors to suggest that 
this was not a covalent attachment. Four polypeptides 
attached non-covalently to HSV DNA were described by Hyman 
(1980) following in vitro iodination of purified viral DNA. 
These polypeptides had apparent mol. w t . of 71K, 50K, 20K 
and 16K but their identity remains unknown. It is to be 
expected that proteins involved in, for example, the 
replication or packaging of HSV DNA, would be found to be 
associated with viral DNA in v i v o , but little is known 
about the functions of the above described polypeptides.
V I . 6 Sequence-specific DNA-protein interactions in HSV
Sequence-specific interactions might be expected 
between viral DNA sequences and polypeptides directly 
involved in processes such as transcription, recombination, 
replication and packaging of viral DNA. Only recently has 
evidence been provided for such interactions. Thus, IE 
polypeptide Vmwl75 has been shown to specifically interact
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with promoter-regulatory regions of a number of HSV genes 
(Beard et a 1. , 1986; Faber and Wilcox, 1986; Kristie and 
Roizman, 1986); Vmw21 and Vmw22 have been shown to specifically 
interact with the HSV-1 'af sequence, a sequence involved 
in recombination and packaging of the virus genome (Dalziel 
and Marsden, 1984); and a virus-induced protein(s) has been 
shown to specifically interact with an HSV-1 origin of 
viral DNA replication, orig, (Elias et a l . , 1986).
(a ) Specific interactions between promoter- regulator y regions 
and Vmwl75
As already mentioned (section IV) Vmwl75 is phospho- 
rylated, located predominantly within the nucleus of infected 
cells, and binds relatively strongly to DNA (Powell and 
Purifoy, 1976; Pereira et a l . , 1977; Marsden et a l . , 1978, 1982; 
Hay and Hay, 1980; Wilcox et a l ., 1980). The use of m o n o ­
clonal antibodies and a gel retardation assay demonstrated 
the presence of Vmwl75 in specific complexes formed between 
promoter-regulatory domains of selected IE, early and 
late genes and infected cell polypeptides (Kristie and 
Roizman, 1986a). Multiple binding sites were thought to 
be present in at least some of these pro moter-regulatory 
regions. Using a similar assay, and by DNase I foot p r i n t i n g , 
Muller (1987) demonstrated an association between Vmwl75 
and its own transcription start site. Beard et a l . (1986)
demonstrated that Vmwl75 in a partially-purified form 
(claimed to represent approximately 5% of the total protein) 
would form complexes with sequences spanning the 5 ’ end 
of the gD gene, as assessed by immunoprecipitation of 
radiolabelled fragments of DNA. Again several binding sites 
were indicated, the strongest association being with a
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fragment spanning the region -263 to +11 with respect to 
the mRNA start site, with adjacent fragments being more 
weakly bound. Footprinting experiments demonstrated that 
partially purified preparations of Vmwl75 protected a 
region from -81 to -111 with respect to the gD RNA capsite 
from DNase I digestion (Faber and Wilcox, 1986). Two 
additional binding sites located at the 5 ! end of the 
tetracycline resistance gene of pBR322 were also protected 
in footprinting experiments and showed sequence homology 
with the protected gD region. Thus, a consensus sequence 
5 '-A T C G T C N N N N Y C G R C - 3 1 was suggested to be an essential 
component of the putative Vmwl75 binding site. Interestingly, 
Kristie and Roizman (1986b) identified a binding site 
within the promoter region of IE gene 1, protected from 
digestion by exonuclease I H , which showed considerable 
sequence homology with this consensus.
The relationship between this gD binding site and 
transcriptional activation by Vmwl75 is unclear. Beard 
et a l . (1986) demonstrated that partially purified Vmwl75
stimulated transcription from this gene in v i t r o , acting 
at the level of transcription initiation. Interestingly, 
they also found that purified Vmwl75 could stimulate 
in vitro transcription from the HSV gC and VP5 genes (two 
late genes) but inhibited in vitro transcription from IE 
gene 4 (Pizer et a l . , 1986), consistent with the known 
activity of Vmwl75 in vivo (see section IV). However,
Everett (1983) previously demonstrated that sequence 
elements required for fully regulated transcription from 
the gD gene reside within 83 bp of the RNA capsite, outwith 
the binding site identified by Faber and Wilcox. In addition, 
by scanning HSV sequence data the latter authors concluded
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that although sequences homologous with their consensus 
site were found upstream from IE genes 1 and 3, they could 
not find similar sequences upstream from the other IE genes 
nor from the TK gene. Kristie and Roizman (1986a, 1986b),
using gel retardation assays, demonstrated the presence 
of Vmwl75 in complexes formed between infected cell p o l y ­
peptides and the promoter-regulatory domains of IE gene 2, 
and with a fragment derived from the promoter region of 
IE gene 3 which showed no apparent homology with the consensus 
sequence. Thus binding sites other than the consensus 
sequence must be involved in the interaction between 
V m w l 75 and HSV DNA.
Although there is no evidence for a strong association 
between Vmwl75 and other polypeptides - par tially-purified 
Vmwl75 appearing to exist as a homodimer (Metzler and Wilcox,
1985) - it is unclear at present whether Vmwl75 can bind 
directly to DNA. Freeman and Powell (1982) demonstrated 
that purified Vmwl75 failed to bind to DNA in the absence 
of added cellular proteins, but did so in their presence, 
suggesting that Vmwl75 may only bind to DNA via a cellular 
p o l y p e p t i d e (s ) .
(b ) Specific interaction between the HSV-1 'a' sequence 
and Vmw21
The HSV-1 ‘a ’ sequence plays an important role in 
recombination and packaging of HSV DNA (discussed more 
fully in section X). Using a DNA competition binding assay, 
Dalziel and Marsden (1984) demonstrated that two virus- 
induced polypeptides of apparent mol. w t . 21,000 and 22,000 
could be preferentially eluted from salmon testes DNA 
cellulose columns by DNA fragments containing the HSV-1
-40-
'a’ sequence, but not by control fragments lacking this 
sequence. The 21K polypeptide was by far the more predominant. 
Whether this represented a direct or indirect interaction 
was unknown, and occasionally, but not consistently, three 
other polypeptides of 140K, 75K and 33K were also eluted.
The 21K/22K polypeptides were synthesised predominantly 
late in infection, and were tentatively identified as Vmw21 
and Vmw22 (Marsden et a l ., 1976). Vmw21 has previously 
been shown to be a major HSV DNA-binding protein (Bayliss 
et a l ., 1975). The relationship between these apparently 
’a' sequence-specific DNA-binding proteins and the protein 
complexes described by Wu et a l . (1979) at the ends and
joint region of HSV DNA, and also with the 20K polypeptide 
found by Hyman (1980) to be strongly associated with 
purified HSV DNA, remains unknown.
(c ) Specific interaction between a viral origin of DNA replication 
and a virus-induced poly peptid e(s )
The HSV genome contains three potential origins of 
DNA replication -orig, present in two copies, and (see
later, section IX). Elias et a l . (1986), using a n i tr o­
cellulose filter-binding assay, demonstrated that protein(s) 
present in nuclear extracts from infected cells could 
specifically bind fragments of DNA containing the HSV-1 
orig sequence. This protein(s) was partially purified by 
phosphocellulose chromatography and shown to elute separately 
from the DNA polymerase and major DNA-binding protein, 
while time course experiments indicated that it has similar 
induction kinetics to these two polypeptides. In DNase I 
footprinting experiments (Elias et a 1 . , 1986) the partially-
purified protein protected a region of 18 bp which over-
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lapped one of the two 45 bp inverted repeats which form
the 90 bp minimal functional origin (Stow and McMonagle,
1983). However, it has yet to be established whether this 
orig-binding protein plays a direct role in the initiation 
of viral DNA replication.
SECTION V H  : VIRION POLYPEPTIDES
V H . 1 Structural polypeptides and the HSV virion
Herpes simplex virus virions are composed of four 
main structural elements, the core, capsid, tegument and 
envelope (reviewed recently by Dargan, 1986; see Figure 6A). 
Within the nuclei of infected cells empty nucleocapsids
devoid of any core structure can be seen, in addition to
the full nucleocapsids containing DNA - the A and B capsids, 
respectively, of Gibson and Roizman (1972). Mature enveloped 
virions are seen only in the cytoplasm of infected cells.
The protein composition of the different capsid forms is 
summarised in Table 1.
The core of the HSV virion consists of DNA spooled 
around a central cylindrical mass with regular 4-5nm spacing 
(Furlong et a l ., 1972). Gibson and Roizman (1972) suggested 
that the core protein might be the virion polypeptide 
VP21, since this was the only protein absent from empty 
nucleocapsids but present in full nucleocapsids and virions. 
VP21 is probably equivalent to the virion polypeptide Vmw43. 
Interestingly, Vmw43 comigrates in SDS-polyacrylamide gels 
with a major HSV-1 DNA-binding protein (Bayliss et a l . , 
1975), The cylindrical core structure appears to be 
connected to the inner poles of the capsid, and so may 
provide a mechanical support for the orderly winding of
FIGURE 6
Herpes simplex virus virions.
Schematic diagram of HSV virions. The virions are composed 
of four main structural elements - the core, capsid, 
tegument and envelope. Within the core, viral DNA is 
spooled around a cylindrical protein mass. The virion 
envelope contains a number of glycoproteins, visible on 
electron microscopy as spikes protruding from the envelope.
Intercapsomeric  fibrils. The capsid is composed of 150 
hexameric and 12 pentameric capsomeres. Adjacent capso- 
meres appear to be connected at their vertices by a matrix 
of intercapsomeric fibrils.
Six-fold symmetry of the hexameric capsomeres. Hexameric 
capsom ere s are believed to have six-fold symmetry, 
probably consisting of six molecules of the major capsid 
protein, Vmwl55.
:\v aiztsfrT n r m r  i m m i i n i u  r
Table 1 : Protein compos iti on of n u cl eo capsids
Protein no menclature is given as in re ferences 1, 2 and 
3. The presence (+) or absence (-) of a given protein 
from empty or full nucleoc apsid s (Gibson and Roizman, 
1972) is indicated.
Refe ren ces
1. Gibson and Roizman, 1972
2. Cohen et a l .t 1980
3. Heilman et a l . , 1979
4. Spear and Roizman, 1972 ^
5. Mars den et a l . , 1976
6. Vernon et a l . , 1981
7. Steven et a l ., 1986
8. Braun et a l . , 1984b
9. Heine et a l . , 1974
10. Braun et a l . , 1984a
11. Gibson and Roizman, 1974
12. Zweig et a l ., 1979a
13. Zweig et a l ., 1980
14. Preston et a l ., 1983
15. Knopf and Kaerner, 1980
16. Frazer J Rixon, personal communi cat ion
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the viral DNA (Nazerian, 1974; Smid et a l . , 1977).
The core is enclosed within an icosahedral capsid, 
consisting of 150 hexameric and 12 pentameric capsomeres 
(Wildy et a l . , 1960). These are described as hollow, 
elongated polygonal prisms whose axial channel tapers in 
width from the outer to the inner capsid surface (Wildy 
et a l . , 1960; Steven et a l . , 1986). Adjacent capsomeres 
appear to be connected at their vertices by a matrix of 
intercapsomeric fibrils (Vernon et a l ., 1974; Palmer et al . , 
1976; see Figure 6B). The hexameric capsomeres are generally 
believed to have six-fold symmetry (Furlong, 1978; Steven 
et a l . , 1986; see Figure 6C) and it is probable that each 
capsomere is composed of six molecules of the major capsid 
protein, Vmwl55 or pl55 (Spear and Roizman, 1972; Marsden 
et a l . , 1976; Vernon et a l . , 1981; Steven et al . , 1986).
In addition, the virion protein p50 (VP19, NC2) may form 
part of the pentameric capsomeres (Vernon et a l . , 1981).
Indeed, Zweig et a l . (1979b) have shown that p50 and the 
major capsid protein, pl55, may be present in a disulphide- 
linked complex in HSV-2 nucleocapsids. Similarly, p40 
(VP22a) appeared to form disulphide-linked complexes, but 
the components of these could not be resolved. Surface 
iodination experiments (Braun et a l . , 1984a) suggested that
p40 coats the surface of full but not empty nucleocapsids, 
strengthening the previous suggestion that this protein 
might be involved in the binding of tegument proteins and 
the subsequent envelopment of the nucleocapsids (Gibson 
and Roizman, 1972). However, immune electron microscopy 
studies, using two different monoclonal antibodies, have 
localised p40 on partially-cored rather than full n u c l e o ­
capsids, and shown this polypeptide to be present on
nu cleocapsids formed at the non-permissive temperature 
following infection with D N A - p o s i t i v e , packaging-negative 
ts mutants (Frazer J Rixon, personal communication). The 
apparent absence of p40 in these studies from full n u c l e o ­
capsids would appear to be in direct contrast to the findings 
of Gibson and Roizman (1972) and Braun et a l . (1984a). One 
possibility is that the procedure used by these latter 
authors to purify nucleocapsids may have resulted in prep ­
arations containing both full and partially-cored nucleo- 
capsid structures. The true location of the p40 polypeptide 
is therefore at present unresolved. Studies involving a t_s 
mutant containing a lesion within the gene for p40 suggest 
that processing of this polypeptide may be essential for 
the encapsidation of viral DNA (Preston et a l . , 1983).
The tegument is a rather ill-defined layer which lies 
between the capsid and the envelope of the virion. Proteins 
believed to reside within the tegument include the very 
high molecular weight polypeptides VP1-3 (>200K) which are 
thought to intercalate between the capsid and the envelope 
(Gibson and Roizman, 1972) and the 65K virion transactivating 
factor (Batterson and Roizman, 1983; Campbell et a l . , 1984).
A protein kinase activity has “also been associated with 
cap sid-tegument structures (Lemaster and Roizman, 1980).
Only those nucleocapsids containing full genome-length 
fragments of DNA become enveloped. The envelope, acquired 
by budding through the inner nuclear membrane (Darlington 
and Moss, 1968) contains several viral glycoproteins, and 
these have a number of important roles in the virus 
replicative cycle.
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V]I.2 G l y c o p r o t e i n s  s p e c i f i e d  by h e r p e s  s i m p l e x  v i rus
Herpes simplex virus type 1 encodes at least seven 
glycoproteins, gB, g C , gD, gE, gG, gH and gl (Spear, 1976; 
Marsden et a l . , 1978, 1984; Baucke and Spear, 1979; Buckmaster 
et a l . , 1984; Roizman et a l . , 1984; Longnecker et a l , 1987; 
McGeoch et a l . , 1987), all of which, except gl, have been 
shown to be present in virions (Spear, 1976; Para et a l . , 1980; 
Buckmaster et a l ., 1984; Frame et a l . , 1986; Richman et a l . ,
1986). An HSV-2 counterpart has been identified so far for 
gB, g C , gD, gE and gG (reviewed in Spear, 1985; Marsden, 1987). 
Four of the glycoproteins, gC, gE, gG and gl, are not essential 
for growth in tissue culture (Hoggan and Roizman, 1959; Heine 
et a l . , 1974; Cassai et a l . , 1975/1976; Holland et a l . , 1984; 
Zezulak and Spear, 1984; Longnecker and Roizman, 1986, 1987;
Longnecker et a l . , 1987; Weber et a l . , 1987). The properties 
of the glycoproteins are summarised in Table 2.
No single glycoprotein has been identified as a virus 
receptor. Adsorption to cells appears to be mediated by at 
least two glycoproteins -gB and gD. Antibodies to gB, and to 
a lesser extent to gD and g C , inhibited the attachment to 
cells of virosomes (liposomes containing purified virion p o l y ­
peptides), while virosomes depleted in either gD or gB bound 
to cells less efficiently than non-depleted virosomes (Johnson 
et a l . , 1984). Although both antibodies against gC and high
levels of Fc fragments of IgG can inhibit HSV adsorption 
(Fuller and Spear, 1985) it seems unlikely that either gC, gE 
or gl (the latter two glycoproteins form an Fc-binding complex, 
see below) are essential components of the virus receptor, 
since all three are dispensable for growth in tissue culture.
Glycoprotein B may also be involved in virus penetration, 
since ts mutants containing lesions within the gB gene
Table 2 : Properties of the HSV-encoded glycoproteins
GLYCOPROTEIN POSSIBLE FUNCTIONS
gB Essential for replication in tissue culture
Implicated in adsorption, penetration and 
cell fusion.
gC Not essential for replication in tissue culture
Implicated in adsorption, penetration and 
cell fusion.
gC-1 can act as a C 3 b - r e c e p t o r .
gD No t_s mutants yet described.
Implicated in adsorption, and in cell fusion.
gE Not essential for replication in tissue culture
Implicated in adsorption.
Interacts with gl to form an Fcif-receptor.
gG Not essential for rep lication in tissue culture
gH Essential for replication in tissue culture.
Implicated in cell fusion and in cell-to-cell
spread of infectious virus.
gl Not essential for replication in tissue culture
Interacts with gE to form an F c # - r e c e p t o r .
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adsorb to cells but fail to penetrate (Sarmiento et a l . , 1979; 
Little e t a l . , 1981). However, t_s lesions lying outwith the 
gB gene also affect penetration (Addison et a l . , 1984),
suggesting that other polypeptides may also be involved.
Syncytium formation, fusion between individual cells to 
form large multinucleated cells (syncytia), appears to involve 
a large number of viral functions, since at least seven, and 
possibly eight, loci have been mapped to date (reviewed in 
Spear, 1985; Marsden, 1987). These include g B , gD and gH. G l y c o ­
protein H also appears to be involved in egress of virus from 
infected cells. A monoclonal antibody against gH inhibits 
plaque formation, suggesting a possible role for gH in the cell- 
to-cell spread of infectious virus (Buckmaster et a l . , 1984).
The HSV-induced glycoproteins are the major virus- 
specific polypeptides recognised by the host immune response 
following infection, generating both humoral and cell-mediated 
immunity. Antibodies capable of neutralising infectious virus 
in vitro have been described against all the identified HSV 
glycoproteins, except gl, and passive protection of animals 
against a potentially lethal dose of HSV is conferred by m o n o ­
clonal antibodies against gB, gC, g D , gE and gH (reviewed by 
M a r s d e n , 1987).
It is interesting that three glycoproteins which are 
apparently non-essential in tissue culture - gC, gE and gl - 
can interact with key elements of the humoral immune system.
Thus, gC — 1, but not gC-2, has the capacity to bind to the C3b 
component of the complement system (Cines et a l . , 1982;
Friedman e t a l . , 1984; Cohen e t a l . , Abstract, lO*"*1 International 
Herpesvirus Workshop, pl58), while gE and gl form a functional 
complex which can bind to the constant (Fc) region of immun o­
globulin G (IgG) (Johnson D.C., Stow N.D., Feenstra V., Cross 
A.C. and Frame M .C ., manuscript in preparation). This Fc#-
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receptor binds to IgG from a number of animal species, including 
man (Baucke and Spear, 1979; Para et a l ., 1982; Johansson 
et a l . , 1984). Although it is not known whether these represent
the physiological ligands for gC and the gE/gl complex in v i v o , 
such a function would not seem unreasonable, since these 
receptors could function in vivo to protect infected cells 
against immune cytolysis. However, there is no evidence as yet 
that the presence of these glycoproteins confers a selective 
advantage in v i v o . Indeed, evidence is accumulating which 
suggests that gC-negative mutants do not show reduced p a th o­
genicity in vivo compared to wild-type virus (Dix et a l . , 1983;
Johnson et a l . , 1986). In vivo studies involving gE deletion
mutants have not yet been reported.
SECTION VUE : STRUCTURE AND ORGANISATION OF THE HSV GENOME
The genome structure of HSV has already been described 
(section H . 3) . The organisation of mRNA transcripts for 
some of the HSV polypeptides can be seen in Figure 7. There 
is no gross clustering of genes specifying similar functions. 
Thus, for example, glycoproteins can be found in both L and 
S, enzyme activities are found in both L and S, and there 
is no apparent organisation into 'early' and 'late' regions. 
However, some clustering is evident. The IE genes are all 
located in or close to the repeat elements, while a group 
of five consecutive genes within Ug (Ug4-Ug8, see Figure 8) 
encode known or potential membrane proteins. The significance 
of this clustering is uncertain.
Analysis of the DNA sequence of Ug and mapping of the 
mRNA transcripts therein (Rixon and McGeoch, 1984, 1985;
McGeoch et a l . , 1985) reveals a compact organisation of the
FIGURE 7
O rgani sa ti on of the HSV genome. This diagram shows the HSV-1 
genome divided into 0-1 map units. The three origins of viral 
DNA replication, ori^ and orig (see text), are indicated (f ). 
Below, the locations and orientation of IE genes 1-5, and
the genes for a number of other v i ral pol ypeptides - including
c I
the seven known glycoproteins, some vir us-induced enzyme
activit ies  and DNA-binding proteins, and a few structural
poly pep tides - are shown.
exo alkaline exonuclease; pol DNA polymerase; 65K^gp 65K 
DNA-biirding protein ( ICSP34 , 35) ; PK protein kinase;
6 5K t i f  virion polypeptide, Vmw65 (65K trans -in ducing factor).
Taken from Wagner (1985) and Schaffer et a l . (1987).
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HSV genome (Figure 8), and illustrates the point that 3 ’ 
co-terminal families of mRNAs occur relatively frequently 
in HSV (Wagner, 1985). One interesting observation concerns 
the location of the putative origins of DNA replication - 
orig, which is present in two copies, and ori^. Both 
origins are located between divergently transcribed genes, 
but the significance of this location is unclear (Figure 7). 
These are discussed in more detail below.
SECTION IX : HERPES SIMPLEX VIRUS DNA REPLICATION
The precise mechanism by which HSV DNA replicates is 
poorly understood. Following infection viral DNA rapidly 
accumulates in the nucleus, where it appears to circularise 
(Davison and Wilkie, 1983; Poffenberger and Roizman, 1985). 
Large tangled masses of replicating DNA have been described 
on electron microscopy (Hirsch et a l . , 1977; Jacob and 
Roizman, 1977), and late in infection HSV DNA is found in 
a very rapidly sedimenting form, relatively lacking in 
termini (Jacob et a l ., 1979; Jongeneel and B a c h e n h e i m e r , 
1981). Thus, viral DNA may replicate via a rolling circle 
mechanism, generating long head-to-tail concatemers of 
viral DNA. However, whether the circular HSV DNA is initially 
amplified via bidirectional, or theta type, replication - 
as may be the case for PRV (Ben-Porat and Tokazewski, 1977; 
Jean et a l ., 1977) - is unknown.
Electron microscopic studies (Friedmann et a l . , 1977;
Hirsch et a l . , 1977) and studies on defective virus DNA 
(Frenkel et a l . , 1975; Kaerner et a l . , 1979) suggested 
that there were at least two separate c is-acting signals 
for HSV DNA replication, one near the middle of (ori^)
and one in the short repeat region (orig) and hence present 
in two copies in the virus genome. Direct evidence that 
these regions contained a functional origin of DNA replication 
was provided by Frenkel and coworkers, who showed that 
purified monomeric units of defective virus DNA could be 
amplified by cotransfection with helper wild-type virus 
DNA, producing long concatemers of head-to-tail repeating 
units (Vlazny and Frenkel, 1981; Spaete and Frenkel, 1982; 
Spaete and Frenkel, 1985). Extension of this approach to 
a plasmid system, using cloned fragments of HSV DNA, has 
since more finely mapped these origins (Mocarski and Roizman, 
1982a; Stow, 1982; Weller et a l ., 1985), and both have now
been sequenced (Gray and Kaerner, 1984; Whitton and Clements, 
1984; Quinn and McGeoch, 1985; Weller et a l . , 1985). 
Interestingly, both ori^ and orig are located between two 
divergently transcribed genes, orig lying between the 
pro moter-regulatory regions of the IE genes 3 and 4/5, while 
ori^ lies between the 5 ’ ends of two early genes, those 
encoding the DNA polymerase and major DNA-binding protein 
(Whitton and Clements, 1984; Quinn and McGeoch, 1985). The 
significance of this location for either replication or 
transcription is unclear.
Deletion analysis of orig has defined a 90 bp fragment 
which contains all the cis-acting signals required for a 
functional KSV-specific origin of replication (Stow and 
McMonagle, 1983). The sequence of this fragment is shown 
in Figure 9. The minimal origin region contains a 45 bp 
imperfect palindrome, at the centre of which is an 18 bp 
A+T rich sequence which appears to be an essential component 
(Stow, 1985). Sequences lying outwith the palindrome (towards 
the left hand side in Figure 9) are also essential for
FIGURE 9
The 90 bp_ minimal orig sequence. The sequence of the 90 bp 
fragment containing the c i s -acting sequences required for 
orig function (Stow and McMonagle, 1983) is shown. This 
represents the upper strand, in the 5 !- 3 T direction, of 
the orig sequence within the short internal repeat.
— > «—  represents the 45 bp imperfect palindrome within
this region.
* represents bases conserved between the VZV and HSV
orig fragments.
i 1 represents the sequence deleted by Stow (1985),
resulting in a plasmid which fails to replicate.
{gggTgj represents the bases on this strand protected by
the or ig-bindin g protein (Elias et a l . , 1986).
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function (Stow and McMonagle, 1983).
Va ri ce 11a-zoster virus also possesses a functional 
origin of DNA replication in an analogous position to the 
HSV-1 c>rig (Stow and Davison, 1986). Comparison of these 
sequences shows two regions of extensive homology (see 
Figure 9), the A+T rich region and an 11 bp region to the 
left of this, overlapping the left hand end of the palindrome. 
This latter region falls within the region of orig protected 
in the DNase I footprinting studies of Elias et a l . (1986).
Interestingly, Stow and Davison (1986) found that HSV-1 
could stimulate replication from the VZV orig.
Considerable homology also exists between the HSV-1 
orig and a 144 bp perfect palindrome found in the region 
of ori^. Weller et a l . (1985) demonstrated that a functional
ori^ mapped to 0.398-0.413 map units on the virus genome, 
and within this 425 bp fragment was a perfect 144 bp 
palindrome. A plasmid containing a 55 bp deletion within 
this palindrome failed to replicate, suggesting that 
sequences from within this region are essential for origin 
function. Out of the 144 bp comprising the palindrome, 90 
were shared with orig, the greatest homology being near and 
to the left of the centre of symmetry (see Figure 10).
Weller et a l . (1985) also described short inverted repeat 
sequences within each arm of the palindrome (Figure 10), 
and suggested that these might reflect recognition sites 
for a DNA-binding protein. Interestingly, ° rig shares two 
of the three inverted repeat sequences located on the left 
side of the palindrome, but not those on the right, leading 
to the suggestion that these differences might reflect 
directionality of function - i.e. that replication from 
ori^ could be bidirectional, but that from orig unidirectional
FIGURE 10
Co mparison  between ori^ and orig of HSV-1. The 144 bp 
perfect palindrome from ori^ is compared with the similar 
region in orig. Conse rved bases are shown below the two 
sequences. This com par ison is taken from Weller et a l . 
(1985). The position of the 3 inverted repeat sequences 
present in the arms of the ori^ palindrome are indicated 
— I r-rr-n— | f — |—  . Two similar inverted repeat sequences found 
in orig are shown below. These are present only in the 
left hand side of the sequence shown. The 18 bp region 
protected from DNase I digestion by the ori g-bi nding  protein 
is indicated below m .

(now U^42 and U^52, respectively) 
0 (U^30 and U^29, respectively)
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(Quinn and McGeoch, 1985; Weller et a l . , 1985). Again, it 
is interesting to note that the region protected from 
DNase I digestion by the putative orig-binding protein 
includes the leftward reading inverted repeats, as shown 
in Figure 10. Although Elias et a l . (1986) stated that they 
found no evidence for other sites of protein binding within 
their orig fragment, it is not clear whether these authors 
also carried out DNase I footprinting on the lower strand.
Thus, it is possible that protein binding on the rightward 
reading inverted repeats may have remained undetected.
The known proteins involved in HSV DNA replication
have already been discussed. However, recently Challberg
(1986) utilised the plasmid replication system to identify
the viral genes required for DNA replication. By cotransfecting
with various cloned fragments of HSV DNA an orig-containing
plasmid could be replicated. This approach identified the
DNA polymerase and major DNA-binding protein as essential
components of the system. Additional unpublished work by
this author, in conjunction with DNA sequence information
from Duncan J McGeoch, has identified seven viral genes
essential for DNA replication - genes U^5, U^8, U^9 and
two genes temporarily designated GC.2L and 6 3 . 2L^ as well
as the DNA polymerase and major DNA-binding p r o t e i n ^ M c G e o c h ,
1987). The ribonucleotide reductase and IE genes 1, 2 and
3 were required for optimal effect. The gene designated 
(UIyi2 )
GC.2Lr*Tias recently been shown to encode the 65K DNA-binding 
protein (D S Parris, A Cross, L Haarr, D McGeoch, A Orr,
M C Frame, M Murphy and H S Marsden, manuscript in preparation), 
but the products of the other four genes are at present 
unknown.
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SECTION X : THE STRUCTURE AND FUNCTION OF THE
HSV ’a ’ SEQUENCE
X . 1 The 'a' sequence
The ’a' sequence is the direct terminal repeat sequence 
of the HSV genome and ranges in size from about 250 to 500 bp, 
varying both between and within strains (Grafstrom et a l . ,
1974, 1975; Sheldrick and Berthelot, 1974; Wad sworth et a l . ,
1975, 1976; Wilkie and Cortini, 1976). It is also present
in an inverted orientation at the L-S junction. The structure 
of the 'a’ sequence is summarised in Figure 11. The ’a ’ 
sequence itself is terminally redundant, possessing a short 
(17-21 bp) direct repeat sequence termed direct repeat 1 
(DRj), adjacent to which are two unique regions known as 
U^ and U c by virtue of their proximity to the flanking b ’ and 
c' sequences, respectively. Between the unique sequences 
are two further repeat elements, DR^, a 12 bp repeat unit 
present in 1 to at least 22 copies and DR^, a 37 bp sequence 
present in 1-3 copies (Davison and Wilkie, 1981; Mocarski 
and Roizman, 1981). Although the precise nucleotide sequence 
of the 'a1 sequence varies from strain to strain, some 
regions are quite highly conserved. These are depicted in 
Figure 11. With respect to the virus strains used in this 
study, the !a ’ sequence of HSV-1 strain 17syn+ is a p p r o x ­
imately 400 bp in length and contains one copy of a DR^ 
homology, whereas that of HSV-2 strain HG52 is approximately 
250 bp in length and contains one DR£ and one DR^ homology 
(Davison and Wilkie, 1981). These will be described in more 
detail in later sections.
A single copy of the ’a ’ sequence is found at the S 
terminus, but more than one copy may be present at the L
FIGURE 11
Str ucture.of the HSV-1 ’a' sequence. A prototype  virus 
genome with, below, an expansion showing the structure of 
the ‘a ’ sequence in the orientat ion found at the L-S 
junction, is presented.
U^ ' a  unique sequence located toward the b ’ sequence.
U^ a unique sequence located toward the c 1 sequence.
DR^ a 17-21 bp element, present as a direct repeat at
the ends of the ’a ’ sequence.
DR^ a 12 bp repeat element, present in 1 to at least 22
copies.
DR^ a 37 bp repeat element, present in 1-3 copies.
■■i indicates regions of unique DNA sequence highly
co nserved between different strains of HSV.
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terminus and L — S junction (Summers and Skare, 1977; Wagner 
and Summers, 1978; Locker and Frenkel, 1979a). Tandem 
copies of the fa' sequence share a single intervening DR^ 
(Mocarski and Roizman, 1981), while at the L and S termini 
the DR^ element is incomplete (see Figure 12). Mocarski 
and coworkers (Mocarski and Roizman, 1982b; Mocarski et a 1 . ,
1985) found that the L termini of both HSV-1 strains F and 
Justin possess 18.5 bp of a 20 bp DR^ element (i.e. 18 bp 
plus a single nucleotide 3' extension) while the S termini 
possess the remaining 1.5 bp of the DR^ element. A similar 
situation was found for HSV-1 strain 17syn+ (Davison and 
Rixon, 1985). In this case the S termini contain only 0.5 bp 
of the 21 bp DR^ sequence while the L termini contain the 
remaining 20.5 bp. In each case the L and S termini together 
form a complete D R ^ .
The fa' sequence plays an important role in a number 
of events during the virus life cycle, including circular- 
isation of the genome following infection, site-specific 
inversion to generate the four genome isomers and cleavage 
and packaging of unit length monomers from the long linear 
concatemers generated during viral replication. In addition, 
the ’a* sequence contains the promoter-regulatory domain 
of a gene located within the adjacent ' b ' sequence (Chou 
and Roizman, 1986).
X . 2 Circularisation
The HSV genome circularises rapidly following infection 
and a small proportion of packaged viral DNA may already 
be in this form (Poffenberger and Roizman, 1985). Although 
it was originally proposed that circularisation could 
occur via exonuclease digestion of terminal ’a sequences
FIGURE 12
Structure of L and S termini.
A. Tandem copies of the ’a ’ sequence share an intervening 
DR^. The ' a f sequences are shown in the ori enta ti on seen 
in Figure 11. Cleavage through the int er venin g DR^ element 
(^) would generate the termini shown in (B).
B. Structure of the L and S termini. Termini are shown in 
the same ori entation as (A). L and S termini possess only 
partial terminal DR^ elements (DR^*), with single nucleotide 
3 ’ extensions, such that annealing of an L and an S terminus 
would form a complete DR^, as in (A).
t
e
r
m
i
n
u
s
 
S 
t
e
r
m
i
n
u
s
-53-
followed by annealing of the exposed single-stranded ends 
(Roizman, 1979), it is more likely that circularisation 
results from direct ligation of termini (Davison and Wilkie,
1983). This latter mechanism is compatible with the structure 
of the termini shown in Figure 12 and with the observation 
that intertypic HSV-l/HSV-2 recombinants with heterotypic 
'a' sequences at the L and S termini are viable (Davison 
and Wilkie, 1983). In addition, not all herpesviruses are 
terminally redundant, for example VZV and PRV (Davison,
1984; Davison and Rixon, 1985) and therefore the genomes 
of at least these herpesviruses would not be circularised 
following exonuclease attack. Interestingly, circular PRV 
DNA molecules have been described following infection 
(Jean and Ben-Porat, 1976; Jean et a l . , 1977; Ben-Porat 
et a l . , 1980).
C ir cul ari sation of the HSV genome is not dependent 
on viral protein synthesis (Poffenberger and Roizman, 1985) 
suggesting that ligation of the termini involves either a 
host or a virion factor. Poffenberger and Roizman (1985) 
suggested that rapid circularisation of the HSV genome 
(this was maximal by 30 minutes post-infection, the earliest 
time point analysed) might be facilitated if the ends of 
the genome were held closely together following encapsidation , 
possibly by proteins bound to the terminal ’a ’ sequences. 
Proteins which appear to bind to the 'a 1 sequence have 
been discussed (section VI).
X . 3 Inversion
Inversion of the HSV genome results in the generation 
of four equimolar populations differing only in the relative 
orientation of the L and S segments. Whether inversion
-54-
occurs simply as a consequence of the structure of the 
virus genome or whether it plays a biologically important 
role is unknown. The four genome isomers appear to be 
functionally equivalent at least in tissue culture, since 
variants have been isolated which are 'frozen* in P, Ig 
and I^g configurations, respectively (Preston et a l . , 1978; 
Poffenberger et a l . , 1983; Jenkins and Roizman, 1986).
Single plaque isolates of wild-type virus yield equimolar 
amounts of all four forms, indicating that each isomer 
must be capable of giving rise to all others. Site-specific 
recombination need not be postulated for the generation 
of all four genome isomers. Two of the four isomers could 
be generated simply through a choice of cleavage sites on 
concatemeric DNA : i.e. both P and could be generated
by cleavage of either a P or concatemer, while both
Ig and 1^ could be generated by cleavage of either an Ig 
or 1^ concatemer.
Insertion of a copy of the 'a' sequence into the virus 
TK gene results in additional inversion events between 
inverted repeats of the 'a' sequence, and deletion events 
between directly repeated copies (Mocarski et a l ., 1980; 
Mocarski and Roizman, 1981, 1982b; Smiley et a l . , 1981). 
Smiley et a l . (1981) noted that the deleted segments were
packaged as appropriately-sized dimers, in approximately 
equal numbers to complete genomes. Since the deleted 
segments each contained an origin of DNA replication, it 
was proposed that the segment was first deleted and then 
replicated to produce concatemeric molecules from which 
dimers - of approximately one normal genome length in size - 
were cleaved and packaged. On the assumption that the 
recombination events leading to segment deletion were very
-55-
similar to those leading to segment inversion, the authors 
suggested that isomerisation could occur prior to the 
formation of concatemeric DNA. The site-specific inversion 
events appear to require the expression of viral genes 
(Mocarski and Roizman, 1982a).
Deletion studies (Chou and Roizman, 1985) suggest that 
the unique sequences and U c are not required for site- 
specific inversion, nor are two intact copies of DR^. 
Inversion was significantly impaired following deletion of 
the DR^ sequences, and abolished by further deletion of 
the D R 2 sequences. Analysis of the products of inversion 
events suggested that the crossover occurs within D R 2 and 
possibly D R ^ . Thus the signals required for site-specific 
inversion appear to reside within the direct repeat elements, 
D R 2 and DR^. The ’a ’ sequence of HSV-2 strain HG52, however, 
contains only a single copy of the D R 2 and DR^ elements, 
suggesting that the events leading to inversion are not 
simply a consequence of the presence of tandem repeats.
Although a number of unique sequences, when inserted 
in an inverted orientation within the TK gene, do not 
induce genome rearrangements (Mocarski et a l ., 1980; Lee
et a l . , 1982; Gibson and Spear, 1983; Pogue-Geile and 
Spear, 1986), the ability to mediate genome inversion events 
is not restricted to the 'a' sequence. Sequences from within 
HSV-1 map co-ordinates 0.706-0.744 induced inversion when 
inserted in the opposite orientation into the HSV TK gene 
(Pogue-Geile et a l ., 1985), as did a fragment derived from 
the ’c' sequence of the short repeat, albeit at a low 
frequency (Varmuza and Smiley, 1985). In addition, a virus 
mutant lacking a junctional ’ a f sequence and frozen pr e­
dominantly in the Ig configuration, generated a minor 
population of molecules, presumably through recombination
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between 'b' sequences within the long repeat (Longnecker 
and Roizman, 1986). Whether all these inversion events occur 
by a similar mechanism, or whether there is a specific 
mechanism operating on the 'a' sequence, remains to be 
d e t e r m i n e d .
X . 4 Cleavage and packaging
Cleavage of concatemers into unit length genome 
molecules and packaging of these unit length genomes into 
viral capsids are tightly linked (Ladin et a l . , 1980;
Deiss and Frenkel, 1986). Thus, DNA-positive t_s mutants 
which fail to encapsidate viral DNA also fail to cleave 
it, accumulating 'endless' DNA. Temperature shift experiments 
demonstrated that the appearance of monomeric genome DNA 
was concomitant with the appearance of full nucleocapsids 
(Ladin et a l . , 1980).
Insertion of additional 'a' sequences into the virus 
genome results in the appearance of novel termini which 
correspond in position to the inserted 'a' sequence (Smiley 
e t a l . , 1981; Mocarski and Roizman, 1982b; Varmuza and 
Smiley, 1985). In addition, although plasmid constructs 
containing an HSV origin of DNA replication can be r e pli­
cated they only become packaged and thus propagated in 
virus stocks as defective particles or 'amplicons' if they 
also contain an 'a' sequence (Stow et a l ., 1983; Deiss 
and Frenkel, 1986). Thus, the HSV 'a' sequence contains 
signals for the cleavage and packaging of viral DNA.
As mentioned already, the sequence of standard viral 
L and S termini suggests that cleavage occurs through the 
shared DR^ component of two adjacent 'a' sequences (Figure 
12). However, nucleotide sequencing of a Justin defective
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particle demonstrated that only 4 bp of the DR-^ element 
were present at the novel U g - ’a* joint, suggesting that 
a complete DR^ was not required at each boundary for the 
cleavage and packaging of the defective DNA (Mocarski 
et a l ., 1985). These authors suggested that the recognition
signal for cleavage may therefore not reside within the DR^ 
repeat itself but rather at an internal site, with cleavage 
occurring at a measured distance from the internal signal.
By inserting various subfragments of the 'a' sequence 
into the viral TK gene, Varmuza and Smiley (1985) have 
shown that the Smal F fragment (the location of which is 
indicated later, in Figure 14) contains a functional cleavage 
and packaging signal. Sequence analysis demonstrated that 
the novel termini arose by cleavage events outwith the 
Smal F insert. Thus, the novel L terminus contained 7 bp 
of 3' flanking TK DNA, whereas the novel S terminus contained 
36 bp of 5' flanking TK DNA. Both termini contained an 
intact Smal F fragment. (This is illustrated in Figure 13). 
Since the precise nucleotide sequences of these termini 
were unrelated this suggested that the novel L and S termini 
arose by two distinct cleavage events. Comparison of the 
relative position of these termini with the standard viral 
termini (see Figure 13) suggested that their location was 
dictated by their distance from a signal(s) within the 
Smal F fragment (Varmuza and Smiley, 1985). Since the number 
of DR^ and DR^ repeats within different 'a' sequences can 
vary considerably, and since a subfragment of Smal F 
containing the intact D R 2 repeat element was inactive, 
it was suggested that two separate cleavage/maturation 
signals reside within the unique and U c sequences. 
Furthermore, two subfragments containing an intact U b and
FIGURE 13
Gen era tion of novel termini by insertion of additional copies 
of the ’a ’ sequence into the HSV-1 genome. This figure 
summarises the results of Varmuza and Smiley (1985). The 
Sma I F fragment (see Figure 14c) was inserted into the TK 
gene of HSV-1 strain K O S . Novel L and S termini, generated 
by cleavage outwith the Sma I F fragment, were detected.
(a) Structure of a virus genome compatible with the novel 
termini. ■  indicates the S m a l  F insert.
(b) Structure of the novel termini. The Sma I F fragment, 
inserted into T K , is shown. The flanking sequences are 
arbitrarily designated x and y. The novel L terminus contains 
an intact Sma I F fragment, plus 7 bp of flanking y sequence 
(Ay). The novel S terminus contains an intact Sma I F 
fragment plus 36 bp of flanking x sequence (Ax).
(c) Structure of a double S m a l  F joint. Seq uencing and restriction 
enzyme analysis of double Sma I F joints suggested that these 
joints had been formed by direct ligation of the novel L and
S termini - i.e. the joint contained 2 Sma I F fragments, 
separated by the Ay and Ax sequences.
(d) Alignment of novel termini with standard viral termini. 
Although no sequence homology exists between the cleavage 
sites, their position relative to the Sma I F fragment is 
well conserved. Standard termini are located 37 bp (S) and 
5 bp (L) from the Sma I F fragment, compared with the novel 
termini which are located 36 bp (S) and 7 bp (L) from
the S m a l  F fragment.
( a ) -CD CD—CO
--------ED—CO----■*
novel novel
S terminus L terminus
Smal F
(b)
X
u b
u
D C
U. U
Ay novel L terminus
novel S terminus Ax U h uD c
(c)
X
U, U
b c
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U K Ub c w w u u w v
37
(d)
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— //—
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an almost intact , respectively, were individually 
inactive, suggesting that these two signals acted in concert.
These conclusions were supported by the recent 
deletion analysis of Deiss et a l . (1986), who found that HSV
amplicons containing ’a ’ sequences with deletions within 
failed to be packaged, while those containing ’a ’ sequences 
deleted within were only packaged if they first acquired 
an insertion of a wild-type 'a’ sequence derived from the 
helper virus DNA.
The role of the Dl^ and DR^ repeat elements is unclear. 
Since the HSV-2 strain HG52 contains only a single copy of 
the D R 2 and DR^ repeat elements, it follows that one copy 
of these elements must be sufficient for cleavage and 
encapsidation of viral DNA. In addition, different strains 
of HSV can efficiently package heterologous ’a ’ sequence- 
containing DNA (Vlazny and Frenkel, 1981; Deiss and Frenkel, 
1986) suggesting that the cleavage and packaging signals 
might reside within those regions of the ’a* sequence which 
are highly conserved. Davison and Wilkie (1981) described 
an approximately 28 bp region within which was highly 
conserved between HSV-1 and HSV-2. Homologous sequences 
were subsequently found to be present in VZV, PRV (Davison 
and Rixon, 1985), EBV and HVS (Deiss et a l ., 1986). Deiss 
et al . (1986) termed this region of homology p a c - 1 , and
described a second, less strong, homology within U , which 
they termed p a c - 2 . The pac-1 and pac-2 ’consensus' sequences 
are shown in Figure 14. Interestingly, Spaete and Mocarski 
(1985) had previously noted sequence homology between CMV 
and HSV within the region of pac-1, and suggested that this 
might be responsible for the observed ability of a CMV 'a' 
sequence to serve as a cleavage/packaging signal for HSV.
FIGURE 14
Conserved regions within the ’a 1 sequence.
(a) Structure of the HSV-1 ’a* sequence.
(b) Unique DNA sequences conserved between different strains 
of HSV.
(c) The Sma I F fragment of the ’a ’ sequence.
(d) Pac-1 and pac-2 regions, as defined by Deiss et a l . (1986).
These regions are conserved between a number of h e r p e s ­
viruses (see^ text) .
For HSV, pac-1 has the sequence :
[C5 ][G6 ] [T GTGTTT ^] [Gg ]
[C5 ][Gg ] [ TGTTTTT T] [G9 ]
HSV-1
HSV-2
For HSV, pac-2 has the sequence :
[ C G C CG CG ]-n31- [ T 6 ]
[ C G C CG CG ]-n29- [ T 6 ]
HSV-1
HSV-2
where n = any nucleotide.
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X . 5 Models for cleavage/packaging of viral DNA
The mechan ism of cleavage/maturation is however unclear. 
Several models have been proposed and none is proven. These 
models obviously have to take into account the various 
products generated by the cleavage and packaging process. 
Certain features are common to each model. Firstly, the 
assumption that HSV DNA is packaged directiona lly from L 
to S, and that it is the first ’a' sequence encountered 
that is cleaved, would account for the almost uniform 
presence of S termini with only a single ’a ’ sequence (Deiss 
et a l . , 1986). As yet, no evidence exists either for or 
against a directional model for packaging. However, the 
absolute requirement for the signal (Deiss et a l . , 1986)
might suggest that cleavage and possibly packaging are 
initiated by this signal, and would support the directional 
model for packaging. Secondly, following encapsidation 
cleavage occurs at the next directly repeated ’a' sequence. 
That a ’h e a d f u l l ’ mechanism does not play an overriding role 
in packaging is suggested by studies with defective genomes 
(Vlazny et a l ., 1982), or amplicons (Stow et a l ., 1986).
A significant proportion of defective genomes or amplicons, 
both of which consist of multiple head-to-tail repeat units, 
are packaged into nucleocapsids as correctly-term inated 
fragments containing an integral number of repeat units 
from one upwards. However, capsids containing these less- 
tha n-genome-size molecules do not become enveloped and 
remain in the nucleus, suggesting a possible 'headfull' 
mechanism of control at the level of envelopment and 
transport from the nucleus. Thirdly, L termini appear to 
be generated by cleavage through the DR^ element adjacent 
to , presumably via a U^-located cleavage signal, while
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S termini appear to be generated by cleavage through the 
DR^ element adjacent to U^, presumably via a U b~located 
cleavage signal (Mocarski and Roizman, 1982b; Varrnuza and 
Smiley, 1985; Deiss et a l . , 1986).
A simple model for the cleavage and packaging of HSV 
DNA is outlined below. Each end of the HSV genome contains 
an fa' sequence terminating in an incomplete DR^ element. 
These ends become directly ligated following infection, to 
generate a double ’ a T sequence joint, sharing the i n ter­
vening D R ^ . Replication by a rolling circle mechanism then 
generates concatemeric DNA molecules with interspersed 
double and single ’a' sequence joints (assuming that the 
input genome contained a single ’a* sequence at each terminus 
and at the L-S junction). A putative cleav age/packa ging 
complex encounters a signal and directs a staggered 
cleavage event through the adjacent D R ^ . Packaging ensues, 
possibly in the L-S direction, and the signal on the 
next directly repeated 'a* sequence then directs a second 
staggered cleavage event, again through the adjacent DR^. 
Cleavage at the double ’a T sequence joints will generate 
two single ’a* sequence-containing termini, with no r e q u i r e ­
ment for amplification of ’a* sequences.
Cleavage is probably not restricted to double ’a T 
sequence joints. Monomeric units from defective molecules 
or amplicons, containing a single ’a' sequence, are 
propagated as concatemeric molecules containing an ’a' 
sequence at each terminus (Deiss and Frenkel, 1986; Stow 
et al . , 1986). A number of models have been suggested to 
explain this apparent amplification of the 'a' sequence.
These are summarised in Figure 15.
FIGURE 15
Models for the cleavage and packaging of viral DNA.
(a) The wastage model (Varmuza and Smiley, 1985; Deiss et a l . ,
1986) proposes that cleavage at a single ’a ’ sequence 
generates one functio nal terminus, co nt ain ing an ’a f 
sequence, which is packaged, and one no n-fu n c t i o n a l  terminus 
lacking an ’a ’ sequence, which is either rapidly degraded
or repaired.
(b) The single-stra nd nick/r epa ir model (Varmuza and Smiley, 
1985) proposes that the cleavage event generates two single­
strand nicks at either end of a single ’a\ sequence, the 
strands separate, and are then repaired to generate two
’a f s e q u ence- co nt ainin g termini which could then be packaged
(c) The do uble-stra nd gap/repair model (Deiss et a l . , 1986) is
more complicated, and is detailed in Figure 16. Simply,
DNA is packaged prior to cleavage, the two directly repeated 
’a' sequences then align and are amplified, by a d o u b l e ­
strand break/repair  mechanism, to generate two double ’a* 
s e q u ence- co nt ainin g junctions. Cleavage between the double 
’a ’ sequences then generates 4 'a' seq ue nce-con ta ining 
t e r m i n i .
'a' sequences are designated by ■ ■ ■  , or I ""1 in (c).
(a) Wastage model
degradation 
or repair
1cleavage
packaged
(b) Single-strand nick/repair model
I cleavage
i repair
(c) Double-strand gap/repair model
packaging
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(a ) Wastage model
This is the simplest model (Varmuza and Smiley, 1985; 
Deiss et a l . , 1986). Cleavage occurs at the single ’a'
sequence as before, generating a packaged molecule containing 
an ’a* sequence at each terminus, but in the process also 
generating two unpackaged termini lacking an ’a ’ sequence. 
Since terminal fragments lacking an !a ’ sequence have never 
been detected, these must be rapidly degraded.
(b ) Single-strand nick/repair model
Two other models have been proposed. The single-strand 
nick/repair model was proposed by Varmuza and Smiley (1985). 
This model suggests that the putative cl ea vag e/packagi ng  
complex recognises the and the signals to generate 
two single-strand nicks, one at each end of the ’a ’ sequence. 
The strands separate and repair synthesis then regenerates 
an ’a' sequence at both termini. This model would therefore 
not generate termini lacking an ’a ’ sequence and would 
allow amplification of ’a' sequences. However, this model 
fails to account for the generation of the 3 ’ single 
nucleotide extensions found at the L and S termini.
(c ) Double-strand gap/repair model
The double-strand gap/repair model was proposed by 
Deiss et a l . (1986), and is detailed in Figure 16. In
this model, packaging is initiated as before, but without 
cleavage. When the next directly-repeated ’a ’ sequence is 
encountered the two ’a* sequences become aligned and a 
U n d i r e c t e d  double-strand cleavage occurs through the DR^ 
element of, for example, the L-terminal 'a* sequence 
(designated junction A in Figure 16). This is followed by
FIGURE 16
Double-strand gap/repair model. Taken from Deiss et a 1 . ( 1986),
DNA is packaged prior to cleavage, and the directly - 
repeated ’ a ’ sequences which will form the L and S termini 
then align (junctions A and B, respectively).
A U n d i r e c t e d  double-strand cleavage occurs through the DR^ 
( a )  of junction A. The cleaved ends align with the DR^ 
elements of junction B.
One strand from junction A then invades junction B, displacing 
the equivalent strand. (For simplicity this dia gram is drawn 
with the top and bottom strands of junction B reversed).
The displaced strand from junction B aligns with the partial 
DR-^ elements of junction A, and serves as a template for 
repair synthesis.
Similarly, the non-displaced strand from junction B serves 
as a template for repair synthesis between the invading 
partial DR^ elements.
Resolution of the Holliday structure results in the presence 
of two directly repeated copies of the 'a' sequence at 
junction A.
A similar process is then envisaged to take place for 
junction B. Cleavage between the adjacent ’a 1 sequences 
then generates the L and S termini of the packaged DNA.
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strand invasion by the free terminus into the intact ’a T 
sequence, copying of that ’a* sequence with resultant 
displacement of the upper strand, and the use of this 
displaced strand as template to repair the first junction. 
Resolution of the Holliday structure at or near DR^ then 
leaves the first junction with a second copy of the 1 a ' 
sequence. A similar event is then envisaged to take place 
at the second junction, so that two adjacent ’a ’ sequences 
are present at each terminus. Cleavage then occurs between 
adjacent ’a* sequences. Therefore, as with the single­
strand gap/repair model, this model does not generate 
termini lacking Ta ’ sequences and allows amp lification of 
'a' sequences. However, this model would appear to depend 
on sequence homology at the DR^ elements of the ’a ’ sequence 
to allow correct insertion of a complete second copy of 
the ’a' sequence. Therefore, it can not then account for 
amplification of terminal sequences such as those found by 
Varmuza and Smiley (1985), where the L and S termini ended 
in different sequences outwith the Smal F fragment, and 
only a single partial copy of DR^ was present. The sequence 
of a double Smal F-containing joint fragment suggested 
that it had arisen by direct ligation of the termini (see 
Figure 13) and restriction enzyme analysis of 24 such 
junctions suggested that only 2 had arisen via recombination 
events.
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SECTION XI : V m w 2 1 AND AIMS OF THE PROJECT
X I . 1 Virus polypeptide Vmw21
Two polypeptides of apparent mol. w t . 21,000 and 22,000 
(Vmw21, Vmw22) are made in abundance late in infection (Marsden 
et a l . , 1976) and have been mapped to the short region of the
genome, map co-ordinates 0.93-0.99 (Marsden et a l . , 1978). 
Synthesis of these polypeptides is highly dependent on viral 
DNA replication (Marsden et a l . , 1976; Honess and Watson, 1977; 
Johnson et a l ., 1986), a feature of 'true' late gene products. 
Hybrid-arrested translation experiments (Rixon and McGeoch,
1984) suggested that gene Ugll, which lies in the short unique 
region (McGeoch et a l . , 1985; see Figure 8) might encode the 
21K polypeptide (and possibly the 22K polypeptide), and this 
was confirmed using an antiserum raised against a synthetic 
oligopeptide representing the carboxy-terminal seven amino 
acids of the predicted polypeptide product of this gene 
(Dalziel, 1984; Johnson et a l . , 1986). The predicted product 
of gene Ugll has a highly unusual amino acid composition. The 
carboxy-terminal portion of the protein contains 24 tandem 
repeats of the sequence ’X - P r o - A r g ’, where X is any one of 
nine amino acids - Ala, Asp, Gin, Glu, lie, Pro, S e r , T h r , Val 
(Rixon and McGeoch, 1984). The repeating unit represents 
approximately 45% of the protein.
Vmw21 is phosphorylated and may be a minor virion 
component (Marsden et a l . , 1976). Vmw21, Vmw22 are equivalent 
to polypeptides designated ICP47,48 (Honess et a l . , 1980) 
and both have been shown to exhibit interstrain variability 
in apparent mol. wt. (Lonsdale e t a l . , 1979; Honess et a l . , 
1980). Since Vmw21 and Vmw22 consistently show similar a l t e r ­
ations in mol. w t . (Lonsdale et a l ., 1979), map to a similar
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region of the genome (Marsden et a 1 . , 1978) and both interact
with the anti-peptide sera to the Ugll gene products (Johnson 
et al . , 1986), it would seem likely that these polypeptides
are products of the same gene - gene Ugll. The reason for the 
interstrain variability in apparent mol. wt. is unclear, as 
there is no extensive reiteration within the DNA coding 
sequences of gene Ugll, since all the potential codons for 
proline and arginine are used (Rixon and McGeoch, 1984). 
However, a short 18 bp sequence is present as three tandem 
repeats in HSV-1 strain 17syn+ (Rixon and McGeoch, 1984), but 
only as two tandem repeats in HSV-1 strain Patton (Watson and 
Vande Woude, 1982), and it has been suggested (Rixon and 
McGeoch, 1984) that variation in the number of repeats of this 
18 bp sequence may account for this interstr ain variability 
in apparent mol. w t . Whether this might also account for the 
difference between Vmw21 and Vmw22, or whether these may 
represent different processed forms of the same polypeptide, 
is unknown.
A 21K polypeptide was found to be both a predominant and 
strong DNA-binding protein (Bayliss et a l . , 1975), and Dalziel
and Marsden (1984) demonstrated that two late polypeptides 
of apparent mol. w t . 21K and 22K could spe cifically interact 
with the *a? sequence of HSV-1. Whether these polypeptides 
are Vmw21 and Vmw22 has yet to be formally proven. However, 
the high arginine content of the predicted Ugll gene product 
renders it a very basic protein, compatible with a DNA-binding 
f u n c t i o n .
X I . 2 Aims of the pro ject
The results of Dalziel and Marsden (1984) were the first 
published account of a sequence-specific interaction between
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HSV polypeptides and HSV DNA sequences. The ’a ’ sequence is 
involved in a number of important functions - c i r c u l a r i s a t i o n , 
site-specific recombination and packaging. Any of these might 
be expected to involve a sequence-specific DNA -binding protein.
It was therefore believed to be important to further c h ar ac ­
terise this protein and its apparent interaction with the !a' 
sequence.
Initially we intended to purify Vmw21, using an i m muno ­
logical approach. Utilising the predicted amino acid sequence 
of the Ugll gene product we would synthesise o l ig o­
peptides representing various regions of the protein. Ant i ­
sera against these oligopeptides could then be used in an 
attempt to purify 21K. Anti-peptide antibodies have the 
advantage that specifically bound proteins can be eluted from 
immuno-affinity columns using peptide as a competitor - 
thereby avoiding the use of harsh and possibly denaturing 
eluting agents. The hopefully functional 21K polypeptide 
could then be studied with respect to its DNA-binding properties. 
For this we would have to develop a more sensitive and con ­
venient assay than the somewhat crude and cumbersome c om ­
petition assay originally employed (Dalziel and Marsden, 1984) 
such as, for example, a gel retardation or DNase I foot- 
printing assay.
Additionally, since 21K is a relatively small and possibly 
sequence-specific DNA-binding protein, it would be interesting 
(as a long term objective) to purify it in sufficient amounts 
to crystallize it and determine its 3-dimensional structure 
by X-ray diffraction analysis. For 21K this would be 
particularly interesting because of its unusually high (24%) 
proline content.
One potential drawback to the use of anti-oligopeptide
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antibodies, however, is that they may not be of sufficiently 
high affinity to allow purification of the quantities of 
protein required for such studies. The generation of higher 
affinity monoclonal antibodies might allow bulk purification, 
where recovery of a functionally active protein may not be 
so important. The immunological reagents generated in the 
course of this study could then be used to further characterise 
the products of gene Ugll.
MATERIALS
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MATERIALS
Chemicals
Chemicals were standardly obtained from either Sigma 
Chemical Co. Ltd., Poole, England or BDH Ltd., Glasgow, and 
were of analytical reagent grade or better. Exceptions are
listed below, 
acetic acid (glacial)
acetone
acetonitrile (HPLC grade)
acrylamide
agarose (for RID) -
isogel for isoelectric 
focussing
alpha2-macroglobulin 
ammonium persulphate 
ampicillin ( 1 p e n b r i t i n ’) 
boric acid
bovine serum albumin (BSA), 
for molecular biology
brain heart infusion agar
caesium chloride 
chloroform 
deoxyribonuclease I
May and Baker Ltd., Dagenham, 
England
May and Baker Ltd., England
Rathburn Chemicals Ltd., 
Walkerburn, Scotland
Koch-Light Laboratories, 
Haverhill, England
FMC Corporation, Rockland,
USA
Boehringer Mannheim GmbH.,
W. Germany
Bio-Rad Laboratories, Richmond, 
California
Beecham Research Laboratories, 
Brentford, England
Koch-Light Laboratories,
England
Boehringer Mannheim GmbH.,
W. Germany
Difco Laboratories, Detroit,
USA
Koch-Light Laboratories, England
Koch-Light Laboratories, England
Worthington Biochemicals 
Corporation, New Jersey
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dimethylsulphate
dimethylsulphoxide
ethanol - absolute 
alcohol 100
ether 
F icoll 
formamide
F r e u n d ’s adjuvant, complete
F r e u n d ’s adjuvant, incomplete
glutaraldehyde
glycerol
hydrazine
hydrochloric acid
Lowicryl K4M resin
methanol (HPLC grade)
piperidine 
proteinase K
rabbit anti-mouse 
immunoglobulin
’Repelcote' - 2% dimethyl- 
chlorosiline in 1,1,1— 
trichloroethane
sodium hydroxide
sodium metabisulphite
sodium nitrite
TEMED - N ,N ,N ’,N ’-tetra- 
methylethylenediamin e
TPCK-treated trypsin
(L-l-tosylamide-2-phenyl- 
ethylchloromethyl ketone 
(TPCK) - treated trypsin)
Fluka AG, Buchs S G , Switzerland 
Koch-Light Laboratories, England
James Burrough (F.A.D.) Ltd., 
Witham, England
Koch-Light Laboratories, England
Pharmacia, Uppsalla, Sweden
Fluka AG, Switzerland
Gibco, Paisley, Scotland
Gibco, Scotland
Agar Aids, Cambridge, England
Koch-Light Laboratories, England
Eastman Kodak, Rochester, USA
May and Baker Ltd., England
Agar Aids, England
Rathburn Chemicals Ltd.,
Scotland
Fluka AG, Switzerland
Boehringer Mannheim GmbH.,
W. Germany
Cedarlane Laboratories Ltd., 
Hornby, Canada
Hopkins and Williams, Essex 
England
Koch-Light Laboratories, England 
May and Baker Ltd., England 
Hopkins and Williams, England
Bio-Rad Laboratories, California
Worthington Biochemicals 
Corporation, USA
FIGURE 17
Schematic representation of plasmid constructs p R 9 , pRIO 
and p A ^ .
(i) pR9 (Stow et a l ., 1983) contains an HSV-1 ’a 1 sequence
derived from the S terminus plus app roximately 150 bp of
flanking ’c* sequence, inserted into Hind HE/Sma I digested 
p U C 9 .
(ii) pRIO (Stow et a l ., 1983) contains an HSV-1 'a* sequence
derived from the L terminus plus approximately 200 bp of
flanking ’b 1 sequence, inserted into Hind HI/Sma I digested 
p U C 9 .
(iii) pAH 2 (constructed by Martin Murray) contains an HSV-2 'a1 
sequence derived from the L-S junction plus approximately 
200 bp of flanking ' b' ’ sequence, inserted into Hind IH/Sma I 
digested pUC8.
Seed stocks of pR9 and pRIO were supplied by Dr Nigel Stow, 
while a seed stock of pAH2 was supplied by Mr Martin Murray.
R Eco RI site 
H Hind HI site
pR9
pRIO
pAH
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(±L) p R I O c o n t a i n s  the HSV-1 ’a' sequence derived from the
long terminus plus approximately 200 bp of flanking ’b ’ 
sequence, inserted into Hind UI/Sma I digested pUC9 as 
shown in Figure 17 (Stow et a l ., 1983).
(iii) pSl contains a 535 bp Sau 3A fragment, containing the 
HSV-1 origin of DNA replication from the short repeat 
region (orig), inserted into the Bam HI site of pAT153 
(Stow and McMonagle, 1983).
(iv) P A H 2 , constructed by Martin Murray, contains an HSV-2 
’a 1 sequence derived from the L-S junction plus a p p r o x ­
imately 200 bp of flanking ’ b! 1 sequence, inserted into 
the Sma I/Hind HI sites of pUC8 (see Figure 17).
(v) The vectors pAT153 and pUC8 have been described previously 
(Twigg and Sherratt, 1980; Vieira and Messing, 1982).
Radiochemicals
Radiolabelled compounds were obtained from Amersham
International, pic.
specific activity
(i) N a l ^ ^ ,  carrier free -
( ii ) [^~*S ]-L-methionine >1000 Ci/mmol
(iii) 5 ’ [<x-^^P ]-deoxynucleoside 3000 Ci/mmol
t r i phosphates
3 9
(iv) 5 ’[)f- P]-adenosine triphosphate 5000 Ci/mmol
Synthetic oligopeptides
Synthetic oligopeptides were obtained from Cambridge
Research Biochemicals, Cambridge, England.
Cells
Baby hamster kidney (BHK) 21 clone 13 cells (Macpherson
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and Stoker, 1962) were used throughout this study.
Virus
Two wild-type strains, HSV-1 strain 17syn+ (Brown et a l .,
1973) and HSV-2 strain HG52 (Timbury, 1971), and two mutants,
•£
PAA -1, a phosphonoacetic acid-resistant mutant derived from 
HSV-1 strain 17syn+ (Hay and S u b a k - S h a r p e , 1976) containing 
a mutation within the DNA polymerase gene (Crumpacker et al . , 
1980) and X12, a deletion mutant derived from HG52 lacking 
part of the right hand end of the short region of the genome, 
including gene Ugll (Brown and Harland, 1987), were used in 
this s t u d y .
Tissue culture medium and solutions 
E a g l e 's medium :
BHK cells were cultured in Glasgow modified Eagle's 
medium (Busby et a l . , 1964), supplemented with 50ug/ml
gentamycin (Flow Laboratories) and 0.002% phenol red. Tryptose 
phosphate, calf serum and human serum were added as required 
(see method section I).
Versene :
6mM EDTA in PBS (see below) containing 0.0015% (wt/vol) 
phenol red.
Trypsin-versene :
1 volume 0.25% (wt/vol) Difco trypsin in Tris-saline 
(see below), plus 4 volumes versene.
Giemsa stain :
1.5% (vol/vol) suspension of Giemsa in glycerol, heated 
at 56°C for 90-100 rain and diluted with an equal volume of 
m e t h a n o l .
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Bacterial culture media
Bacteria were grown in L-broth (170mM N a C l , 10g/l Difco 
b a c t o p e p t o n e , 5g/l yeast extract) supplemented, unless 
specified otherwise, with 50ug/ml ampicillin. For agar plates 
the L-broth contained 1.5% (wt/vol) agar.
Buffer solutions
B2 buffer 20mM Tris.HCl pH 8.0, 50mM NaCl, ImM E D T A ,
ImM 2 - m e r c a p t o e t h a n o l , 10% glycerol.
PBS-A 17OmM NaCl, 3.4mM K C 1 , lOmM N a 2H P 0 4 , 1.8mM
PBS
K H 2P 0 4 pH 7.2.
PBS-A supplemented with 6. 8mM C a C l 2 and 4.9mM 
M g C l 2 .
TBE^ 89mM Tris, 38mM boric acid, ImM EDTA
TBE^ 89mM Tris, 89mM boric acid, 2mM EDTA
TE, pH 7.4 1OmM Tris.HCl pH 7.4, ImM EDTA
TE, pH 8.0 lOmM Tris.HCl pH 8.0, ImM EDTA
Tris-saline 25mM Tris, 140mM NaCl, 5mM K C 1 , 0.7mM N a 2H P 0 4 ,
lmg/ml dextrose, 0.0015% phenol red (pH 7.4), 
supplemented with 100 units/ml penicillin and 
lOOug/ml streptomycin.
METHODS
METHODS
SECTION I : (A) GROWTH OF CELLS AND VIRUS STOCKS
1 Growth of cells
Cells were grown in 80oz. roller bottles in E a g l e ’s 
medium containing 5% v/v tryptose phosphate and 10% calf 
serum (ETC^ q ), in a humidified atmosphere of 95% air, 5% 
C 0 2 . Once confluent, the cells were harvested by washing 
the monolayer briefly twice with about 10ml of versene and 
once with about 20ml of trypsin/versene (1:4). When the 
cells began to detatch from the glass or plastic substrate, 
10ml ETC-^q was added to inactivate the trypsin. The cells 
were finally resuspended at approximately 12x10 cells/ml 
and stored at 4°C for up to 5 days. Petri dishes were 
seeded at 3x10^ cells/50mm dish or 8x10^ cells/90mm dish 
for use the next day.
2 Growth of virus stocks
Elite stock virus (virus with a low serial passage 
number) was used to infect approximately 80% confluent 
BHK cell monolayers at a multiplicity of 1 plaque forming 
unit (pfu) per 300 cells in 40ml E T C ^ q . Virus was grown 
at 31°C and harvested when the cytopathic effect (cpe) 
was maximal (usually after 4-7 days).
The infected cells were shaken into the medium and 
pelleted by centrifugation at 2000rpm for 5 min in a 
Fisons Coolspin. For HSV-1, the supernatant was spun in a 
Sorvall GSA rotor at 12,000rpm for 2 h and the virus- 
containing pellet resuspended in 5ml of supernatant and 
sonicated in a bath sonicator (50W at 40°C) until homo-
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geneous. This was termed the supernatant virus stock. For 
HSV-2, however, no supernatant virus was collected.
For both HSV-1 and HSV-2 the cell— associated virus 
in the pellet from the 2000rpm centrifugation was resuspended 
in 5ml of supernatant, sonicated in a bath sonicator until 
homogeneous, freeze-thawed, resonicated and then spun at 
2000rpm for 10 min. The supernatant was kept and the pellet 
resuspended in 5ml of fresh E T C ^ q and the above cycle 
repeated. The two supernatants were pooled and this 
represented the cell-associated virus stock.
Virus stocks were stored at -70°C and were checked for 
sterility and titrated before use.
1 . 3 Sterility checks
Brain heart infusion (BHI) plates were prepared by 
dissolving 26g of Difco Bacto BHI agar in 500ml deionised 
water and sterilising by autoclaving for 20 min. This was 
cooled to around 40°C and poured directly onto 50mm petri 
dishes (BHI plates); alternatively, 50ml of horse blood 
(Biocult) was added just before pouring (BHI blood agar 
p l a t e s ).
Cell or virus stocks were checked for fungal co ntam ­
ination by streaking on the BHI plates, in duplicate. The 
plates were sealed with parafilm and then incubated at 
room temperature for 7 days. Similarly, yeast or bacterial 
contamination was detected by streaking on the BHI blood 
agar plates and incubating at 37°C for 7 days. If no 
contamination became apparent within that time the stocks 
were considered sterile.
4 Titration of virus stocks
Virus stocks were titrated, at both 31°C and 38.5°C, 
on approximately 80% confluent BHK C13 cells grown on 50mm 
petri dishes. Virus was serially diluted 10-fold in PBS 
containing 5% calf serum. Medium was drained from the cells, 
0.2ml of each virus dilution was added to each of duplicate 
plates, and the plates were then incubated at 37°C for 
1 h. A 5ml overlay of Eagle's medium containing 4% human 
serum (a pool from several donors, serving as anti-HSV 
antiserum) was then added to prevent any extracellular 
spread of virus, and the plates further incubated at 31°C 
or 38.5°C for 3 or 2 days, respectively. Finally, the cells 
were fixed and stained with Giemsa stain at room temperature 
(RT) for 30 min. Plaques were counted using a dissection 
microscope.
SECTION I : (B) PREPARATION OF INFECTED CELL EXTRACTS
5 Preparation of late extracts
Infected cell extracts were usually prepared using 
monolayers of BHK C13 cells at about 80% confluency.
Stock virus was sonicated and then diluted in E T C ^ q to
g
a concentration of 2x10 pfu/ml, and the monolayers were
infected with virus at a multiplicity of 20 pfu per cell.
Virus was allowed to absorb for 1 h at 37°C and the
plates were then washed twice with me thionine-lab elling
medium (Eagle's medium containing one fifth the normal
concentration of methionine and 2% calf s e r u m ) , and further
incubated in 2ml (50mm dish) or 5ml (90mm dish) of this
35
medium. If labelled extracts were required, [ S ]-methionine 
was added at 50uCi/ml, usually 3-4 h post-infection (0 h
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post-infection (pi) being taken as the end of the 1 h
absorption period).
For large scale, roller bottle, preparations of
extract, cells were infected with 5-10 pfu/cell in 25ml
ETCio and then maintained in 50ml of m e t h i o n i ne -labell in g
35
medium. For labelling, [ S ]-methionine was added at 
1O u C i /m l .
Infected cells were usually harvested 16-24 h pi.
1 .6 Preparation of early extracts
To prepare extracts of proteins produced in the 
absence of viral DNA replication (loosely termed ' e a r l y ’ 
extracts) cell monolayers were pre-treated with phosphono- 
acetic acid (PAA) at 300 ug/ml for 1 h, then infected 
maintained and labelled essentially as for a normal 
infection but with the continuous presence of PAA. Cells 
were harvested at various times pi by the high salt 
extraction procedure (method section I.7b).
1 .7 Harvesting of infected cell extracts
(a ) Detergent lysis procedure
This was used for the preferential extraction of
glycoproteins, and was adapted from Zweig et a l . (1980).
Extraction buffer: lOOmM Tris.HCl, pH 8.0
10% glycerol 
0.5% NP40
0.5% Na deoxycholate 
500uM PMSF (p h e n y l m e t h y 1-
sulphonyl fluoride)
Infected cells were washed three times with PBS.
Extraction buffer - 1ml per 50mm plate -was added, and
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the plates left for 60 min at 0°C. The cell extract was
then spun in a Beckman microfuge for 5 min and the
supernatant stored at -70°C until use.
(b ) High salt extraction procedure
This method was used to preferentially extract DNA-
binding proteins.
Lysis buffer B2 buffer
40mM Tris.HCl pH 8.2 20mM Tris.HCl pH 8.0
4M NaCl 50mM NaCl
2mM EDTA ImM EDTA
2mM 2-mercaptoethanol ImM 2-mercaptoethanol
10% glycerol
Cells were washed twice with ice-cold PBS and once 
with ice-cold sterile deionised water. The cells from a 
90mm dish were scraped into 1.25ml of sterile deionised 
water and transferred to a centrifuge tube. An equal 
volume of lysis buffer was added, with vigorous mixing, 
and this was then incubated at 0°C for 30 min. Centrifugation 
in the Sorvall Ti50 rotor at 40,000rpm for 1 h at 4°C was 
followed by extensive dialysis of the supernatant (S40K) 
against a 100-fold excess volume of B2 buffer changed at 
least twice over 24 h. Material which had precipitated in 
the low salt was then pelleted by centrifugation in a 
Sorvall SS34 rotor at 8,000rpm for 30 min and the s u pe r­
natant (S8K) was stored at -70°C until use.
SECTION H  : GEL ELECTROPHORESIS
I .1 SDS-polyacrylamide gel electrophoresis (SDS-PAGE)
Vertical slab gels - either single concentration
acrylamide gels or 5-12.5% gradient acrylamide gels - 
were used for protein analysis. Fresh stocks of 30%
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acrylamide were prepared in water, the ratio of acrylamide 
to N ,N '- m e t h y 1 ene bisacrylamide (the cross-linking agent) 
being 28.5:1.5 and 29.25:0.75 for the gradient and single 
concentration stocks, respectively. These were then filtered 
through Whatman N°1 filter paper before use. From these 
stocks, gel solutions containing the appropriate percentage 
of acrylamide were prepared in a buffer of final c o ncen­
tration 375mM Tris.HCl, pH 8.9, 0.1% sodium dodecyl 
sulphate (SDS). In the 5-12.5% gradient gels the higher 
concentration acrylamide solution also contained 15% 
glycerol to stabilise the gradient. To polymerise the gels, 
200ul of 10% ammonium persulphate and lOul of TEMED were 
added per 24ml of gel solution (representing a final 
concentration of 3.65mM and 2.75mM, respectively).
The gel solutions were poured between two well-washed 
glass plates separated by 1.5mm spacers and sealed with 
teflon tape, to within 3-4cm of the top of the glass-plate 
sandwich. Butan-2-ol was gently layered on top of the 
acrylamide solution, and following polymerisation a 
stacking gel, consisting of 5% acrylamide in 12 2mM Tris.HCl 
pH 6.7, 0.1% SDS, was added, into which was placed a teflon 
well-forming comb.
Samples were boiled for 5 min in sample buffer at a 
final concentration of 50mM Tris.HCl pH 6.7, 2%SDS, 700mM 
2-mercaptoethanol (2-ME) and 10% glycerol, with sufficient 
bromophenol blue (BPB) to visualise the dye front. E l e c t r o ­
phoresis was carried out in a buffer containing 52mM Tris, 
53mM glycine and 0.1% SDS, at either 60mA for 3-4 h at 4°C 
or at 10-12mA for 16-24 h at RT.
Following electrophoresis gels were fixed for 1 h 
in m e t h a n o l :acetic a c i d :water (50:7:50) with or without
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0.2% Coomassie brilliant blue R250, and then destained 
several times in 5% methanol, 7% acetic acid. They were 
then gently agitated in 3 volumes of En hance (New England 
Nuclear) for one hour and washed twice with 10 volumes of 
water over 20-30 min. The gels were dried under vacuum 
onto Whatman grade 182 filter paper, and exposed to Kodak 
X-Omat XS-1 film at -70°C.
H .2 Non -denaturing polyacrylamide gel electrophoresis
To analyse or purify DNA fragments slab gels were
poured without a stacking gel, using various concentrations
2
of acrylamide in TBE . In this case the a c r y l a m i d e :N ,N ’- 
methylene bisacrylamide ratio was 29:1. Four volumes of
2
sample were mixed with one volume of a solution of 5x TBE
containing 15% Ficoll, lOOmM EDTA and 0.2% BPB, and this was
then electrophoresed at 60mA for 2-4 h. Bands were visualised
either by autoradiography, if labelled, or by soaking the 
2
gel in TBE containing 0.5ug/ml ethidium bromide for 1 h, 
followed by exposure to uv light.
H . 3 Denaturing polyacrylamide gels for DNA sequencing
Sequencing gel mix (6% acrylamide, 8 . 3M urea in TBE^)
was prepared as follows : 225g urea was dissolved in water
with 90ml of 30% acrylamide stock (a c r y l a m i d e :N ,N ’-methylene
bisacrylamide 29:1) and adjusted to 400ml. This was then
deionised by stirring with lOg of amberlite M B .1 for 30
1
min, and after filtering 45ml of lOx TBE was added. This 
solution was then stored at 4°C in the dark for up to one 
m o n t h .
To polymerise the gel, 500ul of 10% ammonium persulphate 
and 55ul TEMED were added to 60ml of sequencing gel mix.
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Gels were poured between sealed plates separated by 0.35mm 
spacers, using a syringe, and once set were pre-electro- 
phoresed at 40W for at least 30 min before loading. Samples 
were boiled for 2-4 min in the presence of 80% deionised 
formamide, 0.1% BPB and 0.1% xylene cyanol, rapidly cooled 
on ice and 2ul loaded using a hamilton syringe. Gels were 
electrophoresed at RT in TBE^ at 40W for the required time
(usually 1^-2 h). The gels were then covered with cling
film and exposed against Kodak X-Omat XS-1 film, at -70°C.
II. 4 Agarose gel electrophoresis
Masking tape was applied around all four edges of a 
163cm x 264cm glass plate to form a 0.75cm wall. The glass
plate was placed on a levelling board and made horizontal.
2
The appropriate concentration of agarose dissolved in TBE
and containing 0.5ug/ml ethidium bromide, was then gently
poured onto the glass plate and allowed to set. After
removing the tape the gel was placed in a horizontal gel 
2
kit and TBE added to each reservoir until just level with
the surface of the gel. Samples were mixed 4:1 with a
solution of 5x TBE^ containing 15% Ficoll, lOOmM EDTA, 0.2% 
BPB, loaded, and electrophoresed at 100V for 3-6 h or 40V 
o v e r n i g h t .
For a rapid assessment of plasmid preparations minigels,
consisting of 20ml of a 1% agarose solution set in a minigel
2
kit, were run in TBE at 40V for 45-60 min. In both cases 
bands were visualised by exposure to uv light.
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SECTION IE : GENERATION AND PURIFICATION OF ANTIBODIES
12 5H I .1 Iodination of oligopeptides using Nal
The iodination reaction is a modification of the method
of Hunter and Greenwood (1962). Synthetic oligopeptides
(lOmg) were resuspended in lOOul of 1M potassium phosphate
1 ? 5
buffer pH 7.5. Then lOOuC of Nal and 50ul of chloramine
T were added, incubated for 20 seconds at RT and the
reaction stopped by the addition of 50ul of sodium meta-
125
bisulphite. Removal of the free Nal involved passage 
through a Sephadex G10 column preblocked with 0.1% BSA in 
0.16M borate pH 9 and equilibrated in 0.16M borate pH 9,
0.13M NaCl (see method section V.l). Iodinated oligopeptide 
was eluted with the equilibration buffer. Fractions of 
0.5ml were collected, assayed in a gamma counter, and fractions 
containing the iodinated peptide (which eluted in the void
volume) were pooled, and either used immediately or stored 
at - 7 0 ° C .
The iodination reactions were carried out by Dr Howard 
S Marsden and Mrs Mary Murphy.
H I . 2 Covalent linkage of synthetic oligopeptides to BSA
(a ) Preparation of bis-diazotised benzidine (DAB)
Bis-diazotised benzidine (DAB) was prepared by Dr 
Howard S Marsden according to the method of Likhite and 
Sekar (1967). 0.23g of benzidine hydrochloride was dissolved 
in 45ml of 0.2M HC1. 5ml of 0 . 5M sodium nitrite was added 
and the solution stirred slowly at 4°C for 1 h. The DAB 
was then aliquoted into 2ml amounts and stored at -70°C.
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(b) Linkage reaction
The coupling reaction was carried out according to 
the method of Bassiri et a l . (1979). Briefly, 30mg of BSA 
was dissolved in 1.5ml of iodinated peptide- (usually lOmg) 
in 0.16M borate pH 9, 0.13M NaCl. 1ml DAB was added and the 
reaction carried out at 4°C for 1^-2 h. Free and coupled 
oligopeptides were separated by passage through a Sephadex 
G25 PD10 column (method section V.l). Samples were eluted 
using PBS and 10 drop (500ul) fractions were collected and 
assayed in a gamma counter. Oligopeptide coupled to BSA 
eluted in the void volume, and the relevant fractions were 
pooled, dialysed extensively against PBS-A to remove residual 
DAB, and stored at -70°C. The extent of coupling could be 
calculated from the formula :
% coupling = cpm coupled x 100 
total cpm loaded 1
This was usually in the order of 20-30%.
Ill. 3 Production of antisera to synthetic oligopeptides
Immunisation schedules varied and are outlined in 
detail in result section 1.1. Generally, New Zealand White 
(NZW) rabbits, about 6 months old, were immunised i n t r a ­
muscularly on several occasions with 500ug of peptide 
(coupled or uncoupled) and bled 7-14 days after each injection. 
Pre-immune sera were collected from most rabbits. For the 
first immunisation the peptides were emulsified in an 
equal volume of complete Freund's adjuvant, subsequent 
injections being in incomplete F r e u n d ’s adjuvant. At least 
2 rabbits were used for each antigen.
The sera were tested for reactivity with the relevant 
peptide by radioimmunoassay (RIA; method section I V . 3).
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Antibodies to BSA were removed by absorpt ion against BSA 
coupled to Sep harose before the sera were tested by immuno- 
blotting for reactivity against the relevant protein (method 
section IV.5). Once good anti-protein responses were detected 
the rabbits were given a final boost and blood collected 
by heart puncture.
UI,4 Production of antisera to 21K protein
In an attempt to raise monospecific antisera to 21K, 
partially purified preparations of protein, prepared by 
DNA cellulose ch romato graphy (see result section I E . 3) 
were separated by SDS polyacrylamide gel electro pho resis 
and transferred to nitrocellulose. The nitroce llulose was 
exposed to X-ray film and aligned with the aut oradiograph 
by means of radioa ctive ink spots. The strip of n i t r o ­
cellulose containing 21K was dissolved in dimethylsulphoxide 
and this solution was emulsified in complete Freund's 
adjuvant for the first injection, or in incomplete Freund's 
adjuvant for subsequent injections, and used to immunise 
2 NZW rabbits intramuscularly. Again the rabbits were bled 
7-14 days after each injection.
• 5 Purification of IgG by ion exchange chromatography
DE-52 (Whatman) is a DEAE-cellulose anion exchange 
resin. Conditions of pH and ionic strength were chosen 
such that IgG was among the few proteins that did not have 
an affinity for the charged resin and therefore passed 
directly through the column.
Serum was equilibrated in low salt buffer (lOmM sodium 
phosphate pH 7.7, 50mM NaCl) by dialysis against at least 
a 100-fold excess volume of buffer at 4°C over 2 days with
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4-5 changes. The DE-52 resin was equilibrated using a batch 
procedure, washing in a large beaker once with 0 . 5M sodium 
phosphate pH 7.6, once with 0.005M sodium phosphate pH 7.7, 
and then several times over 2 days with lOmM sodium phosphate, 
50mM NaCl pH 7.7, decanting the buffer each time the fibres 
had settled. This was necessary to eliminate fine particles 
which would block the column. A column of size 5 times the 
sample volume was poured and washed with several volumes 
of low salt buffer. The serum was then loaded carefully 
onto the column and run through with low salt buffer, 
collecting fractions of 0.5x the original sample volume. 
Fractions were assessed by reading the optical density at 
280nm ( O ^ q q ), radial immunodiffusion, radioimmunoassay and 
SDS-PAGE. Peak IgG-containing fractions were pooled and the 
column discarded after use.
SECTION IV : IMMUNOASSAYS
IV .1 Single radial immunodiffusion (RID)
This method was used to rapidly analyse fractions for 
the presence of IgG. A 1.5% (wt/v) solution of agarose in 
PBS was prepared by boiling, and was then allowed to cool 
to 56°C. Sheep anti-rabbit IgG serum (prepared by Dr C A Moss 
from hyperimmune sheep immunised with DE-52 purified rabbit 
IgG) was added to a final dilution of 1:100, and 4ml 
aliquots carefully poured onto 50mm petri dishes. Once set, 
holes were punched in the agarose using a pasteur pipette. 
Fractions to be assayed for IgG were added to fill the well 
and the plates were incubated in a moist chamber at RT for 
48 h.
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I V .2 Iodination of protein A
Protein A (Sigma, catalogue number P8143) was
reconstituted in PBS at a concentration of 0.5mg/ml,
aliquoted into 20ul amounts and stored at -70°C. To 20ul
(lOug) of protein A was added, in turn, lOul of 1M
17 5 17 5
potassium phosphate buffer pH 7.5, 200uCi of I (Nal , 
Amersham International) and 20ul of chloramine T (0.5mg/ml 
in PBS). This was allowed to react for 20 seconds at RT, 
then 20ul of sodium metabisulphite (lmg/ml in PBS) was
125
added to stop the iodination reaction. Removal of free Nal 
was achieved by passage through a Sephadex G25 PD10 column 
(method section V.l). The iodinated protein A was eluted 
using PBS, and 0.5ml fractions were collected and lOul 
analysed for radioactivity in a gamma counter. Two peaks 
were observed, the first containing the protein A and the 
second the free iodide. Fractions containing the iodinated 
protein A were pooled and stored at 4°C, in the presence 
of 0.01% sodium azide.
The iodination reactions were standardly carried out 
by Dr H S Marsden and Mrs Mary Murphy.
I V .3 Radioimmunoassays (RIA)
The radioimmunoassay for oligopeptides was modified 
from the method of Green et a l . (1982). Peptides were
diluted in PBS and added at 25ul/well to round bottomed 
microtitre plates. The plates were sealed with plate sealers 
(Titertek, Flow Laboratories) and incubated at 37°C o v e r ­
night. Excess liquid was shaken off and peptide fixed to 
the wells by adding 200ul/well of methanol and incubating 
for 5 min at RT. Remaining non-specific protein binding 
sites were blocked using 0.5% pol yoxyethylenesorbitan
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monolaurate (Tween 20) in PBS at 200ul/well for 1 h at 
37°C. Plates were washed once with PBS and could then be 
stored at -20°C until use.
To determine whether rabbit serum contained antibodies 
against the immunising peptide the rabbit serum/ purified 
IgG was diluted in PBS, added at 25ul/well and incubated 
for 1 h at 37°C. Samples were standardly tested in duplicate. 
The wells were washed three times with 200ul of 0.05%
Tween 20 in PBS and then 25ul (20,000 cpm) of iodinated 
protein A, diluted in 0.05% Tween 20 in PBS, was added to 
each well. After 30 min incubation at 37°C unbound protein A 
was washed off by flooding the plates three times with PBS.
To elute and quantitate the bound protein A, 200ul of 5M 
NaOH was added per well, left at least 15 min and then 
removed and counted in a gamma counter.
Radioimmunoassays to detect antibodies directed against 
protein antigens (such as BSA) were carried out in an 
identical manner, except that the methanol fixation step 
was omitted, since proteins, being much larger than the 
synthetic peptides, should be capable of efficiently 
adsorbing to the plastic without fixation.
I V .4 Immunoprecipitation
Immunoprecipitation experiments were carried out in 
the presence of detergent lysis extraction buffer (method 
section I.7a). Rabbit antiserum (25-50ul) was incubated for 
1 h at 37°C in a shaking water bath with 100-200ul of 
infected or mock-infected cell extract, in the presence or 
absence of peptide. Following incubation, 60ul of protein 
A-Sepharose (Sigma, catalogue number P3391), diluted 1:1 
in extraction buffer, was added and further incubated at
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0°C for 1-2 h. The protein A-Sepharose pellet was washed
4 times, and antigen-antibody complexes then eluted by 
boiling for 5 min in denaturing buffer (50mM Tris.HCl
pH 6.7, 2% SDS, 700mM 2-ME and 10% glycerol) and analysed 
by S D S - P A G E .
I V .5 Immunoblotting
The immunoblotting technique was based on the method 
of Towbin et a l . (1979), but with several modifications.
Cells were harvested into denaturing buffer (method section
IV.4) at a concentration of 10^cells/ml. After boiling for
5 min samples were loaded onto SDS -polyacrylamide gels in
£
broad wells, at approximately 10 cell equivalents per cm. 
Following electrophoresis proteins were transferred from the 
gel to a sheet of nitrocellulose using a BioRad ’Transblot' 
apparatus. Following the m a n u f a c t u r e r ’s protocol, the gel 
was placed on a sheet of Whatman grade 182 filter paper on 
top of a foam pad - both presoaked in transfer buffer (25mM 
Tris.HCl pH 8.3, 192mM glycine, 20% methanol) - and numbered 
strips of nitrocellulose, also pre-soaked, were placed 
face down on the gel, being careful to exclude air bubbles. 
Finally, a further sheet of pre-soaked filter paper and 
then another foam pad were placed over the gel and the 
sandwich (held tightly together in a plastic holder) was 
placed in an electrophoresis tank with the gel towards the 
cathode and the nitrocellulose towards the anode. Proteins 
were transferred to the nitrocellulose by electrophoresis 
in transfer buffer at 250mA for 3 h at RT.
Following transfer the nitrocellulose strips were 
blocked overnight at either 37°C or 65°C in a lx solution 
of wash buffer (ImM Tris.HCl pH 7.4, 15.4mM NaCl, 0.01%
sodium azide) containing 0.05% Tween 20 (Batteiger et a l . , 
1982). The strips were then placed protein side up in 
shallow (2mm) wells cut in perspex blocks, a piece of 
Whatman grade 1 chromatography paper placed on top, and 
250ul of appropriately diluted antiserum then layered evenly 
along the strip. This was incubated for 2 h at 37°C (or 
alternatively at 4°C overnight). The strips were then 
washed extensively in wash buffer containing 0.05% Tween 20 
by gently shaking at 37°C, with at least 3 changes of buffer 
over 2 h. To detect bound antibody, the strips were again 
placed protein side up in wells cut in perspex blocks (5mm 
deep), and were covered with 3ml of a solution of lx wash 
buffer containing 3% BSA (Sigma, catalogue number A-4503) 
and 5xl0^cpm of iodinated protein A. The blocks were gently 
shaken at 37°C for 2 h, and the strips then removed and 
washed twice for one hour in wash buffer containing 1M 
potassium iodide, followed by a brief (15 min) wash in PBS. 
The strips were placed on tissues to dry and then taped to 
cardboard sheets for autoradiography.
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To determine with which of the [ S ]-methionine
125
labelled proteins the I-labelled protein A interacted,
the procedure described by Haarr et a l . (1985) was used.
By this procedure, the strips were simultaneously exposed
to 3 films - one film directly on top, followed by a sheet
of black paper, 2 further films and an image intensifying
35
screen. Thus, the first film detects the [ S ]-methionine
label which does not penetrate as far as the second film.
125
The high energy emission from the I passes through the 
three films with little absorption and interacts with the 
image intensifying screen producing photons which are 
detected mainly on the third film and partly on the second
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film and prevented from reaching the first film by the
125black paper. Thus the contribution from the I to the
image on the first film is kept minimal. Ra dioacti ve ink 
1A 123
(containing C and I) spotted onto the cardboard allowed 
the 3 films to be aligned.
IV. 6 Immune electron microscopy
Monolayers of BHK C13 cells were either mock-infec ted 
or infected with HSV-1 at a multiplicity of 10 pfu/cell, 
and the cells then harvested at various times post-inf ectio n 
by scraping into PBS. After pelleting into BEEM capsules 
(Agar Aids Ltd) the cells were fixed for 1 h with 2.5% 
glutaraldehyde in PBS and washed with PBS. Dehydration was 
performed through a graded ethanol series. The samples 
were placed in 30% ethanol at 4°C for 30 min, then in 50% 
ethanol for 60 min, and shifted to -20°C. The samples were 
placed sequentially in 70,90 and 100% ethanol for 1 h 
periods and infiltrated with Lowicryl K4M resin by 1 h 
exposures to a 1:1 mixture of resin and ethanol followed 
by two changes of pure resin. Polymeris ation was performed 
using a 360nm wavelength uv lamp (Taab Lab oratories  Ltd, 
Reading, England) for 24 h at -20°C and a further 2 days 
at RT. Sections were cut using a glass knife and collected 
on uncoated nickel grids. Grids were stored at RT until 
use .
Preferential staining of rib onu cleoproteins was based 
on the method of Bernhard (1969). Briefly, grids were 
stained for 1-2 min by submerging in 0.5% aqueous uranyl 
acetate, destained for 2-10 min in 4,10 or 40mM EDTA and 
then incubated for 1 min in lead citrate (prepared according 
to Reynolds, 1963) to enhance the uranium stain.
Unstained grids were submerged in antis erum diluted 
in PBS containing 0.05% Tween 20 (PBS/Tween 20) for 45 min 
at R T , in the absence or presence of varying amounts of 
peptide, and then jet washed with PBS/Tween 20, and further 
incubated in a 1:50 dilution of goat ant i-r ab bit/gol d (lOnm) 
(Miles Ltd) in PBS/Tween 20 for 45 min. The grids were jet
washed as before, with a final wash in deionised water,
and then dried. Contrast was enhanced by exposing the sections 
to 0s0^ vapour for 2 h and the sections were examined using 
a Jeol 100S electron microscope.
The sections used in these studies were prepared by 
Dr Frazer J Rixon.
SECTION V : PURIFICATION OF PROTEINS BY CHR OM ATOGRAPHY
A number of different methods of chromatogra phy have 
been employed, the specific details of which will be given 
in the relevant results sections. A general outline for 
each is given below.
1 Sephadex G25 (PD10 columns)
Pre-packed PD10 columns containing a 9ml bed volume 
of Sephadex G25 were obtained from Pharmacia Laboratories. 
Non-specific protein binding sites were blocked by washing 
with 20ml of buffer containing 0.1% BSA, before the columns 
were equilibrated with the buffer required.
2 CNBr-activated Sepharose 4B
The coupling of proteins to cyanogen bromide (CNBr)- 
activated Sepharose 4B (Pharmacia Laboratories) was carried 
out according to the procedure recommended by the manufacturers.
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Briefly, lg of the dried beads was swollen and washed for
15-30 min with ImM HC1 (200ml), on a scintered glass filter,
and then rinsed with coupling buffer (0.1M NaHCOg pH 8.3,
0.5M NaCl). The protein to be coupled (usually at 5-10mg/ml
of gel, assuming lg of gel swells to 3.5ml) was either
dissolved in, or dialysed against, the coupling buffer,
adjusted to a volume of 5ml and mixed end -ov er-en d with the
gel for 2 h at R T . The beads were then washed with 100-
200ml of coupling buffer, the wash collected and the 0 D oor.Z  o  U
read. The coupling efficiency was calculated from the formula 
Coupling efficiency = (0^280 x v o l u m e ) ^ n p Ut:~ ^ ^ 2 8 0  X v o -*-unie)
(0Doorv x volume).
280 'input
x 100
This was usually in the order of 90-100%, but fell when 
coupling around lOmg/ml gel.
Any remaining active groups on the gel were blocked 
by incubating end-over-end with 15ml of 1M ethanolamine 
pH 8.0 for 2 h at RT. Non-covalently adsorbed proteins were 
removed by 3 cycles of a low pH wash followed by a high 
pH wash, using 0.1M acetate buffer pH 4.0 containing 0. 5M 
NaCl, and 0.1M bicarbonate buffer pH 8.3 containing 0 . 5M 
NaCl. Finally the beads were washed in PBS and stored at 
4°C in PBS containing 0.01% sodium azide.
V . 3 DNA cellulose
(a ) Preparation of calf thymus DNA
One gram of calf thymus DNA (Sigma, catalogue number 
D-1501) was dissolved in 300ml of SSC (150mM NaCl, 15mM 
trisodium c i t r a t e ) containing 2% SDS at RT for 1-2 days.
wash
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The DNA was then extracted twice with an equal volume of 
c h l o r o f o r m :isoamylalcohol 40:1 by shaking for 10-15 min 
followed by centrifugation at 2000rpm for 10 min. The upper 
phase contained the DNA. Then 2 volumes of ethanol were 
added and the DNA precipitate was spooled out using a glass 
rod, and lyophilised in the freeze drier. The dried DNA was 
again dissolved in 300ml SSC (without SDS), digested with 
lOug/ml RNase A (Sigma; pretreated at 90°C for 5 min) for 
30 min at 37°C, and then extracted twice with chloroform: 
is o a m y l a l c o h o l , precipitated with ethanol and dried, as 
above. Finally, the DNA was redissolved in 150ml of TE 
(lOmM Tris.HCl pH 7.4, ImM EDTA) and stored at -20°C. The 
concentration of DNA, calculated from the 0 D 3^ q , using the 
formula 1 = 50ug/ml, was usually l-2mg/ml.
(b) Preparation of cellulose
M u n k t e l l ’s cellulose powder (N°401), obtained from 
BioRad Laboratories, was purified before use as follows :
One volume of powder was washed 3 times with 10 volumes of 
boiling ethanol, then twice each at RT with 10 volumes of 
0.1M HC1, 0.1M NaOH, water and finally 20mM Tris.HCl pH 8.0, 
ImM EDTA. Between each wash the cellulose was left to 
settle and the buffer decanted. The cellulose was then 
lyophilised and stored in a sealed container at RT until 
use .
(c ) Preparation of DNA cellulose
100ml of calf thymus DNA (at l-1.5mg/ml) was mixed into 
a thick paste with 100ml of dry cellulose and spread around 
the walls of a 51 beaker using a sterile pipette. This was 
left at 31°C until dry (24-48 h). Fines were removed by
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resuspending the beads in a 10-fold excess volume of 20mM 
Tris.HCl pH 8.0, ImM EDTA and leaving to settle overnight 
at 4 ° C . The buffer was then decanted and the beads again 
washed as before, for a further 2 h. After decanting the 
second wash the beads were resuspended in 3 volumes of B2 
buffer (20mM Tris.HCl pH 8.0, 50mM NaCl, ImM EDTA, ImM 
2-ME, 10% glycerol) containing BSA at 500ug/ml total volume, 
to block any non-specific binding sites, and incubated for 
at least 2 h.
The DNA cellulose and the column buffers were degassed 
using a vacuum pump before use. The beads were then poured 
carefully into a Pharmacia column (diameter 2.5cm) and 
packed overnight in B2 buffer at 4°C using an LKB peristaltic 
pump to drive a flow rate of around 0.8ml/min. Before use 
the column was washed with a low-to-high salt gradient and 
then re-equilibrated with B2 buffer overnight (details can 
be found in the relevant result sections). When not in use 
the column was stored at 4°C in B2 buffer containing 0.01% 
sodium azide.
V . 4 Phosphocellulose
Ten grams of phosphocellulose (Whatman Pll grade) were 
washed once with 500ml of 0.1M HC1 by gently stirring at RT 
for 30 min, several times with deionised water by filtering 
until the pH was neutral, once with 500ml of 0.1M NaOH by 
stirring for 30 min, once with 500ml of 1M EDTA pH 8.0 
by stirring for 30 min, and then again with water until 
the pH was neutral, before being finally equilibrated in 
B2 buffer. Between washes the beads were allowed to settle 
and the buffer decanted. Beads were stored at 4°C in B2 
buffer containing 0.01% sodium azide. Columns were prepared
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as described above (method section V.3c).
V . 5 Hydroxylapatite
Hydroxylapatite beads (BDH) were washed by resuspending 
in 0.2M NaOH, then neutralised by several washes with water, 
decanting between washes each time. The beads were then 
equilibrated in B2 buffer by washing several times, and 
stored at 4°C in B2 buffer containing 0.01% sodium azide 
until use.
V . 6 Heparin-Sepharose
Hep arin-Sepharose (Pharmacia Laboratories) was 
resuspended and washed with B2 buffer on a scintered glass 
filter, and stored at 4°C in B2 buffer containing 0.01% 
sodium azide until use.
V . 7 ATP agarose
ATP agarose beads (Pharmacia Laboratories) were washed 
with water and then equilibrated in a buffer containing 
20mM Tris.HCl pH 8.0, 50mM NaCl, 5mM M g C l 2 , O.lmM EDTA,
ImM 2-ME and 10% glycerol. After use the column was washed 
with a 50-100-fold excess volume of 1M NaCl and then 6M urea 
before being finally washed with water and stored at -20°C 
in 50% glycerol containing 0.02% sodium azide.
V . 8 DEAE-cellulose
Whatman DE-52 beads were washed on a scintered glass
t
filter with 0.1M HC1 followed by 0.1M NaOH, then deionised 
water until the pH was neutral. The beads were equilibrated 
in B2 buffer by resuspending in a beaker and allowing the 
beads to settle before decanting the buffer, thus removing
-95-
the fines which float at the top. The beads were stored at 
4°C in B2 buffer containing 0.01% sodium azide and were 
discarded after use.
V . 9 Sephacryl S200
Sephacryl S200 (Pharmacia Laboratories) was equilibrated 
in the buffer in which chromatography was to be performed.
The beads and buffers were degassed using a vacuum pump and 
a column was carefully poured in a Pharmacia C16 column 
(dimensions 40cm x 1.6cm) and packed overnight at a p p r o x ­
imately 0.5ml/min.
V . 10 HPLC chromatography
This was carried out on a Waters HPLC system. All 
buffers were prepared using high quality deionised water 
(deionised through an Elgastat Spectrum apparatus) and 
were degassed by filtering before use. Columns were 
equilibrated in the relevant buffer (see below) and samples, 
ranging in volume from 200ul to 1ml, and dialysed against 
the appropriate buffer, were loaded and then eluted with 
a linear gradient over 20-22 min, while 0.5ml fractions 
were collected. Samples were analysed by SDS-PAGE.
The following columns were used :
1. Protein Pak SP 5PW - a cation exchange column.
This column was equilibrated in 20mM phosphate buffer 
pH 7.0 and samples were eluted using a linear gradient 
over 20 min from 0 - 0 . 5M NaCl or 0-1M MgCl^.
2. Protein Pak DEAE 5PW - an anion exchange column.
This column was equilibrated in a buffer containing 
20mM Tris.acetate pH 8.0, ImM dithiothreitol and 10% 
glycerol. Samples were eluted using linear gradients over
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22 min from 0 - 0 . 5M NaCl, 0-1M NaCl or 0-1M M g C l 2 .
3. Bondapak - a hydrophobic, reverse-phase column.
This column was equilibrated in 0.05% trifluoroacetic 
acid (TFA) in water, and samples were eluted using a linear 
gradient over 22 min from 20-100% of 0.05% TFA in a c e t o n i t r i l e .
V . 11 FPLC chromatography
A mono Q anion exchange column was used on a Pharmacia 
FPLC system. Buffers were prepared as described for the 
HPLC system. The column was equilibrated in 20mM Tris.HCl 
pH 8.0, 50mM NaCl, ImM EDTA, ImM 2-ME. Samples were eluted 
using a linear gradient of 50-400mM NaCl over 20ml, and 
remaining proteins were then removed using 1M NaCl. The 
column flow rate was 1.5ml/min and 1ml fractions were collected 
and analysed by SDS-PAGE.
SECTION VI : TRYPTIC PEPTIDE MAPPING OF POLYPEPTIDES
V I .1 Preparation of tryptic peptides
Polypeptides were separated by SDS-PAGE and the gels 
dried immediately without fixing and then exposed to X-ray 
film. Four radio-active ink spots placed at the corners 
of the gel allowed alignment with the bands on the a u t o ­
radiograph. The polypeptide to be digested could then be 
identified and excised by cutting through the autor adiograph  
into the underlying gel.
The polypeptides were eluted from the gel slices by 
the method of Anderson et a l . (1973). Briefly, the gel 
slices were packed into a column containing electro phoresis 
buffer (25mM Tris, 190mM glycine, 0.1% SDS) and carrier 
protein (5ug BSA per column), then electrophoresed into a
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small dialysis sac attached to the bottom of the column, 
containing about 300ul of electrophoresis buffer, at 100V 
for 16 h at 4°C.
The samples were desalted on prepacked PD10 columns 
(method section V.l) by eluting in water, then lyophilised. 
The SDS was then removed by the method of Henderson et a l . 
(1979). Briefly, the polypeptides were resuspended in a 
solution containing acetone, t r i e t h y l a m i n e , acetic acid and 
water (85:5:5:5) and incubated at 4°C for 1 h. This should 
precipitate the polypeptides while solubilising the SDS. 
Following cen trifugation at 13,000rpm for 10 min in a 
Beckman microfuge, the polypeptide pellet was washed once 
with the above solution and then twice with acetone alone, 
by dispersing the pellet by sonication and then repelleting 
by centrifugation.
For trypsin digestion the polypeptide-containing  
pellet was resuspended in lOOul of a 1% solution of ammonium 
bicarbonate containing 5ug of TPCK-treated trypsin, and 
digested for 16 h at 37°C. An additional 5ug of trypsin was 
then added and incubated for a further 4 h, after which 
the sample was lyophilised.
The peptides were then oxidised with performic acid 
(Hirs, 1967). Performic acid was generated by incubating 
0.5ml of hydrogen peroxide (30 volumes) with 10ml of formic 
acid for 2 h. Then lOOul of performic acid, 23ul of methanol 
and 40ul of performic acid were added, in turn, to each 
pellet with thorough mixing. This was incubated at RT for 
2.5 h, then diluted with 8ml of water and lyophilised.
V I .2 Separation of tryptic peptides
The peptides were taken up in 5ul of pH 2.1 e l e ctr o­
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phoresis buffer (glacial acetic acid, formic acid, water
8:2:90) and applied, lul at a time, to a spot 4cm from
each of two adjacent edges of a thin layer cellulose
chromatogram (Eastman Kodak). After each application the
chromatogram was dried in a stream of cold air. Following
electrophoresis at 600V for 45 min, the chromatogram was
dried, again in a stream of cold air, and then ascending
chromatography was performed, in a direction perpendicular
to that of electrophoresis, in 80ml of a buffer containing
water, butan-l-ol, pyridine and acetic acid (24:30:20:6).
The chromatogram was finally dried in hot air, sprayed with 
3
En Hance (New England Nuclear) and exposed to X-ray film 
at - 7 0 ° C .
SECTION V H  : GROWTH AND PURIFICATION OF PLASMID DNA
The methods described in sections V H , VUE, IX and X U  
were modified from Maniatis et a l . (1982) and references 
t h e r e i n .
V H .1 Growth of bacterial cultures
Overnight cultures of bacteria were set up using 
either 25ul of a bacterial stock (stored in 50% glycerol 
at -20°C or -70°C) or a sterile cocktail stick touched 
against a single plaque on an agar plate, and were grown 
in 5ml of L-broth, containing 50ug/ml ampicillin, by 
shaking overnight at 37°C. The overnight cultures were then 
transferred to 21 flanged flasks containing 500ml of L-broth 
with 50ug/ml ampicillin, and shaken at 37°C at 220rpm on 
an orbital shaker for a further 24 h before harvesting.
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V H . 2 H a r v e s t i n g  of pl asm id  DNA by a l k a l i n e  lysis
Bacterial cells were pelleted by centrifugation in a 
Sorvall GSA rotor at 8000rpm for 5 min, washed once by 
resuspending the pellet in 10ml of TE (lOmM Tris.HCl pH 8.0, 
ImM EDTA) and then pelleted again in an SS34 rotor at 
10,000rpm for 5 min. Each pellet derived from a single 500ml 
culture was resuspended in 7ml of a solution containing 50mM 
glucose, 25mM Tris.HCl pH 8.0 and lOmM EDTA (solution I), 
then 50mg of lysozyme was added and the mixture vortexed 
and incubated at RT for 5 min. Freshly prepared solution IE, 
containing 0 . 2M NaOH, 1% SDS, was then added (1 4 m l / p e l l e t ) 
to lyse the bacteria and the tubes were gently inverted 
several times and incubated for 10 min on ice. Finally,
10.5ml of ice cold solution HE (3M potassium acetate, 11.5% 
glacial acetic acid) was added and the tubes were mixed 
by inverting sharply several times and then incubated on 
ice for 15 min.
Cell debris and DNA was pelleted by centrifugation 
in an SS34 rotor at 15,000rpm for 30 min, at 4°C, and the 
supernatant, containing the plasmid DNA, was extracted 
2-3 times with an equal volume of p h e n o l :chloroform (1:1) 
and once with chloroform alone. Centrifugation at 2000rpm 
for 5 min caused a sharp interface to form and the upper 
phase containing the DNA was collected. The DNA was then 
precipitated by the addition of either 2 volumes of ethanol 
or 0.6 volumes of isopropanol followed by incubation at 
RT for 15 min. The DNA precipitate was pelleted by ce nt r i ­
fugation in an SS34 rotor at 12,000rpm for 30 min, at RT, 
and the supernatant discarded. The pellet was then either 
washed once with 70% ethanol by briefly vortexing, repelleted
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by centrifugation at 12,000rpm for 30 min, dried in a 
vacuum dessicator and then finally resuspended in 0.5ml of 
TE pH 8.0, or simply dried without a 70% ethanol wash, 
resuspended in TE pH 8.0 and applied to a caesium chloride 
gradient (see below).
V H .3 Purification of plasmid DNA by caesium chloride gradient 
centrifugation
The resuspended DNA was added to 15g of caesium chloride 
and lOmg of ethidium bromide, and TE added until the mixture 
weighed 3ll0.2g. The caesium chloride was thoroughly mixed 
until it dissolved and the solution centrifuged in the 
Sorvall Ti50 rotor at 40,000rpm for 40 h, at 15°C. Bands 
were visualised under long wave uv light and the lower 
band, containing the supercoiled plasmid DNA, was collected 
by puncturing the tube with a syringe needle. Thus, the 
plasmid DNA was purified away from any host DNA or nicked 
circular plasmid DNA which would band higher up the gradient, 
or RNA which pellets to the bottom of the tube.
The ethidium bromide was extracted from the DNA by 3 
washes with an equal volume of either caesium chloride- 
saturated isopropanol or isoamyl alcohol, the DNA this time 
being in the lower phase. The DNA was then dialysed against 
TE pH 8.0 at 4°C for 2 h with one change of buffer, and 
then precipitated overnight at -70°C in the presence of 0.1 
volumes of 3M sodium acetate pH 5.5 and 2 volumes of ethanol. 
The DNA was then pelleted and washed with 70% ethanol, as 
described above, dried in a vacuum dessicator and finally 
resuspended in 0.5ml TE. The concentration of DNA was 
calculated from the O D 2 6 0 ’ tak in§ * 00 unit to indicate 
50ug/ml, and the purity of the sample judged by agarose
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gel electrophoresis.
V H . 4 Harvesting of small scale cultures by a modified alkaline 
lysis procedure
Overnight cultures were grown from isolated plaques 
as described (method section V H . l ) ,  and harvested by a 
modification of the alkaline lysis method. Briefly, 1.5ml 
from each culture was pelleted by centrifugation in a 
Beckman microfuge, then resuspended in lOOul of solution I 
containing 4-5mg/ml lysozyme. After 5 min at R T , 200ul of 
solution H  was added and the tubes were then inverted 5 
times and incubated on ice for 10 min. 150ul of solution 
HI was added and the tubes vortexed in an inverted position 
and further incubated for 10 min on ice. Following c e n t r i ­
fugation for 5 min in the microfuge the supernatant was 
extracted once with phenol/chloroform and once with ether, 
then the DNA was precipitated in 2 volumes of ethanol at 
RT for 2 min and centrifuged for 5 min in the microfuge. 
The pellet was washed in 70% ethanol with a brief vortex, 
repelleted and dried in a 's p e e d i v a c ' vacuum dessicator.
SECTION VIH : PURIFICATION OF DNA FRAGMENTS BY AGAROSE
GEL ELECTROPHORESIS
V H . 1 Restriction enzyme digestion of DNA 
General rest riction enzyme buffers :
Tris.HCl
NaCl
MgCl2
DTT
low salt 
l O m M , pH 7.5
1 OmM 
ImM
medium salt 
lOmM, pH 7.5 
50mM 
lOmM 
ImM
high salt 
5 0 m M , pH 7.5 
1 OOmM 
lOmM 
ImM
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Specific r e s t r i c t i o n  en zy me  b u f f er s :
Aha IE
Tris.HCl lOmM, pH 8.0 
NaCl lOOmM
Mg C l 2 lOmM
2-ME 6mM
E a S I
lOmM, pH 8.2 
150mM 
lOmM 
lOmM
lOx stocks of these buffers were prepared and stored at -20°C
Some res triction enzymes, their preferred buffers and sites 
of action :
Enzyme Buffer Site
Aha H Aha IE G Pu^C G Py C
Bam HI medium G*G A T C C
Bgl IE low A*G A T C T
Eag I Eag I C*G G C C G
Eco RI high G*A A T T C 
A^A G C T THind HE medium
Hinf I medium G*A N T C
Pvu H medium C*A G C T G
Sal I high G*T C G A C
Reacti on volumes varied from 40ul to 500ul, containing 
DNA in a solution with final con centrations of lx reaction 
buffer, lOOug/ml BSA, the appropriate restriction enzyme 
at approximate ly 1 unit per ug DNA, and, if required, 
25ug/ml of RNase A (the latter ingredient being used when 
the plasmid DNA had not been purified by caesium chloride 
gradient centrifugation). Reactions were carried out at 
37°C for 2-24 h. As a rule, when two or more enzymes were 
used together the higher salt conditions were employed.
For electrophoresis, the samples were simply diluted with
-103-
2
0.25 volumes of running buffer (5x TBE containing 15% 
ficoll, lOOmM EDTA, 0.2% BPB) and loaded directly onto the 
g e l .
VUE.2 Purification of insert DNA
To purify insert DNA, the plasmid was cleaved at unique
restriction enzyme sites flanking the inserted DNA fragment
and then elect rophoresed on 1.2% agarose gels as described
(method section IE.2). The DNA was visualised under long
wave uv light and the insert was always well separated from
plasmid DNA or RNA, running just above the dye front, and
could be easily sliced out without risk of contamination.
The gel slice was placed in a boiled dialysis sack with 
2
TBE , then excess buffer and air bubbles were squeezed out
carefully and the bag was immersed in a shallow layer of
buffer in an electrophoresis tank. Electrophoresis at 100V
for 3-4 h efficiently extracted all detectable insert DNA.
The current was briefly reversed (1-2 min) to remove the
DNA from the side of the dialysis bag, the gel slices were
2
removed, and the TBE within the sac carefully collected.
The sac was then washed with a small volume of buffer.
The gel slice could be restained to ensure complete recovery 
of the insert DNA.
The insert DNA was then extracted 2-3 times with i s o ­
amyl alcohol, to remove any ethidium bromide, precipitated 
with 2 volumes of ethanol, 0.1 volumes of 3M sodium acetate, 
rinsed with 70% ethanol, dried and finally resuspended in 
TE pH 8.0. Again, the concentration of DNA was calculated 
from the 0 D o .~.
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SECTION IX : PURIFICATION OF END-LABELLED FRAGMENTS 
BY POLYACRYLAMIDE GEL ELECTROPHORESIS
To end-label DNA inserts, plasmids were standardly 
cleaved at a unique restriction enzyme site to one side 
of the insert, end-labelled at this site, and then cleaved 
again at a second unique restriction enzyme site to the 
other side of the insert. The labelled insert is then 
readily separated from the labelled plasmid by p o l yacryl­
amide gel electrophoresis. The DNA must be extracted from 
the reaction mix between each step.
IX . 1 Extraction of DNA
The DNA was (unless otherwise stated) extracted once 
with an equal volume of saturated phenol and once with an 
excess of ether, before being precipitated in 2 volumes of 
ethanol and 0.1 volumes of 3M sodium acetate, by chilling in
an ethanol/dry-ice bath for at least 5 min. The DNA was
pelleted by centrifugation in a Beckman microfuge for 5 min, 
the pellet washed once in 70% ethanol by brief vortexing, 
repelleted as before, and finally dried in the 's p e e d i v a c ' 
vacuum dessicator.
IX. 2 End-labelling of DNA
(a ) End-labelling at the 3 1 end
Plasmid DNA (approximately 5ug) was cleaved at the 
relevant site to produce a 5 f overhang and extracted as 
above. The DNA was then end-labelled at the 3 ’ end by re­
suspending in NT buffer (50mM Tris.HCl pH 7.9, 5mM M g C ^ .  
lOmM 2-ME) containing a radiolabelled nucleoside triphosphate
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32
(o<[ P]-dNTP) complementary to the most 3 ’ nucleotide of 
the 5 ’ overhang. Reactions were carried out in a volume of 
25ul, containing 5ul of the radio-labelled nucleoside t ri­
phosphate and 1u 1 (2 units) of Klenow reagent to catalyse 
the reaction, at 16°C for 40 min. (Klenow reagent is the 
large fragment of E. coli DNA polymerase I, and contains 
the 5 ' - 3 ’ polymerase and the 3 ' - 5 f exonuclease activities). 
The reaction was stopped by extraction and precipitation 
of the DNA, as described above (method section I X . 1).
For some unknown reason Hind III sites did not label 
well using this method, so a slight modification was used. 
In this case, the first two positions were filled by cold 
nucleoside triphosphates (dATP and dGTP, at 0.16mM) while 
<x [^p ]-dCTP filled the third. Thus the Hind III site which, 
when cleaved, produces a 5' overhang 5 1- A G C T -3 ’, is
filled in by this procedure to yield 5 ’- A G C T -3*
*C G A ---- 5 ’
(b ) End-labelling at the 5* end
Plasmid DNA (5ug) was cleaved with the appropriate 
restriction enzyme, extracted and precipitated as described 
(method section I X . 1). The DNA was resuspended in 25ul of 
a buffer containing 50mM Tris.HCl pH 8.0, ImM EDTA and 
incubated at 37°C for 60 min in the presence of 0.5ul (11 
units) of calf intestinal phosphatase, to remove the 5' 
phosphate group. To inactivate this enzyme, 3ul each of 
proteinase K (500ug/ml) and 2% SDS were added and the 
reaction continued for a further 60 min at 37°C. The DNA 
was then extracted twice with phenol and twice with ether 
before being precipitated (method section I X . 1).
The DNA was labelled by resuspending in kinase buffer
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(50mM Tris.HCl pH 7.6, lOmM M g C l 2 , O.lmM EDTA, O.lmM 
spermidine, 5mM DTT) containing lOul of # [ ^ P ] - A T P  and 
0.5ul (5units) T4 polynucleotide kinase, followed by 
incubation at 37°C for 30 min. The DNA was then extracted 
and precipitated as usual.
IX . 3 Purification of end-labelled inserts
The end-labelled plasmids were cut with a second 
restriction enzyme to remove the insert and the fragments 
were separated on polyacrylamide gels as described (method 
section H .2). Standardly, inserts of 400-500bp were 
separated on 5% polyacrylamide gels, while smaller fragments 
of 100-200bp were separated on 10% polyacrylamide gels.
One glass plate was removed and the wet gel covered with 
cling film, wiped with alcohol to remove static, and exposed 
to Kodak X-Omat XS-1 film, with an intensifying screen, at 
RT. A strong signal was usually seen within 1-2 min exposure. 
The gel could then be aligned with the autoradiogr aph with 
the aid of a hand-held minimonitor (type S*10E), and the 
relevant band was excised using a scalpel, and the gel 
re-exposed to film to ensure that the correct band had 
been completely removed without contamination.
The acrylamide slice was then placed in a small ampoule 
and mashed gently using a glass rod, 400-500ul of elution 
buffer (500mM ammonium acetate, ImM EDTA, 0.1% SDS) was 
added and the DNA eluted overnight at 42°C. The mixture was 
then filtered through siliconised glass wool in a small 
(0.5ml) eppendorf tube punctured 3-4 times with a medium 
gauge needle, and the flow-through was collected into larger 
(1.5ml) eppendorf tubes. The gel pieces were then washed 
with 1-1.5ml of elution buffer, until less than 10% of the
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total counts were retained on the column.
Following elution, 2 volumes of ethanol were added 
(without any additional salt) and the DNA precipitated by 
chilling. The pellet was washed by resuspending in lOOul 
of water and then precipitated with 200ul of ethanol without 
salt, as before. Finally, the DNA was rinsed with 95% 
ethanol and dried. The dried DNA was stored at -20°C and 
usually used within 2 weeks of preparation.
SECTION X : DNA SEQUENCING AND DNase I FOOTPRINT REACTIONS
X . 1 Preparation of carrier calf thymus DNA
Calf thymus (CT) DNA, lOOmg, was dissolved in 10ml 
sterile distilled water, at 37°C, then sonicated using a 
soniprobe for 3x30 seconds, in an ice bath. The DNA was 
extracted 3 times with an equal volume of saturated phenol, 
centrifuging at 2000rpm for 5 min at RT, to achieve a sharp 
interface between the two phases, then extracted a further 
3 times with ether, before being dialysed overnight against 
sterile distilled water. Following a further 3 h dialysis 
against fresh distilled water the concentration of DNA 
was calculated from the and aliquots adjusted to
lmg/ml and stored at -20°C.
X . 2 DNA sequencing reactions
The sequencing reactions were based on the method of 
Maxam and Gilbert (1980). This involved the modification 
of bases in reactions that are relatively base-specific, 
and then cleavage of these modified bases by piperidine.
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G+A reaction buffer
O.lg diphenylamine
5 ml 66% formic acid/
ImM EDTA
DMS stop solution
1.5M sodium acetate 
pH 7.0
1M 2-ME
lOOug/ml tRNA
formamide dye mix
lml deionised formamide 
lOOul 1% BPB 
lOOul 1% xylene cyanol
(a ) G + A reaction
Dried DNA (usually 200cps) was resuspended by vortexing 
in lul CT DNA (lmg/ml) and 15ul G+A reaction buffer, and 
then incubated at 25°C for 5 min. The reaction was stopped 
by the addition of 45ul of deionised water, then extracted 
3 times with an excess of ether, frozen on dry-ice and 
lyophilised. The DNA was then treated with piperidine, as 
described below.
(b ) G reaction
Dried DNA (usually lOOcps) was resuspended by vortexing 
in 5ul of water, lul of CT DNA (lmg/ml) and 200ul of G 
reaction buffer. This was then incubated with lul of di- 
methylsulphate (DMS) at 25°C for 2-3.5 min (for example, 
500bp fragments were incubated for 2 min, whereas 150bp 
fragments were incubated for 3.5 min). The reaction was 
stopped by the addition of 50ul of DMS stop solution.
G reaction buffer
50mM sodium cacodylate pH 8.0 
lOmM M g C l 2 
ImM EDTA
hydrazine stop solution
0.3M sodium acetate pH 5.2 
O.lmM EDTA 
25ug/ml tRNA
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The DNA was then precipitated by the addition of 750ul of 
95% ethanol, chilled in a dry-ice/ethanol bath and micro- 
fuged for 5 min to pellet the DNA, then resuspended in 250ul 
of 0.3M sodium acetate followed by the addition of 750ul 
of 95% ethanol and again chilled and pelleted. The DNA 
was rinsed in 95% ethanol by vortexing, microfuged and 
dried. The sample was then treated with piperidine, as 
described below.
(c ) C+T reaction
Dried DNA (usually 200cps) was resuspended in 20ul 
water, lul CT DNA (lmg/ml) and 30ul hydrazine, and then 
incubated at 25°C for 5 min. The reaction was stopped by 
the addition of 200ul of hydrazine stop solution. The 
DNA was then precipitated and washed exactly as described 
for the G reaction protocol, and then treated with piperidine 
as described below.
(d ) C reaction
Dried DNA (usually lOOcps) was resuspended in 5ul 
water, lul CT DNA (lmg/ml), 15ul 5M NaCl and 30ul hydrazine, 
then incubated at 25°C for 5 min. The reaction was stopped 
by the addition of 200ul of hydrazine stop solution. The 
DNA was then precipitated and washed exactly as described 
for the G reaction protocol, and then treated with piperidine 
as described below.
(e ) Piperidine reaction
The dried DNA was resuspended in lOOul of 1M piperidine 
(prepared by diluting a 10M stock solution in water), and
- 110 -
incubated at 90°C for 30 min. Then lOOul of water, 20ul 
3M sodium acetate, 5ul CT DNA (lmg/ml) and 500ul 95% 
ethanol were added and the mixture chilled in a dry-ice/ 
ethanol bath for 15-20 min, then microfuged for 5 min.
The pellet was rinsed with 70% ethanol, microfuged and 
dried. The dried DNA was washed twice by resuspending in 
lOul of water then l y o p h i l i s i n g .
Samples were finally resuspended in formamide-dye 
mix at 10-15cps/ul, for the single base reactions (G,C) 
and 20-30cps/ul for the double base reactions (G+A,C+T) 
and analysed on sequencing gels as described (method 
section II . 3 ) .
X . 3 DNase I footprinting assay
The DNase I footprinting assay was modified from that 
originally described by Galas and Schmitz (1978). A standard 
procedure is outlined below although the reaction conditions 
were occ asionally varied, as described in the relevant 
result sections.
DNA binding reactions were carried out in a 50ul 
volume containing 10-20ng end-labelled DNA fragment (lOOcps), 
lug unlabelled competitor CT DNA and variable amounts of 
protein in a buffer of final concentration 20mM Tris.HCl 
pH 8.0, 50mM NaCl, ImM EDTA, ImM 2-ME, 10% glycerol, 2mM 
M g C ^ ,  0 . lmg/ml BSA. Samples were kept on ice, the protein 
being added only immediately prior to incubation at 37°C 
for 5 min, after which the reactions were stopped by cooling 
rapidly on ice. The samples were then warmed to RT and 
digested for 60 seconds by the addition of lul of DNase I 
(lOug/ml). The DNase digestion was terminated by the 
addition of 12.5ul of a DNase stop solution (3M sodium
- 111 -
acetate, 250mM EDTA, lmg/ml CT DNA) and the samples were 
immediately phenol extracted. The DNA was precipitated in 
lOul 3M sodium acetate/200ul ethanol and pelleted (method 
section I X . 1). The pellet was resuspended in lOOul water, 
reprecipitated as before and then finally rinsed with 70% 
ethanol and dried. Pellets were resuspended in formamide- 
dye mix at 10-15cps/ul (in a minimum of 3ul) and analysed 
on sequencing gels (method section H  . 3) .
SECTION XI : SYNTHESIS AND PURIFICATION OF SYNTHETIC
OLIGONUCLEOTIDES
Synthetic oligonucleotides were synthesised on a 
Biosearch 8600 DNA synthesiser by either a macroscale or 
microscale synthesis procedure. The DNA was then eluted 
from the column by resuspending the beads in 1ml of ammonia 
and incubating at 55°C for 5 h. The ammonia was removed 
by lyophilisat ion in the ' s p e e d i v a c ' vacuum dessicator, 
and the dried samples were purified by denaturing poly ac ryl­
amide gel electro ph or esis.-
75ml of 16% sequencing gel mix, polymerised with 400ul 
of 10% ammonium persulphate and 40ul T E M E D , was poured 
between two 20x22cm glass plates separated by 1.5mm spacers. 
Wells of approximately 1cm in width were formed using an 
8-tooth teflon comb. The DNA samples were resuspended in 
50ul of water by vortexing, then microfuged for 3 min.
The supernatant was transferred to 50ul of sample buffer 
(28ul lOx T B E ^ , 117ul water, 800ul deionised formamide) 
and boiled for 10 min then quenched on ice and loaded 
immedia te 1y .
2ul of formamide-dye mix was loaded in a separate
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well to act as a molecular weight marker. The gels were 
electrophoresed slowly, at 3.5-4mA overnight in TBE'*'.
To visualise the DNA the gel was removed, wrapped in 
cling film and viewed against a white chromatograph plate 
by angled long-wave uv light. If the synthesis had been 
successful then a predominant, strong top band with possibly 
a few minor lower mol. wt. bands was seen. The top band 
was cut out with a scalpel and mashed and eluted exactly 
as described in method section IX.3, except that chilling 
in dry-i ce/ethano l was always for at least 20 min. Finally, 
the recovered DNA was resuspended in water and the 
determined. For synthetic oligonucleotides the conversion 
factor is taken as 1 0D unit = 20ug/ml.
SECTION X U  : DNA CLONING
X U . 1 Preparation of competent bacteria
lml of an overnight culture of DH1 cells (a strain 
of Escherichia coli K12, Hanahan (1983)) was transferred 
to 22ml L-broth without ampicillin in a medium-sized (250ml) 
tissue culture flask and shaken slowly for approximately 
90 min, until the of the culture was about 0.2
(equivalent to mid-log phase). The cells were then cooled 
on ice for at least 10 min, pelleted in an SS34 rotor at 
8000rpm for 5 min, resuspended in 10ml ice-cold 50mM C a C ^  
and incubated on ice for a further 20-30 min. The cells 
were again pelleted and resuspended in lml 50mM C a C ^ ,  
divided into lOOul aliquots and stored on ice overnight 
before u s e .
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XH . 2 Pr e p a r a t i o n  of a m p i c i l l i n  plates
L-broth in agar was melted and then allowed to cool 
until the flask containing it was comfortable to hold. 
Ampicillin was added to a concentration of lOOug/ml, and 
the agar poured into 90mm sterile petri dishes and allowed 
to set. The plates were dried in an inverted position 
before being stored at 4°C and were used within 3 weeks.
X U .3 Cloning of DNA fragments
Insert DNA was cloned into the Bam HI site of the 
vector pUC8. The plasmid DNA was cleaved with Bam HI at 
37°C for 6 h in the presence of 0.5ul (11 units) of calf 
intestinal phosphatase, then further incubated for 60 min 
in the presence of 50ug/ml proteinase K and 0.2% SDS, to 
inactivate the phosphatase. The DNA was then extracted 
twice each with phenol and ether and precipitated as 
described (method section I X . 1). The DNA fragments to be 
inserted all had 5' overhangs equivalent to a Bam HI site 
and therefore should anneal with the ends of the Bam HI 
digested plasmid. Removal of the 5 ’ phosphate groups on 
the plasmid should minimise religation of plasmid molecules 
without an insert.
For ligation, a DNA concentration of approximately 
50ug/ml was used, in a volume of 20ul, and with a ratio 
of approximately 10:1 wt/wt i n s e r t :plasmid DNA. Thus, 
approximately O.lug of pUC8 DNA was incubated overnight 
at RT in the presence of 0.9ug of insert DNA in ligase 
buffer (50mM Tris.HCl pH 7.5, lOmM M g C l 2 , ImM ATP, 20mM D T T , 
50ug/ml BSA) containing 0.5ul T4 DNA ligase. Following 
ligation the DNA was extracted and precipitated as described.
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X H  . 4 T r a n s f o r m a t i o n  of b a c t e r i a
Dried DNA was resuspended in 20ul of water or TE. 
Varying amounts (0.1-0.5ug in 5-10ul) of DNA were mixed 
with 50ul of competent DH1 cells and 25ul of 50mM C a C l 2 
and incubated on ice for 45 min. The cells were then heat 
shocked at 42°C for 90 seconds, placed on ice for 60 
seconds, then 400ul of L-broth without ampicillin was added 
and the cells incubated at 37°C for 60-90 min. lOOul of 
cells were then spread with an L-shaped glass rod onto 
ampicillin plates, at various dilutions (usually neat, 1/10, 
1/100) and incubated at 37°C for 16-24 h.
Individual plaques were analysed by growing overnight 
cultures, isolating the plasmid DNA and testing for the 
presence of insert DNA by restriction enzyme analysis. 
Cultures were grown from positive clones and stocks were 
then stored in 50% glycerol at both -20°C and -70°C.
RESULTS
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RESULTS
SECTION I : GENERATION AND CHARACTERISATION OF ANTISERA
1 .1 Generation of anti-peptide sera
The original aim of this project was to purify and 
characterise the 21K DNA-binding protein, believed to be the 
product of gene Ugll (see introduction section XI). The 
available DNA sequence information (Rixon and McGeoch, 1984) 
was used to obtain synthetic oligopeptides corresponding to 
5 regions within the predicted U g H  gene product. These are 
shown in Figure 18. A number of studies have suggested that 
the best results in inducing anti-peptide sera which cross- 
react with the native protein are obtained by using amino- 
or car boxy-terminal peptides or peptides representing h y d r o ­
philic regions of the protein (reviewed in Palfreyman et a l ., 
1984). Thus, peptides corresponding to amino acids 1-11, 151— 
161 and 155-161 were chosen, since they represent the amino- 
and carboxy-termini of the predicted polypeptide, respectively, 
while peptides corresponding to amino acids 48-58 and 132- 
138 were chosen on the basis of their hydrophilicity (see 
Figure 18). The amino acid sequence predicted for the Ugll 
gene product contains a region which shares limited homology 
with a consensus sequence for oc-helix 3 of known sequence- 
specific DNA-binding proteins (Gicquel-Sanzey and Cossart,
1982; Takeda et a l ., 1983). Amino acids 66-76 lie within this 
region (Figure 19).
The peptides used in this study have been named simply 
on the basis of the amino acid sequence they represent, ie. 
peptide 1-11, 48-58 e_t c e t e r a . In addition, for simplicity 
in the figures, the terminal peptides have been designated
FIGURE 18
Schematic diagram of the Ugll gene product. The predicted 
product of gene Ugll is a 161 amino acid protein with a 
predicted mol. w t . of 17,756 (Rixon and McGeoch, 1984; 
McGeoch et a l ., 1985), and has the unusual feature of 
containing 24 tandem repetitions of the sequence X-Pro-Arg 
towards the carboxy-terminus. The hydropathicity profile 
of this putative polypeptide, obtained using the program 
SOAP, based on the method of Kyte and Doolittle (1982), is 
shown above the schematic diagram of the predicted gene 
product. Negative hydropathicity values indicate h y d r o ­
philic regions of the protein. Synthetic oligopeptides, 
corresponding to amino acids 1-11, 48-58, 66-76, 132-138, 
151-161 and 155-161, respectively ( ■ ■  ) , were used to 
generate antisera. The amino acid sequences of these oligo­
peptides are shown below. An additional amino-terminal 
tyrosine residue was added to each sequence to facilitate 
coupling to BSA.
20
10
0
-10
-20
[X-Pro-Arg]24
-COOH
11 48 58 66 76 132 144 151 161
Amino acid sequence of the synthetic oligopeptides
1-11 : (Tyr)-Met-Ser-Gln-Thr-Gln-Pro-Pro-Ala-Pro-Val-Gly
48-58 : (Tyr)-Arg-Gly-Asp-Asn-Asp-Gln-Ala-Ala-Gly-Gln-Cys
66-76 : (Tyr)-Val-Gly-Ala-Asp-Thr-Thr-Ile-Ser-Lys-Pro-Ser
132-138
138-144
151-161
155-161
(Tyr)-Glu-Pro-Arg-Ser-Pro-Arg-Glu
(Tyr)-Pro-Arg-Glu-Pro-Arg-Thr-Ala-Arg-Gly-Ser-Val 
(Tyr)-Arg-Thr-Ala-Arg-Gly-Ser-Val
FIGURE 19
Homology between the Ugll gene product and known sequence- 
specific DNA-binding proteins. The consensus sequence 
derived for oc-helix 3 of known sequence-specific DNA- 
binding proteins (Gicquel-Sanzey and Cossart, 1982; Takeda 
et a l ., 1983) is shown. Thirteen different sequence- 
specific DNA-binding proteins were compared by the former 
authors, and the number of these which are conserved at a 
given amino acid is indicated. The nature of the amino 
acid - ie. polar (P), non-polar (NP), acidic (A) or basic (B) 
is also shown for comparison. The region within the 
predicted Ugll gene product (21K) from amino acids 64-77, 
inclusive, is shown below. This has limited homology with 
the consensus sequence, and in particular shares a highly 
conserved region found between positions 7 and 10 (*).
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N 1 1 , C n  and C^, indicating that they represent the amino- 
terminal 11 amino acids, the carboxy-terminal 11 amino acids 
and the car boxy-terminal 7 amino acids, respectively. Peptide 
132-138 represents not only amino acids 132-138, but also 
amino acids 138-144 : the amino acid sequence of this peptide 
(excluding the amino-terminal tyrosine residue, see below) 
forms part of a trimeric repeat sequence [Ser-Pro-Arg-Glu-Pro- 
Arg] found between amino acids 129 and 146.
The synthetic peptides were obtained from Cambridge 
Research Biochemicals (CRB) Limited. They all contained an 
additional amino-terminal tyrosine residue, to facilitate 
coupling to carrier protein (Bassiri et a l . , 1979). It has 
long been believed that small molecules, such as synthetic 
peptides, are poorly immunogenic, and that coupling to a 
carrier protein greatly enhances their i m m u n o g e n i c i t y . Bovine 
serum albumin (BSA) is an efficient carrier molecule (Palfreyman 
e t a l ., 1984b), readily available and relatively inexpensive
and was therefore used throughout.
The peptides were iodinated, via the tyrosine residue, 
in order to monitor the efficiency of the coupling reaction.
The iodination reactions were carried out by Dr Howard S Marsden 
or Mrs Mary Murphy and are therefore not shown. Coupling to 
BSA was carried out as described in method section III. 2, 
using bis diazobenzidine as the cross-linking reagent. Since 
this procedure has been fully described (Dalziel, 1984) 
results will not be shown. A brief outline is, however, given 
b e l o w .
Peptide-BSA conjugates were separated from uncoupled 
peptide by passage through a Sephadex G25 column. Collected 
fractions were analysed for radioactivity in a gamma counter.
Two peaks were observed - the first peak representing coupled
-117-
peptide and the second free peptide. Fractions from peak 1 
were then pooled and the coupling efficiency calculated 
(method section HI.2b). Over the 12 coupling reactions that 
were carried out in total, coupling efficiencies ranged from 
18% to 40%, with an average coupling efficiency of 28.7%.
This represents 3-10 moles of peptide per mole of BSA. Coupled 
peptides were dialysed against PBS-A before use.
To monitor the preparation of the BSA-peptide conjugates, 
samples taken before and after coupling were subjected to SDS- 
PAGE and analysed by both Coomassie blue staining and a ut o­
radiography. Prior to coupling no label was seen comigrating 
with the BSA, whereas after coupling this protein appeared 
strongly labelled. By subjecting samples at various stages 
of the procedure to SDS-PAGE, it was established that neither 
passage through Sephadex G25 nor the subsequent dialysis 
resulted in significant loss of the BSA-peptide conjugate 
(results not shown).
New Zealand White rabbits were immunised according to 
the schedule shown in Table 3 (see method section H I .3). For 
each immunisation 400-500ug of either free, uncoupled peptide, 
or peptide coupled to BSA, immulsified in complete or incomplete 
Freund's adjuvant, was injected intramuscularly, into both 
rear legs. The rabbits were bled 7-14 days after each injection. 
Pre-immune sera were obtained from all rabbits, except numbers 
14059 and 14060.
I • 2 Establishment of a radioimmunoassay for anti-peptide antibodies
(a ) Optimal concent ration of peptide
Immune sera were assessed for reactivity against the 
immunising peptide by a radioimmunoassay (RIA). This is
Table 3 : Immunisation schedule used to generate a nti­
peptide sera
New Zealand White rabbits were immunised with peptide, 
either alone (free) or conjugated to BSA. For simplicity, 
the rabbits have been designated numbers 1-17, but the 
full rabbit number is also given.
<{ The day upon which the rabbits were either immunised 
or bled. Day 0 is defined as the date of the first 
immunisation of a given rabbit. All subsequent dates 
are relative to this.
* Serum 17 (12848) was raised by R.G. Dalziel and H.S. 
Marsden, and has been described previously (Dalziel, 
1984).
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out lined in method section I V. 3. To establish the optimal 
concentration of peptide to use as antigen, doubling dilutions 
of peptide in PBS were adsorbed onto microtitre plates, and 
then tested against doubling dilutions of antibody. In theory, 
the antigen dilution giving the highest antibody titre for 
a given serum is the most sensitive assay condition to use.
A positive reaction was taken as >3 times the normal rabbit 
or pre-immune serum control value, a control serum being 
present on each microtitre test plate. Examples of antigen 
dilution curves are shown in Figures 20A and 20B.
For some peptides there was an obvious reduction in 
sensitivity as the antigen concentration fell. For example, 
for peptide 155-161 (Figure 20A) there was a rapid fall in 
the antibody titre measura ble after an antigen dilution of 
1/4 (4ug/ml). However, for other peptides, for example peptide 
132-138 (Figure 20B), there was no obvious loss of sensitivity 
with decreasing concentrations of antigen. Therefore, in 
these cases con sideration was also taken of the absolute counts 
measured. The higher the counts the more reliable the assay, 
as the percentage error in the measurement of radioactivity 
would be less. In Figure 2 0 C , a constant dilution of antiserum 
against peptide 132-138 (a n t i - ( 132-138)) was reacted against 
doubling dilutions of peptide. The counts measured fell 
sharply after an antigen dilution of 1/4 (4ug/ml). In 
comparison, the normal rabbit serum control values were approx ­
imately 300-400 cpm for each antigen dilution. Therefore, for 
both the peptides shown, a concentration of 4ug/ml was 
considered sufficiently sensitive for our purpose. In a similar 
manner, the optimal con centration of each of the other peptides 
was calculated (see Table 4).
FIGURE 20
To determine the optimal concentration of peptide antigen 
for RIA. Assays were carried out as described in method 
section IV.3.
A,B Doubling dilutions of peptide 155-161 (A) or peptide 132- 
138 (B), from 16 ug/ml, were adsorbed onto microtitre 
plates and reacted against serial dilutions of either (A) 
anti - ( 155-161) serum 12848, or (B) a n t i - (132-138) serum 
12851. Reactions ^.3x the NRS control were considered 
positive. The antibody titre represents the highest dilution 
of antiserum considered positive.
C Doubling dilutions of peptide 132-138, from 16 ug/ml, were
adsorbed onto microtitre plates and reacted against anti-
(132-138) serum 12851, diluted 1/10. Bound antibody was 
125detected using I-labelled protein A, and the absolute 
level of counts measured is shown. The NRS control bound 
between 290-414 cpm (results not shown).
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Table 4 : Concentration of peptides used in the RIA
The concentration of peptide subsequently used in the RIA 
was determined as described in the text. 25ul of peptide, 
at the concentration indicated, was added per well of a 
microtitre plate. From the estimated mol. w t . of each 
peptide, the approximate number of picomoles of peptide 
added was calculated.
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(b ) Specificity of the radioimmunoassay
In order to confirm the specificity of the assay, sera 
were tested against several different antigens. The ant i­
peptide sera only reacted against specific peptide and not 
against unrelated peptides or proteins. An example of one 
such test is shown in Table 5A. Using an antiserum against 
the BSA-conj uga ted peptide 132-138, a strong reaction is 
detected against BSA, the related protein ovalbumin, and the 
peptide 132-138, but not against an unrelated peptide (peptide 
155-161), the amino acid glycine or the unrelated protein 
lysozyme. No reaction is seen in the absence of antigen, 
indicating that non-specific binding sites are efficiently 
blocked by the Tween 20 blocking reagent.
(c ) Removal of anti-BSA antibodies from anti-peptide sera
To obtain truly mono-specific antisera against the 
peptides, antibodies to BSA were removed. This was achieved 
by covalently coupling BSA to Sepharose 4B (method section 
V.2), incubating the anti-peptide serum on the S e p h a r o s e :BSA 
column for 1 h at RT and then eluting with PBS. Material was 
collected from the first drop of reddish-brown colour to the 
last drop of colour, resulting in a 2-3-fold dilution of the 
antiserum. The degree of colour, which probably corresponds 
to the concentration of serum, was shown to correlate with 
the presence of antibody, as assessed by RIA (Mary Murphy, 
personal communication), and this procedure therefore safely 
included all significant antibody-containing fractions.
The sera were then tested for the presence of antibodies to 
BSA and peptide. Sera which had not been absorbed with 
S e p h a r o s e :B S A , and therefore still contained anti-BSA ant i ­
bodies, were termed nonabsorbed (NA) sera, while those which
Table 5 ; Specificity of the RIA, and removal of 
anti-BSA^ antibodies
Peptide, at the concentration shown in Table 4, glycine
(1M), lysozyme, ovalbumin, BSA (all 0.1% in PBS) or PBS
alone (nil), were adsorbed onto microtitre plates, fixed
and blocked as described (method section IV .3). The plates
were then reacted with an ti-(132-138) serum 12851, either
absorbed against BSA (PC), or not absorbed (NA), or normal
rabbit serum (not shown). Results are expressed as a ratio 
125
of the I-labelled protein A (cpm) bound by the antiserum 
compared to the control serum.
Peptide 155-161 (4 ug/ml) or BSA (0.1%) were adsorbed onto
microtitre plates and reacted against a n t i - ( 155-161) serum
12848 either non-absorbed (NA) or absorbed against Sepharose:
BSA (PC), the antibodies eluted from the Sepharose:BSA
column by 3M sodium thiocyanate and dialysed against PBS (EL),
or normal rabbit serum (NRS), diluted as indicated. The 
125
level of bound I— labelled protein A, in cpm, is given.
Table 5 : Specificity of the RIA,
and removal of anti-BSA antibodies
A.
A n t i g e n A n t i - ( 132 NA
- 1 3 8 )
PC
1 3 2 - 1 3 8 2 8 . 6 22 . 2
1 5 5 - 1 6 1 1.1 1.0
G l y c i n e 1.5 1.2
L y s o z y m e 2 . A 1.0
O v a l b u m i n 10.9 2 . A
B S A 11 .A 0 . 9
n i l 1.1 1.1
B.
D i l u t i o n A n t iNA
- ( 1 5 5 -
PC
161)
EL NRS A n t i g e n
1 5 3 2 9 1001 3 5 6 0 2 7 A A
10 A 8 3 8 118 1 7 1 A 255 B S A
1 00 2 A 9 9 81 57 3 67
1 0 0 0 6 8 8 99 91 A2
1 2 6 2 5 2 5 3 9 109 160
10 1 A 1 6 8 3 5 110 101 1 5 5 - 1 6 1
10 0 3 2 5 1AA 93 112
1 0 0 0 136 103 56 110
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had been absorbed against S e p h a r o s e :BSA were termed post­
column (PC) sera.
Tables 5A and 5B show the effect of absorption of anti­
sera with BSA. In Table 5A, removal of anti-BSA antibodies 
significantly reduces the reaction with both BSA and ovalbumin 
without significantly affecting the response to peptide 132- 
138. Thus, within the limits of sensitivity of the assay, the 
antiserum is now mono-specific. In Table 5B, antiserum against 
peptide 155-161 was absorbed with S e p h a r o s e :B S A . After 
extensive washing of the column, specifically retained a n t i ­
bodies were eluted using 3M sodium thiocyanate, and then 
dialysed against PBS. This material was termed the eluate (EL). 
In the non-absorbed serum a high titre of anti-BSA antibodies 
was present (^1000), whereas following absorption the titre 
was not detectable (ie. was not significantly different from 
the normal rabbit serum (NRS) control). Radioimmunoassays 
for BSA antibodies always had a high background with undiluted 
serum, and the results for these samples must be interpreted 
with caution. In addition, it should be mentioned that during 
chromatography the post-column and eluate samples were diluted 
2.5-fold in volume compared to the non-absorbed serum. Neither 
the non-absorbed serum nor the NRS control were similarly 
diluted to take this into account. Bearing these comments in 
mind, there would still appear to be at least a lOOyfold 
(probably 1000-fold) reduction in the anti-BSA titre, while 
in comparison the anti-peptide response was diminished less 
than 10-fold. Titration experiments have shown that, in 
general, absorption against S e p h a r o s e :BSA results in a 2-4- 
fold reduction in anti-peptide titre. Since absorption also 
causes a 2-3-fold increase in volume this represents overall 
a very small loss of anti-peptide antibodies. Material eluted
-121-
from the S e p h a r o s e :BSA specifically reacted with BSA antigen, 
to a titre of about 100, while it did not react at all with 
peptide antigen (Table 5B). This would represent a recovery 
of approximately 10% of the anti-BSA activity. Full recovery 
would not be expected since 3M sodium thiocyanate is a rather 
harsh and denaturing treatment.
Thus, it can be concluded that absorption against BSA 
specifically removes antibodies to BSA without a significant 
loss of anti-peptide antibodies.
1 .3 Titration of anti-peptide sera by radioimmunoassay
Sera were assessed for response to peptide by RIA prior 
to removal of the BSA antibodies. The results are shown in 
Table 6. It was interesting to note that in a number of cases 
the anti-peptide titres fell with time, despite further 
immunisation. No attempts were made to boost using different 
carrier proteins. Four rabbits were immunised with free 
peptide, but produced only very low or undetectable titres 
of anti-peptide antibodies. However, when coupled to BSA 
these peptides induced high levels of antibody (compare rabbits 
1,2 with 3,4 and 13,14 with 15,16). Therefore, at least for 
these two peptides, using this immunisation protocol, the 
coupling to carrier protein was essential for a good a n t i ­
peptide response.
f • ^  Interaction of anti-pep tide antibodies with HSV polypeptides
(a ) Establishment of the immunoblotting assay
The antisera were screened for reactivity against protein
by immunoblotting. The immunoblotting procedure is described
3 5
fully in method section IV .5. Very briefly, [ S ]-methionine
Table 6 : Anti-peptide response of immunised animals
Sera were assessed for response to peptide by RIA prior 
to removal of anti-BSA antibodies. Rabbit numbers and 
immunogens are designated as in Table 3. Consecutive 
bleeds from each rabbit were assessed simultaneously.
The titres represent the highest dilution of a given serum 
considered positive (ie. ^.3x the pre-immune or NRS 
c o n t r o l ).
PI pre-immune 
nd not determined 
- no such bleed exists
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labelled polypeptides, electrophoretically separated by SDS-
PAGE and transferred to nitrocellulose, were reacted with
antiserum and the bound antibody molecules then detected using 
125 I-labelled protein A. The nitrocellulose strips were set
up for autorad iography in such a way that the signals from 
35 125
the S and I were detected on separate X-ray films. The 
films were then aligned by means of marker spots of radio­
active ink, allowing identification of the proteins recognised 
by the antisera. This is illustrated in Figure 21.
The HSV polypeptides themselves serve as mol. w t . markers. 
They produce a characteristic banding pattern on SDS-PAGE, 
and apparent mol. w t . values have previously been very care ­
fully determined for each of these bands (Marsden et a l . ,
1976). In Figure 21, antiserum against peptide 151-161 is seen
to react with a number of low mol. wt. polypeptides. By
35
alignment with the corresponding S-labelled protein profile, 
these can be identified as having apparent mol. wt. 22K, 21K,
17.5K, 14K and 11K„ A faint band can also be seen in the 
region of 12K, but for reasons which will be discussed later, 
this is thought to represent a non-specific interaction.
Anti-pe pti de antibodies react in immunoblotting experiments 
to varying extents depending on the temperature at which the 
nitrocellulose strips are blocked (Howard S Marsden, personal 
communication). The reason for this behaviour is not known, 
but it is possible that heat denaturation of the protein may 
lead to some epitopes becoming more (or in some cases, less) 
accessible to the relevant antibody. Thus, two blocking 
temperatures were originally used, 37°C (the 'non-d enatur in g1 
temperature) and 65°C (the 'denaturing' temperature). For all 
our antisera, the immunoblotting reactions were as good or 
better at 65°C when compared to 37°C, and for this reason the
FIGURE 21
Immunoblotting with a n t i - C ^  serum 14328. Immunoblotting
was carried out as described in method section I V.5. The
3 5first track shows S-methionine labelled HSV-l-infected 
cell proteins transferred to nitrocellulose. The second 
track shows the polypeptides on the nitrocellulose that 
are detected by the a n t i - C ^  serum. Alignment of the two 
lanes allows the apparent mol. wt. of the polypeptides 
to be identified (Haarr et a l . , 1985).
_y
-21
- 17-5
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blocking reactions were subsequently carried out at 65°C.
In immunoblotting experiments it was necessary to use 
antisera after the removal of BSA antibodies. Non-absorbed 
sera reacted with a 68K polypeptide, presumably corresponding 
to BSA, and also showed a high level of background staining 
on the immunoblots (Figure 22), possibly due to the presence 
of multiple breakdown products of BSA (Dalziel, 1984) or 
cross-reaction with cell or viral proteins. In contrast, the 
post-column antisera showed a relatively low level of b ack­
ground staining. Pre-immune sera varied in their level of 
background staining, but never reacted with a 21K/22K band, 
suggesting that this represents a specific interaction.
(b ) Reactivity of anti-peptide sera by immunoblotting
A typical example of an immunoblotting reaction is shown
for each serum in Figure 23. The arrow represents the position
occupied by the 21K polypeptide, determined by comparison with
35
the corresponding [ S]-labelled polypeptide profile (not 
shown). In some cases, the 21K and 22K bands are clearly 
resolved (for example, rabbits 7, 10, 14; see also Figure 21),
indicating that both 21K and 22K polypeptides are being 
recognised. However, often these bands run very close together 
and cannot be clearly distinguished on immunoblots.
The sera raised against the BSA-conjugated peptides (ie. 
all sera excluding 3, 4, 15 and 16), all reacted with a protein
of apparent mol. wt. 21K, with the single exception of the 
antiserum against peptide 132-138 (rabbit 12). This serum 
consistently failed to recognise any apparently specific band 
on immunoblots, and showed a high level of background staining. 
A very faint band in the region of 21K was, however, among 
the many bands present.
FIGURE 22
Effect of removal of anti-BSA antibodies on the im muno­
blotting assay. HSV-l-infected cell polypeptides, separated 
on 10% SDS-polyacrylamide gels and transferred to nitro­
cellulose, were reacted against anti-C-^ serum 14328. PI 
represents pre-immune serum from rabbit 14328; PC represents 
'post-column' serum - ie. a n t i - C ^  serum 14328 absorbed 
against S e p h a r o s e :B S A ; NA represents non-absorbed a n t i - C ^  
serum 14328.
antiserum PI ^ C -m
/V 
PC NA
FIGURE 23
Immunoblotting of HSV— 1— infected cell polypeptides with
the anti-peptide sera. Rabbit numbers are designated as
in Table 3 :
1-4 : anti-N-^ sera 14473, 14474, 14471 and 14472,
respectively. The latter two rabbits were immunised 
with free oligopeptide.
5-8 : anti-(48-58) sera 14059, 14060, 18244 and 18245, 
re spectively.
9-10 : anti-(66-76) sera 18246 and 18416, respectively.
12 : ant i-(132-138) serum 12851.
13-16 : a n t i - C ^  sera 14327, 14328, 14469 and 14470,
respectively. The latter two rabbits were immunised 
with free oligopeptide.
17 : anti-C^ serum 12848, raised by R.G.Dalziel and H.S.
M a r s d e n .
The position of the 21K polypeptide, identified by align-
35ment with the corresponding S-methionine profile, is
indicated ( - ^ ) .
: indicates 3 bands of apparent mol. w t . 17.5K, 15K and
14K recognised by the anti-(66-76) sera. Their specificity 
is uncertain.
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Free, uncoupled peptides were less successful in inducing 
antisera which reacted against the 21K polypeptide. Only one 
serum from each pair reacted with 21K (rabbits 3 and 15, 
respectively), and the reaction with the anti-(l-ll) serum 
(rabbit 3) was only barely detectable. Some sera appeared to 
recognise not only 21K/22K but also additional lower mol. wt. 
polypeptides. These are discussed in more detail below.
(c) Specificity of the immun oblot ting reaction
Specificity of the immunobl otting reaction was suggested 
by a number of findings. Firstly, as already mentioned, pre- 
immune sera did not recognise the 21K and 22K polypeptides 
(Figure 22, and results not shown). Secondly, immune sera 
recognised bands of apparent mol. w t . 21K/22K in HSV-l-infected 
but not moc k-i nfected cell extracts (Figure 24: compare lanes 
1 and 3, and lanes 4 and 6 in (A); compare lanes 1 and 3, 
and lanes 5 and 7 in (C)). And thirdly, incubation of anti- 
(1-11) serum in the presence of homologous but not heterologous 
peptide specifically inhibited the interaction with the 21K 
and 22K bands (Figure 24B). In contrast, lower mol. w t . bands 
in the region of 12K and 14K were not inhibited by the 
homologous peptide, suggesting that these represent n on­
specific interactions.
A number of additional lower mol. w t . polypeptides 
appeared to be specifically recognised in that they were also 
present only in HSV -l-infect ed cell extracts, and only with 
immune sera. A 17.5K polypeptide was recognised by antisera 
against peptides 48-58 (Figure 24C, lanes 1-3), 151-161 
(Figure 24A) and 155-161 (Figure 24C, lane 4). A 15K pol y­
peptide was very weakly detected by antiserum against peptide 
1-11 (Figure 24A) and more strongly detected by antiserum
FIGURE 24
Specificity of the immunoblotting reaction. Polypeptides 
were separated on 5-12.5% SDS-polyacrylamide gels, trans­
ferred to nitrocellulose and reacted with antisera as 
described (method section IV.5).
a n t i - C ^  serum 14327 (lanes 1-3) and a n t i - N ^  serum 14473 
(lanes 4-6) were reacted in immunoblotting experiments 
against extracts from HSV-l-infected cells (lanes 1 and 4) 
HS V-2 -infected cells (lanes 2 and 5) and mock-i nfect ed 
cells (lanes 3 and 6).
a n t i - N ^  serum 14473 was reacted against HSV-l-infec ted 
cell extracts either alone (lane 1) or in the presence of 
100 ug of peptide (lane 2) or of peptide (lane 3).
anti-(48-58) serum 14060 (lanes 1-3) and serum 18244 
(lanes 5-7) were reacted against extracts from mock- 
infected cells (lanes 1 and 5), HSV -2-infected cells 
(lanes 2 and 6) and HSV-1-infected cells (lanes 3 and 7). 
Anti-Cy serum 12848 reacted against HSV-l-infected cell 
extract is shown for comparison (lane 4).
Bands detected by the a n t i - N ^  serum in all cell extracts 
and not inhibited by peptide, are indicated in (B) ( o )•
B
antiserum
antigen
<xC11 oc N 11
17+ HG52 Ml 17+ HG52 Ml 
1 2 3 4 5 6
peptide -
1 2 3
22 v_ 
21 -
17-5- 
14 -
11 -
-15
21- » »
14- | o i o
12-
antiserum r ex 48-58(1)— | ex Cy 
antigen Ml HG52 17+ 17+
1 2  3 4
r ex48-58(2)-1 
Ml HG52 17+ 
5 6 7
if*
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against peptide 48-58 (Figure 24C, lanes 5-7). Both these 
polypeptides appeared to be recognised by the antisera against 
peptide 66-76 (Figure 23, and results not shown), but these 
latter sera were obtained towards the end of this project and 
have not been well characterised. A 14K polypeptide, recognised 
by antisera to all peptides, except 1-11 and 132-138, was 
often strongly detected (Figure 24A, lanes 1-3; Figure 24C, 
lanes 5-7). However, a number of sera non-specifically 
recognised bands in the region of 12-14K (for example, see 
Figure 24C, lanes 1-3), and thus the significance of these 
reactions is not clear. Finally, an 11K polypeptide was 
detected, often strongly, by antisera raised against the 
carboxy-terminal peptides, 151-161 and 155-161 (Figure 24A, 
lanes 1-3; Figure 24C, lane 4). The possible relationship 
between these polypeptides will be discussed later.
None of the sera recognised the polypeptide equivalent 
to Vmw21 in H S V - 2 - i n f ected cell extracts (Figures 24A,C). 
However, since HSV-2 strain HG52 greatly underproduces the 
20.5K polypeptide relative to its HSV-1 counterpart (Marsden 
et a l . , 1978), this may simply reflect a lack of sensitivity
in the assay rather than a lack of homology between these two 
proteins .
(d) Immunoprecipitation of infected cell polypeptides by a nt i­
peptide sera
Im mun oprec ip it ation  experiments were also used to invest­
igate the reactivity of the anti-peptide sera. In Figure 25, 
antisera to peptide 1-11 (lane 5) and 151-161 (lane 2) clearly 
precipitate proteins of apparent mol. wt. 21K and 22K which 
are not precipitated by the pre-immune serum (lane 1). The 
specificity of the reaction was confirmed by incubation of
FIGURE 25
Immunoprecipitation with anti-peptide serum. Proteins 
35labelled with S-methionine were precipitated from an 
HSV-l-infected cell extract (17+ ) by either pre-immune 
serum from rabbit 14327 (lane 1), a n t i - C ^  serum 14327 
incubated in the presence of 0, 1 or 10 ug of peptide
(lanes 2-4, respectively) or a n t i - N ^  serum 14473 (lane 5). 
Bands which appear to be specifically precipitated are 
marked ( ■  ).
antiserum 
peptide (ug)
17+
155 -
65 -
4 5 -
21 -
PI I— C*C-|1 —1 Oc N^ -J
-  0 1 10
1 2 3 4 5
14-
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the a n t i - (151-161) serum in the presence of the relevant 
peptide. This peptide inhibited precipitation of the 21K and 
22K polypeptides without significantly affecting the pre­
cipitation of other proteins (compare lanes 2 and 3). High 
concentrations of peptide caused an overall reduction in the 
intensity of bands (lane 4). The reason for this is unclear, 
but a similar effect can be seen in Figure 24B, lane 3. A 
14K polypeptide would also appear to be specifically precipitated 
by the a n t i - ( 151-161) serum (compare lanes 2 and 3). This 
finding is interesting as no strong 14K band is evident in 
the HSV-1 extract and suggests either that the antiserum has 
a very high affinity for the 14K polypeptide, or that 14K is 
generated during the immunoprecipitation reaction. Co ­
precipitation of polypeptides could arise either if the poly ­
peptides were present as part of a complex, or alternatively, 
if they share antigenic determinants. The interaction with a 
polypeptide of similar mol. w t . in immunoblotting experiments 
(Figure 24A) favours the latter explanation.
The serum against peptide 132-138, which failed to react 
convincingly in immunoblotting experiments, may very weakly 
precipitate 21K, since the 21K and 22K polypeptides, and 
additional lower mol. w t . polypeptides precipitated, were 
absent from the normal rabbit serum control (Figure 26).
However, since no peptide inhibition control was attempted, 
the specificity of these interactions is not unambiguously 
established. The background in immunoprecipitation experiments 
was often high, and in general specific precipitation by the 
anti-peptide sera was rather weak (as, for example, in Figure 
26). For this reason immunoprecipitation reactions were not 
carried out on all sera.
FIGURE 26
Immunoprecipitation with a n t i - ( 132-138) serum. Proteins 
35
labelled with S-methionine were precipitated from an 
HSV-1-infected cell extract (17+ ) by either normal rabbit 
serum (NRS) or anti-( 132-138) serum 12851 (<*132-138). The 
21K and 22K polypeptides precipitated by the immune serum 
are indicated, tt represents additional lower mol. wt. 
polypeptides precipitated only by the immune serum.
17+ NRS 0:132-138

FIGURE 27
Comparison between anti-peptide RIA and anti-protein 
immunoblotting responses of the oligopeptide-induced 
antisera. The rabbit numbers and immunogen are indicated. 
Rabbit numbers are designated as in Table 3. The immuno- 
blots show only the region of the gel encompassing the 21K 
polypeptide. Above each immunoblot is shown the bleed 
number, and below is shown the anti-peptide titre, as 
assessed by RIA.
Rl, R2.... : rabbit number 1, 2....
PI : pre-immune
nd : not done
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immunoaffinity ch rom atography  (see later) unsuccessful. Even 
in immunoblotting experiments, where proteins are presumed 
to be at least partially denatured, and sequential epitopes 
more accessible to antibodies, the antisera could be used 
at best at a 1/4 dilution. Only one anti-peptide serum which 
had a high affinity for 21K on immunoblots was obtained, 
bleed 4 from rabbit 17, prepared by R. Dalziel. This serum 
worked in immun oblotting experiments at a 1/1024 dilution 
(Mary Murphy, personal communication), but was unf ortu na tely 
available in very limited quantity, and even it failed to 
react strongly by immu noprec ip itation  or immuno affinity 
chromatography with 21K.
1.6 Further attempts to raise antibodies to 21K
Due to the poor affinity of the anti-peptide sera for 
21K, attempts were made to raise antibodies to this protein 
by two other methods : firstly, to raise mouse monoclonal
antibodies against both peptides and purified 21K, and 
secondly, to raise monospec ific antisera in rabbits against 
purified 21K. Neither of these approaches met with success, 
and they are therefore outlined only briefly below.
Monoclonal antibodies
Sera from mice immunised with either pa rtially- purified  
21K, prepared by DNA cellulose chromatography (result section 
m*3), or with synthetic oli gop eptides conjugated to BSA, 
wore analysed by i m m u n o p r e c i p i t a t i o n , immunoblotting and RIA. 
0nly the RIA provided evidence for a response to the immunogen. 
Clones, resulting from fusion between spleen cells from the 
immunised mice and a mouse myeloma cell line, were screened 
antibody production in a similar manner, and again only
-129-
the RIA provided evidence for a positive response - and only 
from the peptide-immunised animals. However, we subsequently 
found that mouse monoclonal antibodies gave a high level of 
false positive reactions in our RIA procedure, and no true 
positive cultures were obtained. Therefore, lacking confidence 
in our screening procedure, we made no further attempts to 
pursue this approach.
(b) Monospecific anti-21K sera
The 21K/22K polypeptides were partially-purified by DNA 
cellulose chromatography (result section HI.3), then separated 
by SDS-PAGE and transferred to nitrocellulose. The region 
of the nitrocellulose containing 21K/22K was isolated, 
dissolved in DMSO, and two rabbits then immunised with this 
material on several occasions. Sera from these animals were 
screened by immunoprecipitation and imm unoblot ti ng, but no 
convincing reaction was observed with the 21K/22K polypeptides. 
This approach was therefore discontinued.
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SECTION U  : CHARACTERISATION OF THE Ugll GENE PRODUCTS
In the preceding section the specificity and reactivity 
of the anti-peptide sera were established. Here, they have 
been used to characterise some of the properties of the Ugll 
gene products .
H .1 Temporal regulation of the Ug 11 gene products
(a) Appearance and accumulation of the 21K polypeptide during 
infection
To determine the temporal regulation of 21K, protein 
levels were monitored at different times following infection.
A detailed timecourse was carried out, harvesting samples 
(as described in method section IV.5) at one hour intervals 
from 0-8 h, then at 10, 12, 16, 20 and 24 h pi. The immuno- 
blotting procedure was slightly modified for these experiments 
Briefly, proteins were electrophoretically separated by SDS- 
PAGE and transferred to a single large sheet of nitrocellulose 
Free protein-binding sites were blocked at 65°C and then the 
sheet was incubated with 10ml of a strongly reactive anti­
serum, raised against peptide 155-161 (rabbit 12848, bleed 4) 
and probed with 20x10^ cpm of ^ ^ I - l a b e l l e d  protein A in 
120ml of the relevant buffer.
Using this procedure the 21K polypeptide was first 
detected at 4 h pi (Figure 28). The intensity of the reaction 
rose steadily until 12-16 h pi, when it appeared to plateau. 
This is shown quantitatively in Figure 29. The relative 
intensities of the bands were estimated by densitometric 
analysis of autoradiographs from various exposures of the 
8el (selected to give a linear response between absorbance
FIGURE 28
Timecourse of appearance of the Ugll gene products. Immuno- 
blotting was carried out essentially as described in method 
section IV.5, with the following modifications : Mock- 
infected (mi) or HSV-1-infected cell extracts, harvested 
at the times indicated (hours pi), were separated on 5-12.5% 
SDS-polyacrylamide gels and then transferred to a single 
large sheet of nitrocellulose. The nitrocellulose sheet 
was incubated with 10 ml of anti-Cy serum 12848, diluted
1/20, and after washing was further incubated with 100 ml
125 3
of I-labelled protein A at 2x10 cpm/ml. The apparent
mol. w t . of the polypeptides recognised were determined
35
by alignment with the S-labelled polypeptide profile 
(not sho wn ).
Time (hrs) p. i . 
mi 0 1 2 3 4 5 6 7 8 10 12 16 20 24
FIGURE 29
Timecourse of appearance of the Ugll gene products — 
densitometric analysis. Various exposures of the gel shown 
in Figure 28 (selected to give a linear response between 
absorbance and time of exposure) were subjected to densito- 
metric analysis, using a Joyce—Loebl scanning densitometer 
and measuring the area under the appropriate peaks using 
a program, DENS, written by Dr P Taylor for a DEC PDP 11/44 
computer linked to a digitizing two-dimensional tablet.
The relative intensities of the bands at different time 
points are plotted in arbitrary units.
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and time of exposure), and plotted in arbitrary units. The 
plateau after 12-16 h pi reflects the upper limit of sensitivity 
of the assay, and no longer reflects the absolute level of 
protein (see later, result section H.lc).
As shown previously, additional bands are also recognised 
by this serum. Polypeptides in the region of 12-16K were 
recognised in all samples, including the mock-infected control, 
and are therefore considered non-specific. However, a band 
of apparent mol. w t . 17.5K and a doublet in the region of 11K
appeared approximately 8-10 h pi and increased in intensity 
in parallel to the 21K band, until about 16 h pi (Figure 28). 
Their intensity was quantitated and plotted in Figure 29. In 
addition a band of apparent mol. w t . 14K appeared to increase
in intensity late in infection. However, because of the high 
background from the underlying non-specific bands it was not 
possible to quantitate this reaction. The timecourse of 
appearance of these additional bands (17.5K, 14K and 11K ) 
strengthens the previous suggestions that they are related 
to 21K and are breakdown products or processed forms of the 
Ugll gene product.
In conclusion, within the sensitivity of the assay, the 
2 IK Ugll gene product would appear to be a late viral poly­
peptide .
Is the 21K polypeptide a true late gene product?
To determine whether the 21K polypeptide is regulated 
as a true late gene product - ie. one whose synthesis is 
highly dependent on viral DNA replication - similar time­
course experiments were carried out, in the presence and 
absence of phosphonoacetic acid (PAA), an inhibitor of viral 
UNA replication. As a control, the level of gD, a delayed-
-132-
ear ly cpio protein, was measured. This work was carried out 
in conjunction with Paul Johnson, who analysed the levels of 
Ugll and gD RNA from parallel cultures, and who also measured 
the level of viral DNA synthesis (Johnson et a l ., 1986).
The results of two separate experiments are presented 
in Figure 30. Samples were harvested at the times shown and 
probed as before with the antiserum to peptide 155-161. A 
PAA-resistant mutant, PAA -1 (Hay and S u b a k - S h a r p e , 1976), 
known to have a mutation mapping to the DNA polymerase gene 
(Crumpacker et a l . , 1980), was used as a control to confirm 
that any effect of PAA on protein synthesis was via its 
effects on viral DNA replication.
The control cultures grown in the absence of PAA behaved
(3 h in experiment 2) 
as before, 21K accumulating steadily fronT~4h p T ^ t o 12-16 h
pi, when the reaction begins to plateau. In the presence of
PAA there was a significant reduction in the level of 21K
which was undetectable in the first experiment and only barely
detectable in the second (Figure 30). There was no obvious
reduction in 21K under these conditions with the PAA-resistant
mutant. However, since this assay is not sensitive at high
levels of antigen concentration (see later) a small reduction
would not have been detected. Interestingly, the ,21K,22K*
polypeptides of the PAA-resistant mutant show an altered
mobility in comparison to the HSV-1 wild-type virus 21K,22K
polypeptides - a feature previously described for the viral
polypeptides Vmw21, Vmw22 (Lonsdale et a l . , 1979).
For comparison, the appearance and accumulation of gD
was measured in the same cultures by immunoprecipitation of 
35
[ S ]-methionine labelled gD with a gD-specific monoclonal 
antibody. This antibody precipitates two bands, of apparent 
mol. wt. 57,000 (gD) and 51,000 (pgD), which are absent from
FIGURE 30
Effect of PAA on synthesis of the Ugll gene products. 
Immunoblotting was carried out as described in the legend 
to Figure 28. Results from two separate experiments are 
shown. Extracts from mock-infected or HSV-l-infected cells, 
cultured in the absence or presence of PAA (-PAA, +PAA, 
respectively), were harvested at the times indicated (hours 
pi). In experiment 1, extracts from cells infected with 
the PAA-resistant mutant, PA Ar- l , were harvested at 16 h 
pi. The PAAr-l 21K polypeptide, labelled in experiment 1/ 
+PAA, migrates with a slightly higher apparent mol. w t . 
than wild-type 21K (compare experiment 1/-PAA).
+ 
PAA
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the ascites control (Figure 31). In both the presence and 
absence of PAA, gD is first detected at low levels at 2 h pi 
(just visible in the exposure shown in Figure 31) and 
continues to accumulate throughout infection. Densitometric 
analysis (Figure 32) shows that gD accumulates very rapidly 
from 2-6 h pi, then continues to accumulate at a reduced rate 
until at least 16 h pi. Treatment with PAA reduces the level 
of gD by approximately 5-fold, but the overall pattern of 
accumulation is not changed. In comparison, the level of gD 
at 16 h pi with the PAA-resistant mutant is reduced about 
2-fold by treatment with PAA (not shown). The level of gD at 
2 h pi is very similar in the presence and absence of PAA, 
consistent with the effect being due to inhibition of viral 
DNA replication, which begins around 2-3 h pi (Johnson et a l . , 
1986). From this series of experiments it was concluded that 
21K is regulated as a true late gene.
(c) Relationship between antigen concentration and intensity 
of the immunoblotting reaction
To establish the relationship between the intensity of 
the immunoblotting reaction and the antigen concentration, 
antigen dilution experiments were carried out. The 16 h 
sample from experiment 1 (Figure 30) was serially diluted 
two-fold and tested by immunoblotting for 21K and by immuno- 
precipitation for gD (Figure 33). The reactions were again 
analysed by densitometry (Figure 34).
There is an approximately linear relationship between 
the intensity of the bands precipitated by the anti-gD m o n o ­
clonal antibody and the level of antigen, with a gradient 
close to 1 (1.2) - ie. a two-fold increase in intensity is 
approximately equivalent to a two-fold increase in antigen
FIGURE 31
Effect of PAA on synthesis of gD, an early polypeptide. 
Mock-infected and HSV-l-infected cells, cultured in the 
presence (+) or absence (-) of PAA, were harvested by the 
detergent lysis procedure (method section I.7a) at the 
times indicated. Immunoprecipitation was carried out 
essentially as described by Zweig et a l . (1980). Forty ul 
of cell extract, 50 ul of a 1/100 dilution of either mono­
clonal antibody 1892 or an ascites control and 5 ul of a 
rabbit anti-mouse Ig, were incubated for 3 h at 4°C, before 
being further incubated with protein A-Sepharose and 
analysed as described (method section IV.4). gD (57K) and 
pgD (51K) are indicated ( • ).
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FIGURE 32
Effect of PAA on the synthesis of 21K and g D . Various 
exposures of the gels shown in Figures 30 and 31 were 
subjected to densitoraetric analysis, as described in the 
legend to Figure 29.
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FIGURE 33
Relationship between antigen concentration and the intensity 
of the immunoblotting and immunoprecipitation reactions.
The 16 h samples from Figure 31 (A) and Figure 30, experiment 
1 (B) were serially diluted two— fold and a constant volume 
(40 ul) tested in immunoprecipitation and immunoblotting 
experiments, respectively, as before. The antigen dilution 
factor is indicated above the relevant lane, 1 representing 
the neat 16 h sample.
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FIGURE 34
Relationship between antigen concentration and the intensity 
of the immunoblotting and immunoprecipitation reactions - 
densitometric analysis. Various exposures of the gels 
shown in Figure 33 were subjected to densitometric analysis 
as described in the legend to Figure 29.
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concentration. This would c on fi rm  the in t e rp r e t a t i o n  from 
Figures 31 and 32, that gD levels are reduced about 5-fold 
in the presence of PAA.
In contrast, in the immunoblotting assay there was 
initially a very shallow gradient, where the intensity of 
the reaction changed very little over a 32-fold dilution of 
antigen. This was followed by a very sharp gradient, the 
intensity of the reaction falling from a near-maximal level 
to an undetectable level over an 8-fold dilution. Thus, there 
is a very short (4-8x) range of antigen concentration over 
which this assay is very sensitive. The assay is not sensitive 
at high concentrations of a n t i g e n . Therefore, little can be 
concluded about the concentration of antigen in the plateau 
region observed in the timecourse experiments (Figures 29 
and 32) .
This experiment also demonstrates that the immuno­
blotting procedure used is capable of detecting at least a 
1/128 dilution of the antigen concentration present in the 
16 h sample from experiment 1. Therefore, the absence of 
detectable 2 IK in the corresponding time point from the 
PAA—treated samples suggests that there is at least a 100- 
fold reduction in the level of 21K. Similarly, in experiment 
2 the reaction with 21K in the PAA-treated samples is only 
barely detectable, and even less intense than in any of the
untreated 4 h samples, suggesting that the level of 21K
synthesised in the presence of PAA is on the borderline of
sensitivity of the assay — and therefore about 100— fold
reduced in relation to a normal 16 h sample.
In conclusion, 21K, under normal conditions is first 
detected at 3-4 h p i ,while gD is detected earlier at 2 h pi. 
Both proteins accumulate rapidly until at least 16 h pi. In
-135-
the presence of PAA only about 1% of the normal levels of
21K protein, but around 20% of the normal levels of gD protein,
are synthesised. Thus the synthesis of 21K is highly dependent 
on viral DNA replication, and 21K can therefore be defined 
as a true late gene product.
H .2 The lower mol, w t . polypeptides and the 21K/22K products of 
gene U p ll have common amino acid sequences
From the previous experiments it is apparent that the
anti-peptide sera specifically recognise the 17.5K and 11K,
and possibly the 14K, polypeptides and that these accumulate 
late in infection in parallel with 21K. The 15K polypeptide, 
however, was not recognised by the antiserum used in the 
timecourse experiments. To investigate further the relation­
ship between the lower mol. w t . polypeptides and the 21K/22K 
products of gene Ugll they were individually subjected to 
tryptic peptide analysis.
To do this, 21K was partially purified by phospho- 
cellulose chromatography (result section H E . 5, Figure 53), 
concentrated and then separated by SDS-PAGE. A portion of 
the gel was removed for immunoblotting and the rest dried 
down and exposed for autoradiography. Immunoblots from this 
gel and from previous experiments were then used to identify 
the bands on the autoradiograph, as shown in Figure 35. The 
proteins were then isolated and subjected to tryptic peptide 
analysis, as described in method section VI.
Tryptic peptide digests were subjected to chromatography 
both individually and after mixing 1:1 with the tryptic peptide 
digest of 2 I K , to confirm suspected identities of apparently 
comigrating spots. The results (Figure 36) clearly demonstrate
FIGURE 35
Separation and identi ficatio n of polypeptides for tryptic
peptide analysis. Pa rtially-pur ified 21K, labelled with 
35
S - m e t h i o n i n e , was prepared by phosphocellulose chromato­
graphy. Material (a pool of the second, third and fourth 
fractions seen in Figure 53, result section HE.5b) was
separated on a 10% SDS-pol yac rylamide gel and exposed for
35
autoradiography. A small portion of this gel is shown ( S).
Bands to be excised were identified by alignment with 
immunoblots carried out on HSV-l-infected cell extracts, 
also separated on 10% SDS-pol yacrylamide gels, using anti- 
C-^ serum 14327 and a n t i - N ^  serum 14473.
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that the 22K, 21K, 17.5K, 15K, 14K and 11K polypeptides have
common amino acid sequences. The 21K and 22K pol ypep tides  
differ mainly in the presence of an additional strong spot 
in 22K (spot 4). The lower mol. w t . polypeptides are s t r i k ­
ingly similar to 21K, all the major spots being present, 
although their relative intensities may be altered. The 14K 
sample also contains a number of spots apparently unr elated 
to 21K (for example, spots a-d), but the region of the gel 
from which this polypeptide was excised contains mock- 
infected cell polype ptides (compare Figures 35 and 24A,B), 
and it is likely that the additiona l spots derive from these.
II.3 The 21K/22K U p lf gene products are DNA -binding proteins 
The 21K/22K polypeptides encoded by gene Ugll are 
regulated as true late gene products (result section II.1).
To determine whether the late 21K/22K UgljL gene products are 
related to the late 21K/22K DN A- binding proteins, we purified 
the latter by DNA cellulose ch ro matogr ap hy (result sec tion 
HI.3) and tested them for reaction with the a nti-pep ti de 
sera. Immunoblotting experiments (Figure 37) confirm that 
the 21K and 22K products of gene Ugll. are indeed DN A- bindin g 
Proteins. A band in the region of 17.5K was detected on one 
occasion (lane 3), but faint bands in this region were also 
Present in the mock-i nf ected control (lane 1) and so the 
specificity of this reaction is uncertain. The ina bility to 
detect the lower mol. w t . polypept ides does not nece ssaril y 
XmPly that they do not bind to DNA, since they were not 
detected in the high salt extract originally applied to the 
DNA cellulose columns (lane 4).
FIGURE 37
The 21K and 22K U g H  gene products are DNA-b inding proteins. 
Pre-immune serum 14328 (lane 5) or a n t i - C ^  serum 14328 
(lanes 1-4, 6-8) were reacted in immunoblotting experiments 
against moc k-infected (lanes 1 and 6) and HSV-l-infected 
(lanes 4, 5 and 7) cell extracts, prepared by the high 
salt extraction procedure (method section I.7b), and 
against proteins eluted by high salt from a DNA cellulose 
column (lanes 2, 3 and 8).
1 2  3
DBP , DBP , DBP represent three separate preparations
of DNA-binding proteins.
0  represents a 17.5K band of uncertain
origin.
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FIGURE 38
Im munol oc al isati on  of the Ugll gene products. Electron 
micro gra ph of a thin section through HS V-l -infected  BHK 
C13 cells harvested at 12 h pi. The section was incubated 
with anti-C.^ serum 14327, in the presence of 1 ug of 
peptide. Bound antibody was visualised using colloidal 
go ld- conjuga ted goat anti-rabbit Ig. The bar marker 
represents 1 um.
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FIGURE 39
Immunoloc al is ation  of the Ugll gene products. Electron 
mi c r o gr ap hs of thin sections through HSV-l-infected BHK 
G 1 3  cells harvested at 12 h pi. The sections were incubated 
with a n t i - C ^  serum 14327, either alone (B) or in the 
presence of 1 ug of peptide (A). Bound antibody was
vis ualised using colloidal gold-conjugat ed goat anti­
rabbit Ig. The bar marker represents 0.5 urn.
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FIGURE 40
Ele ct ron micrographs of thin sections through HSV-1- 
infected BHK C13 cells, harve sted at 2 h pi, stained to 
show preferentially ribonuclear material. Sections were 
stained with uranyl acetate, and then either post-stained 
with lead citrate (A) or destained with 40 mM EDTA before 
post-sta in in g (B). The bar markers represent 2 urn (A) and 
0.5 um (B ).
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FIGURE 41
Electron micrographs of thin sections through HSV-1- 
infected BHK C13 cells, harvested at 12 h pi, stained to 
show preferentially ribonuclear material. Sections were 
stained with uranyl acetate and destained with 40 mM EDTA 
(A) or 10 mM EDTA (B). The bar markers represent 1 um.
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FIGURE 42
Immunolocalisation of the Ugll gene products. Electron 
microg rap hs of thin sections through HSV-l-infected BHK 
C13 cells harvested at 12 h pi. Sections were incubated 
with anti-C-^ serum 14327, and bound antibody detected 
using colloidal gold-conjugated goat anti-rabbit Ig.
(A) An unstained section, osmicated after incubation with 
the antiserum. (B) A uranyl acetate stained section, 
destained with 80 mM EDTA prior to incubation with the 
antiserum. The bar markers represent 0.5 urn.
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FIGURE 43
Immunol oca lisat ion of the Ugll gene products. Electron 
micrograp h of a thin section through HSV-l-infected BHK 
C13 cells harvested at 12 h pi. The section was incubated 
with anti-C-^ serum 14327, and bound antibody detected 
using colloidal gold-conjugated goat anti-rabbit Ig. The 
bar marker represents 1 urn.
CYT1, CYT2, CYT3 cytoplasm of three adjacent cells 
NUC1 nucleus of cell 1 
nl nucleolus
CYT3
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localisation of antibody was seen with pre-immune sera or 
with immune sera reacted with m o c k - i n f e c t e d  cells (results 
not shown). These results would suggest that the localis at ion 
pattern observed accurately reflects the di str ibu tion of the 
Ugll gene products and is not the result of non-spe cific 
interactions or chance cross -reaction  of the antibodies with 
an unrelated cellular protein. Thus, the U g H  gene products 
appear to localise strongly to nuc leoli within infected 
cells, alt hough in some cells it is found in the cytoplasm.
-140-
SECTION HI : PURIFICA TI ON OF THE 21K POLYPEPTID E
U,1 Immunoaffinity chr omatograp hy
Immunoaffinity chromato gra phy is a widely used me thod of 
protein purification, but one disadvantage is the harsh 
conditions under which proteins are often eluted. The use 
of anti-peptide antibodies has the advantage that protein 
absorbed onto the column can be eluted by c ompe ti tion with 
the peptide against which the antibody was raised, incr ea sing  
the probability of recovering functionally active protein.
To prepare these columns, IgG was first purified from 
the relevant antise ra by ion-exchange chroma to graphy  on DEAE-  
cellulose (DE-52). The resin DE-52 was used in preferen ce  to 
the newer synthetic resin, Trisacryl M, since higher yields 
of IgG were obtained (results not shown).
The conditions used for chromatography are intended to 
allow IgG to pass unhindered through the column while most 
other proteins remain bound. Fractions were tested for protein 
by reading the optical density at 280nm ( O ^ q q ), for IgG by 
single radial immu no dif fus ion (RID) against sheep ant i-rabb it  
IgG, and for specific anti-peptide antibodies by RIA (method 
sections I V . 1 and I V . 3). Figure 45 shows the p urific at ion of 
IgG from one an tiserum through DE-52. A relativel y small peak 
°f protein coincident with a peak of both IgG and specific 
antibody is seen in the flow-through. High salt buffer added 
to the column then elutes a very large protein peak which 
contains only a low level of IgG. These fractions were analysed 
ty SDS-PAGE (Figure 46) and the peak antibody fractions then 
Pooled. The IgG recovered in the low salt fractions is very 
pure, containing only a few minor con taminating bands and one 
maJor contaminant, presumed to be haemoglobin on the basis
FIGURE 45
Purific ati on of IgG by ion-exchange chromatography. IgG 
was purified from anti-C^ serum 12848 by passage through 
DE-52 cellulose, as described in method section H I .5. 
Protein which failed to bind to the column eluted in the 
first few fractions collected (approximately, fractions 
3-10). Protein bound to the resin was subsequently eluted 
by high salt buffer, added after fraction 21. Protein 
levels of collected fractions were measured by reading 
the 0 D 2g0 ( □ )  , IgG levels were measured by RID (....) and 
specific anti-peptide antibody levels were measured by 
RIA ( 0 ) .  The 0 D 2gQ readings for the five fractions off 
scale in this diagram (fractions 27-31, respectively) were, 
in order, 0.695, >2, >2, 2, 0.740.
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FIGURE 46
Pu rification of IgG. Fractions from the experiment shown 
in Figure 45 were separated by SDS-PAGE and stained with 
Coomassie blue. The position of the IgG heavy (approximately 
50K) and light (approximately 25K) chains is indicated
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of its size, and the fact that the level of this contaminant 
varies, depending on the degree of haemolysis in the serum 
sample .
Purified IgG was then coupled to Sepharose as described 
in method section V.2. The immunoaffinity columns produced 
are summarised in Table 7. These were then used in an attempt 
to purify 21K, running the columns under a number of different 
conditions : both whole cell extracts and partially-purified 
21K were used as input material; the immunoaffinity beads 
were used either as a column or mixed end-over-end in eppendorf 
tubes with the extracts; incubation was carried out at 
different temperatures for varying lengths of time; both 
phosphate- and Tris-buffered solutions were used; NaCl con­
centrations were ranged from 50-500mM; ionic and non-ionic 
detergents were used at various concentrations - SDS from 
0-1% and sodium deoxycholate and Nonidet P40 at 0, 0.5 and 1%; 
the antigens were heat-denatured, either by heating to 50°C 
and then incubating with the column at this temperature, or 
by heating to 90-100°C for 15-30 min and then incubating with 
the column at RT or 4°C; DNA was added to some samples before 
chromatography in an attempt to stabilise the protein; and 
the columns were run in the presence and absence of protease 
inhibitors .
None of these procedures led to good purification of 21K. 
Figure 47 shows the best purifications obtained by immuno- 
affinity chromatography and these produced only a low yield 
°f 21K and very high levels of contaminating proteins. In 
addition, the proteins were eluted using 3M sodium thiocyanate 
n° protein was eluted using synthetic oligopeptide. The 
Presence of the protease inhibitors PMSF and TLCK did not 
^ pro ve the purification of 21K very significantly, although
Table 7 : Immunoaffinity columns used to purify 21K.
Purified IgG was covalently coupled to Sepharose 4B (Seph), 
at the concentrations indicated. Rabbits 14190 and 14191 
were immunised with purified 21K as described in result 
section I.6b.
NRS normal rabbit serum
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FIGURE 47
Purification of 21K by immunoaffinity chromatography.
Sepharose conjugated to IgG from a n t i - C ^  serum 14328
2
(S e p h :anti(151-161) ) was equilibrated in B2 buffer 
containing (1) no protease inhibitor, (2) 0.5 mM PMSF 
or (3) 0,1 mM T L C K , and then incubated end-over-end at
o c
RT for 90 min with 2 volumes of a S—methionine labelled 
H5V- 1-infected cell extract in the same buffer. Unbound 
material was collected (the flow-through) and the beads 
washed, before the more strongly bound proteins were 
eluted using 3M sodium thiocyanate, containing the appro­
priate protease inhibitor (the eluate). Fractions were 
analysed on 5-12.5% SDS-polyacrylamide gels. The input (I) 
and flow-through (FT) fractions in each case were identical, 
and thus only one example is shown. The region encompassing 
the 21h polypeptide, which appears as a rather diffuse 
band with an apparently increased mol. wt., is indicated (])•
I FT
i--ELUATE— ,
1 2 3
protease inhibitor - - - PMSF TLCK
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they do show slightly greater yields than the untreated 
control. On this gel 21K appears as a broad smear, rather 
higher in mol. wt. than in the whole cell extract. This 
appearance is frequently observed upon partial purification 
of the protein (see, for example, Figure 51).
Most purification attempts resulted in little, if any,
21K protein being recovered, and in no case could protein be 
eluted with peptide. That the protein was not remaining bound 
to the column following the 3M sodium thiocyanate elution was 
shown by analysing a small sample of the column matrix by 
SDS-PAGE. These samples were consistently devoid of 21K (results 
not shown). This approach was therefore considered to be of 
little use and was not pursued further.
H •2 Size exclusion, ion-exchange and affinity chromatography
A number of other procedures were tested for their useful­
ness in the purification of 21K. The results of these are 
summarised in Tables 8 and 9. Many of these techniques met 
with little or no success, and will be discussed here only 
briefly.
The starting material for these procedures was either 
whole infected cell extracts, prepared by the high salt 
extraction procedure (method section 1.7b), or partially- 
purified 21K, prepared by DNA cellulose chromatography (see 
below). A consistent problem, particularly with the partially- 
purified material, was the poor recovery of 21K, irrespective 
of the presence of a protease inhibitor. The protease inhibitors 
PMSF, TLCK or o^ -macr oglobulin  were used. No attempt was made 
to systematically investigate the effect of different protease 
inhibitors, either alone or in combination, on the recovery 
of 21K , and it is possible that a combination of these, or
Table 8 : Purification of 21K by conventional chromatography
Column Input Recovery
Size exclusion 
Sephacryl S200
i
Sephacryl S300
Ion exchange 
DE-52
DEAE-Sepharose CL6B 
Affinity
•JU*T*
Blue Sepharose 
ATP Agarose
ds DNA cellulose 
ss DNA cellulose 
Heparin Sepharose
Hydroxylapatite
Phosphocellulose
pp.21K
pp.21K
HSV-1 extract 
pp.21K
pp.21K 
HSV-1 extract 
pp.21K 
HSV-1 extract 
p p .2 IK 
HSV-1 extract 
p p .2 IK 
HSV-1 extract 
HSV-1 extract 
pp . 2 IK
None
Poor
Good
Fair
V .Poor 
None 
None 
Good 
Good 
Good 
None 
Good 
.Good 
Poor
Purification
Fair
Poor
Poor
Good
Poor
Good
Good
Good
Good
 ^ • Chromatography carried out by Dr Howard S Marsden 
• Chromatography carried out by Dr Graham Hope
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other, protease inhibitors may have been required to stabilise 
this polypeptide.
Two points concerning the HPLC procedures are note-worthy. 
Firstly, dialysis of par tially-purified 21K in the presence 
of salmon sperm DNA, prior to chr omatograp hy on the HPLC anion 
exchange column, prevented loss of the 21K polypeptide but, 
unfortunately, resulted in all the proteins eluting app aren tl y  
equally over 2 fractions - ie. no increase in purification 
was obtained. Secondly, 21K was quite signi ficantly purified 
by reverse-phase chromatography - however, this procedure 
involves highly denaturing elution conditions, and is there fore  
not a method of choice for the puri ficatio n of a functional 
protein .
It has previously been shown that 21K binds to DNA with 
high affinity (Bayliss et a l . , 1975; Dalziel and Marsden, 1984). 
Therefore, a number of columns with an affinity for DNA -bindin g 
proteins were tested, including DNA cellulose, ph os ph ocellul os e  
and heparin -Sepharos e (see below).
DNA cellulose
This procedure is described in method section V.3. Briefly, 
an HSV-l-infected cell extract was passed through a d o u b l e ­
stranded calf thymus DNA cellulose column of appro ximately 
100ml in volume. Immediately upon application of the extract 
to the column, fractions of app roximatel y 10ml were collected 
and an aliquot of each assessed for radioactivity in a 
scintillation counter. The column was washed extensively with 
^2 buffer before proteins were eluted using a linear 50-900mM 
NaCl gradient, applied over 20 fractions (200ml), followed by 
a 2M NaCl wash. A peak of radioactivity eluted in fractions 
66~76. The protein profiles of fractions 66-75 are shown in
-144-
Figure 48. The 21K and 22K proteins are present predominantly 
in two fractions, alt ho ugh low levels are present in several 
additional fractions. Coo ma ss ie blue staining of this gel 
(Figure 49) confirms that 21K is the predominant protein in 
these two fractions (69 and 70), representing probably 3-10% 
of the material present. The DNA cellulose purified 21K was 
often used as the starting material for other purification 
pr ocedures.
1.4 Heparin-Sepharose and phosphoce ll ulose
Other columns which work on a similar pri nciple to DNA 
cellulose were also consid ered potentially useful in the 
purification of 21K. Heparin, being highly nega tiv ely charged, 
can mimic the ionic interactions between DNA and protein, 
while hy dro xy lapatit e and phosp hocellulose are both negatively 
charged and contain phosphate groups, and may therefore also 
have an affinity for pho sphate -bindi ng  proteins. These three 
procedures were compared with DNA cellulose chromatography.
Columns of 0.5ml were prepared and 1ml of an HSV-1- 
infected cell extract applied. After extensive washing, proteins 
were eluted using a 5ml linear gradient from 50m M-2M NaCl. 
Fractions of 0.5ml were collected on ice and analysed by SDS- 
PAGE. The four methods produced a very similar purification 
of 21K. With both DNA cellulose and h y d r o x y l a p a t i t e , 21K 
eluted predom inantly  with the bulk of the other proteins 
(results not shown), whereas with both he pa rin-Se ph arose and, 
in particular, phosp hocel lulose 21K eluted slightly behind the 
majority of the proteins (Figure 50).
The use of partial ly- purif ied 21K as input material was 
tested only on these latter two columns. With phosphocell ulose 
a further purification of 21K was obtained, alt hough  recovery
FIGURE 48
Pur ifi cati on  of 21K by double -strand ed  DNA cellulose
chromatography. A DNA cellulose column, approximately
100 ml in volume, was prepared as described in method 
35
section V.3. A S-methionine  labelled HSV-l-infected 
cell extract in B2 buffer (400 ml; prepared from 10 80oz 
roller bottles) was passed through the column and fractions 
of approx imately 10 ml collected. Following extensive 
wash ing  a linear 50-900 mM NaCl gradient was applied over 
200 ml, followed by a 2M NaCl wash. Proteins eluted with 
the 50-900 mM NaCl gradient are shown. The approximate 
NaCl con centration at various points is indicated.
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FIGURE 49
P ur ificati on of 21K by double- str anded DNA cellulose 
chromatography. Coomassie blue staining of the 50-900 mM 
NaCl elution profile shown in Figure 48. Fracti on numbers 
are indicated. The input sample (I) was diluted 1/20, to 
prevent overexposure on autoradiography, and is thus 
barely visible by Coomassie blue staining.
FIGURE 50
Pur ifi cation of 21K by heparin- Sepharose  and phos pho ­
cellulose. Columns of 0.5 ml were prepared as described
in method sections V.6 and V.4, respectively. One ml of 
35 S-methionine labelled HSV-l-infected cell extract in 
B2 buffer (I) was run through the columns and the flow­
through material collected (FT). After extensive washing, 
bound proteins were eluted with a linear 0.05-2M NaCl 
gradient. Only the major protein-containing fractions are 
shown (ELUATE). Samples were analysed on 5-12.5% SDS- 
polyacrylamide gels.
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was difficult to judge since the polypeptide appeared rather 
diffusely spread on the gel (Figure 51). This is a fairly 
typical example of the frequently observed aberrant migration 
of partial ly- purifie d 21K. In contrast, with h e p a r i n - S e p h a r o s e , 
no 21K was recovered (results not shown).
The apparent instability of the 21K polypeptide, in 
partially-purified form, has greatly hindered the use of 
several successive chr omatographic steps for the purification 
of this protein. For this reason it was decided to derive, 
as far as possible, a one-step purification procedure for 21K. 
Phosphocellulose, appearing to be the most useful of the 
methods described above, was chosen as the basis for 
purification.
H.5 Purification of 21K by phosphocel lulose chromatography
Initial experiments were carried out to establish more 
optimal cond iti ons for the purification of 21K. The results 
of these ex per iments are not shown, but formed the basis for 
the purification procedures outlined below.
Small scale phosphocel lulos e purification
Infected cell extracts were incubated on ice in 30% or 
35% saturated ammonium sulphate and the precipitate removed 
by centrifugation at 7,000 rpm for 30 min in a Sorvall SM24 
rotor. The supernat ant s were then dialysed extensively against 
S2 buffer contain ing 350mM NaCl. Phosphoce llu lose columns 
(2ml) were equilibrated in this buffer and the above samples, 
as well as an untreated infected cell extract (also in the 
Presence of 350mM NaCl), were then applied to the columns.
Sound proteins were eluted firstly with 450mM NaCl and sub- 
Sequently with 2M NaCl. Fractions were analysed by SDS-PAGE
FIGURE 51
Purificati on  of 21K by ph os ph ocellul os e chromatography.
A 3.8 ml phosphoce llulose  column was prepared as described 
in method section V.4. One ml of 21K partially-purified 
by DNA-cellulose chromatogr aphy (fraction 69, Figure 49) 
was run through the column (I) and, after washing, bound 
proteins were eluted with a linear 0.05-2M NaCl gradient, 
applied over 40 ml. One ml fractions were collected and 
analysed on 5-12.5% S D S - polya cr ylamide  gels. The input 
material (undiluted) represe nts  a 36 h exposure of the 
original gel. The eluted material represents a 151 day 
exposure. 21K is seen eluting in later fractions as a 
rather diffuse, smeared band apparently increasing in 
m o l . w t .
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(Figure 52).
The untreated infected cell extract under these conditions 
s h o w e d  only a very faint elution of 21K with 450mM NaCl (not 
shown), while the 2M NaCl eluate contained predominantly 21K 
but also a number of contaminating bands (Figure 52). From 
extracts precipitat ed with ammonium sulphate no 21K was 
eluted from the column with 450mM NaCl. However, 2M NaCl 
eluted 21K almost devoid of contaminating bands. The yield 
of 21K was si gni ficantly better with the 30% rather than 
the 35% ammonium sulphate supernatant, alt hough the 30% 
supernatant contained a faint lower mol. w t . band. Whether 
this band is related to 21K is unknown.
(b) Large scale ph osphoce llulose purification
Scaling up this procedure, however, was unsuccessful.
The 21K polypeptide, although by far the most predominant 
band on autoradiography, was contaminated by a number of 
other proteins (Figure 53), while Coomassie blue staining 
revealed several polypeptides, of which 21K was not one 
(results not shown).
In conclusion, attempts to purify 21K have met with 
limited success. We had originally hoped to purify 21K to 
apparent homogeneity, in order to further investigate its 
DNA-binding properties. We therefore decided to approach 
this problem from another angle - namely, to investigate 
a' sequence-specific DNA-protein interactions, and the 
role of the 21K polypeptide in these interactions.
FIGURE 52
35
Ph osp hoce ll ul ose purification of 21K. S-methionine 
labelled HS V-l-infected cell pol ypeptides were precipitated 
with 30% or 35% saturated ammoni um sulphate (A.S.) and 
the supernatant collected and dialysed against B2 buffer 
containing 350 mM NaCl. Fifteen ml of each supernatant, 
or 10 ml of the original infected cell extract, adjusted 
to a concen tration of 350 mM NaCl, were passed through 2 ml 
phosph oce llulose  columns equilibrated in B2 buffer 
containing 350 mM NaCl. After washing, bound proteins 
were eluted firstly with 450 mM and subsequently with 2 M 
NaCl. Samples were analysed on 5-12.5% SDS-polyacrylamide 
gels.
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FIGURE 53
35
Large scale phospho cellulose  purification of 21K. S- 
methionine labelled HSV-l-in fecte d cell polypeptides in 
high salt extract ion  buffer (2M NaCl) were precipitated 
with 20% saturated ammonium sulphate, and the supernatant 
dialysed against B2 buffer containing 450 mM NaCl. Approx­
imately 185 ml of supernatant (INPUT) was applied to a 
50-60 ml phosp hoce ll ulose  column, the column washed with 
B2 buffer containing 450 mM NaCl, and bound protein eluted 
with a 2M NaCl wash. Fractions were analysed on 5-12.5% 
SD S-pol ya cryla mide gels. A pool from the second, third 
and fourth eluate fractions shown was used in the tryptic 
peptide fingerprint experiments described in result section 
IE.2.
-147-
SECTION IV : DNase I FOO TPR INTIN G ON THE HSV-1 'a f SEQUENCE
It has previously been shown that the 21K and 22K DNA- 
binding proteins specifically interact with the 'a* sequence 
of HSV-1 (Dalziel and Marsden, 1984). However, the precise 
region within the ’a ’ sequence involved in this interaction 
is unknown, and it has yet to be established whether this 
is a direct or indirect interaction.
The assay origina lly used to identify the ’a' seq uence- 
specific DN A- bi nding  proteins was a competition assay involving 
the elution of proteins bound to DNA cellulose columns by 
fragments con tai ning HSV DNA. This rather crude assay uses 
large quantit ies  of competitor DNA and, in my own experience, 
is complicated by a very high background of non -specific 
binding to the DNA fragment. Therefore, two other assays were 
attempted - a gel retardation assay and DNase I f o o t p r i n t i n g .
Of these the DNase I footprinting produced the more immediate 
and interesting, results and therefore this assay was s u b ­
sequently chosen to further investigate specific inte rac tions 
occurring within the ’a' sequence.
Before presenting the results of the DNase I footprin tin g 
experiments, the construction of a plasmid (pASO^) used in 
later experi ments is described.
^  Construction of p l a s m i d  p A S O ^
Our o r i g i n a l  i n t e n t i o n  was to o b t a i n  a p l a sm i d  c o n t a i n i n g  
tandem c o p i e s  of a n u c l e o t i d e  s e q u e n c e  fr om  w i t h i n  the 
region of the HSV-1 ’a 1 s e q u e n c e  w h i c h  s h a r es  a hi gh d e g r e e  
°f ho mology w i t h  a s im i l a r  r e g i o n  w i t h i n  the 'a' s e q u e n c e  of 
HSV-2. T h i s c o r r e s p o n d s  to the pac-1 p a c k a g i n g  si gn al  d e s c r i b e d  
by Deiss et al. (1986).
- 148 -
Two 43 base synthetic olig onucleoti des whose sequences 
were partially complement ary but contained 5 f end overhangs 
corresponding to Bgl H  and Bam HI sites, respectively, were 
synthesised. An nea lin g of these two o l i gon uc leotide s should 
form the product shown in Figure 54 (ii). Since the 5* 
extensions at each end of the annealed product are both 
complementary and palindromic, this product could self-lig ate 
in either orientation. Head-to-head or tail -to-tail ligation 
(inverted repeats) would result in the formation of either 
a Bam HI site, 5 ’- G G A T C C - 3 ', or a Bgl H  site, 5 f- A G A T C T - 3 ’ , 
respectively, at the junction between fragments. In contrast, 
head-to-tail or tail-to-head ligation (direct repeats) would 
not generate these sites, producing instead the sequence 
5’-GG ATCT -3 f, or 5 ’- A G A T C C - 3 ', at the junctions. Therefore, 
direct repeats could be selected by digestion of the ligation 
products with both Bam HI and Bgl H . We used this app roach  
to generate the plasmid pASO^, as follows.
The synthetic oligonucleotides  (which lack 5' phosphate
groups) were 5 ’ end-labelled in the presence of T4 poly-
3 2
nucleotide kinase and X P-ATP as described (method section
IX.2b). The reaction was continued for a further 30 min in 
the presence of excess (cold) ATP to ensure maximal p h o s p h o ­
rylation of the 5* ends (a final conce ntration of ImM ATP was 
used compared with approximately 44uM olig onucleo tide). 
Approximately lOug of each oligonucleoti de were mixed together 
in a final volume of 25ul and allowed to anneal at 37°C for 
1 h. The annealed strands were then ligated and following 
extraction and precipitation the DNA was digested with an 
excess (40 units) of Bam HI and Bgl H  (method sections X U . 3 
and VIU.l). The digested DNA was again extracted and pre- 
ClPitated and then subjected to a second round of ligation/
FIGURE 54
Con str uction of plasmid p A S O ^ .
(i) Schematic rep resentation of the HSV ’a ’ sequence in plasmid 
pR9. This ’a ’ sequence was obtained from the S terminus, 
and thus has an incomplete terminal DR^ ( D R ^ ’). In HSV-1 
strain 17syn+ , the 'a' sequence contains only a single DR^ 
homology, and therefore, for simplicity, this is included 
in the region shown. The sequence to which the synthetic 
oligonucleotides corresp ond is indicated (— — ► ) .
(i±) Product obtained after annealing of the synthetic oligo­
nucleotides. The two ol igonucleo tides are complementary, 
with the exception of 4 bases at the 5* end of each. 
Annealing of these oligonucleot ides would form a structure 
possessing 5 f extensions which are both complementary and 
palindromic, and these could therefore anneal in either 
orientation. The sequence is shown in the orientation 
indicated in (i), and those nucleotides corresponding to 
the region indicated are underlined.
(iii) Structure of pASO^. The synthetic oli gon ucleotides were 
annealed and ligated as described in the text, and then 
cloned into the Bam HI site of the vector pUC8 (method 
section XIE.3). A plasmid was obtained which contained 
three tandem repeats of the oligonucleotide sequence, in 
the orientation shown. This plasmid was termed pASO^.
H Hind III; P Pst I; B Bam HI; S Sma I;
R Eco RI
DRX U c DR 2 REPEATS U b D R ^
□ ------- rrn h i m  it t t -  — q
(ii) GATCTAACGGGCCCCCCCCAAAACACACCCCCCGGGGGTCGCG
ATTGCCCGGGGGGGGTTTTGTGTGGGGGGCCCCCAGCGCCTAG
H P B S R H P S R
pUC8 pASO
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digestion . Since small fragments of DNA ligate more efficiently 
than large fragments, the digested products were separated 
on an acrylamide gel. No attempt was made to isolate individual 
bands since in previous experiments this had met with no 
success. Instead two groups of bands were isolated - (a) those 
fragments estimated to contain 4-6 copies of the oligo­
nucleotide, and (b) those fragments estimated to contain 
more than 6 copies of the oligonucleotide. Fragments containing 
less than 4 copies of the oligonucleotide were discarded.
The purified DNA was cloned into the Bam HI site of pUC8 
as described (method section X U . 3) and used to transform DH1 
cells to ampicillin resistance. Plaques were analysed by 
restriction enzyme digestion. Of 72 plaques analysed, one 
plasmid clone was isolated which appeared to contain 3 repeats 
of the oligonucleotide (ie. an insert of approximately 120 bp). 
This was therefore grown in larger quantity and the DNA 
isolated and purified by CsCl gradient centrifugation (method 
sections V H . 1 , V H . 2  and VII.3).
To determine the nature of the inserted DNA, the Hind HI/ 
Eco RI fragment containing the insert (see Figure 54 (iii)) 
was purified and sequenced as follows. The plasmid was 
linearised by digestion with Hind HI and either 3* or 5 ! end- 
labelled at this site (method sections IX.2a,b). The labelled 
DNA was then digested with Eco RI and the products separated 
on a 10% polyacrylamide gel (Figure 55). The large fragment 
represents vector sequences, while the smaller, strongly 
labelled, fragment represents the insert contained within the 
Polylinker site. Two smaller fragments (indicated by the open 
circles) were also consistently observed, although only in 
!ow quantities. The size of these latter fragments would be 
compatible with the presence within the polylinker site of
FIGURE 55
Purification of end-labelled insert DNA. Plasmid pASO^ 
was digested with Hind HI and either 3 ’ or 5 f end-labelled 
as described (method section IX.2a,b). The labelled DNA 
was digested with Eco RI (see Figure 54), separated on 
10% polyacrylamide gels (method section H . 2 ) ,  and exposed 
for autoradiography for approximately 1 min (lanes 1). 
Insert DNA was cut out from the gel, and the gel re-exposed 
for autoradiography (lanes 2).
o represents two lower mol. wt. bands observed in both 
3' and 5 ’ end-labelled preparations.
3 ’
1 2
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1 2
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m
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only one or two copies, respectively, of the oligonucleotide, 
suggesting that deletion of one or more copies of this 
sequence was occurring at a low frequency.
The insert band was cut out from the gel and the DNA 
eluted (method section IX.3). Re-exposure of the gel confirmed 
that the correct band had been efficiently removed (Figure 
55, lanes 2). The purified end-labelled fragments were then 
sequenced by the method of Maxam and Gilbert (1980), (method 
section X.2). An example gel is shown in Figure 56. From 
this and other experiments it was concluded that the plasmid 
contained 3 tandem copies of the oligonucleotide, with the 
expected sequence, in the orientation shown in Figure 55 (iii). 
This plasmid was termed pASO^.
^•2 DNase I footprinting assay
The DNase I footprinting assay was based on the method 
of Galas and Schmitz (1978) and is described in method section 
X.3. End-labelled DNA fragments were incubated with various 
amounts of infected and mock-infected cell extracts and then 
partially digested with DNase I . The patterns of cleavage 
seen in the presence and absence of protein were then compared 
by analysis on denaturing polyacrylamide gels alongside 
sequence reaction markers. Proteins specifically bound to 
regions of the DNA would interfere with the DNase I digestion, 
resulting in alterations or gaps in the normal cleavage 
pattern.
In these experiments, two plasmids, pR9 and pRIO, were
used (see Figure 57). Plasmid pRIO contains an 'a' sequence
0rived from the L terminus plus about 200 bp of flanking b
sequence, orientated such that the U end of the fa' sequence
c
lles close to the Hind HI site and the f b f sequence lies
FIGURE 56
Sequence of the insert within pASO^. Plasmid pASO^ was 3' 
or 5 ’ end-labelled at the Hind HI site, and the insert DNA 
isolated following Eco RI digestion. Purified end-labelled 
fragments were sequenced as described in method section
X.2, and analysed on 6% sequencing gels.
| indicates the restriction enzyme linker sequence 
within the oligonucleotide insert.
3 ’
G GA C CT
5 ’
G GA C CT
I
* s
I
FIGURE 57
Schematic representation of the insert DNA contained within 
plasmids pR9 and pRIO. Plasmid pRIO contains an ’a' sequence 
derived from the L terminus of HSV-1 plus about 200 bp of 
flanking Tb f sequence, orientated such that the U c region 
lies toward the Hind HI site, and the rb f sequence lies 
toward the Eco RI site. Plasmid pR9 contains an ’a' sequence 
derived from the S terminus of HSV-1 plus about 150 bp of 
flanking 'cT sequence, orientated such that the region 
lies toward the Hind HI site, and the 'c' sequence lies 
toward the Eco RI site. Since this 'af sequence is from 
the S terminus, it contains only 1 bp of the terminal DR^ 
(DR^*). Again, since the HSV-1 strain 17syn+ ’a ’ sequence 
contains only one copy of the DR^ homology, it is included 
in the region designated .
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close to the Eco RI site. Thus end-labelling at the Hind HI 
site allows protein interactions within the and DR£ repeat 
regions to be analysed. Plasmid pR9 contains an 'a* sequence 
derived from the S terminus and about 150 bp of flanking Tc' 
sequence, orientated  such that the end lies close to the 
Hind HI site and the Tc ’ sequence lies close to the Eco RI 
site. Thus, end -labe ll ing at the Hind HE site in this plasmid 
allows analysis of protein interactions within the and DR£ 
repeat regions. Since this 1 a 1 sequence is from the S terminus 
it contains only 2 bp of the terminal DR^.
Interpretation of the DNase I footprin ting assay
Figure 58 illustrates the products generated by either 
a Maxam and Gilbert sequence reaction or by DNase I digestion. 
In the sequence reaction, the base being chemically attacke d 
is eliminated to leave both a 5 ’ and a 3 ’ monophos ph ate group 
on the adj acent bases. Thus, for example, bands des ignated 
fG ! in a G sequence track will lack that terminal G residue. 
DNase I cleavage, in contrast, generates a 5 ’ monoph os phate  
and a 3 ’ hydroxyl group, without loss of a base.
Thus, for example, a 5* end-labelle d fragment containi ng  
the internal sequence 5 1 - p X p G p Y - 3 ', subjected to a G sequence 
reaction, would generate a labelled fragment of length 5 ’-Xp. 
DNase I digesti on  at the 5 1 side of the-G residue would 
Produce a similar fragment, differing only in possessing a 
3* hydroxyl group, in contrast to a 3 f monophosphate. These 
fragments were found to run almost identically, the 3 f hydroxyl 
fragment showing a very slightly faster migration in the 
better resolved (lower) portion of the gel (see Figure 64). 
Similarly, a 3' end-labelled fragment containing the internal 
sequence 5 1- p X p G p Y - 3 1 , subjected to a G sequence reaction,
FIGURE 58
Interpretation of the DNase I footprinting assay.
(i) A hypothetical DNA fragment, containing the internal
sequence S ’-pXpGpY-S* is shown (a). A Maxam and Gilbert *G 1 
sequence reaction would eliminate the G residue, leaving 
a monophosphate group on each of the adjacent bases, as 
shown in (b). If this DNA strand was 5 ’ end-labelled, then 
DNase I digestion to the 5 ’ side of the G residue, shown 
in (c), would produce a labelled fragment of similar 
apparent mol. w t . to that shown in (b). If the DNA strand 
was 3 ’ end-labelled, DNase I digestion to the 3 ’ side of 
the G residue (d) would produce an identical end-labelled 
fragment to that shown in (b).
(ii) A second hypothetical sequence is shown, dis playing
enhancement of cleavage at the dinucleotide bonds indicated 
( ) in the presence of DNase I. (For simplicity, enhance­
ment rather than protection of cleavage is shown). As 
mentioned above, Maxam and Gilbert sequence reactions 
generate fragments of DNA which lack the nucleot ide being 
chemically attacked. Thus, DNase I digestion at a given 
dinucleotide bond will generate a labelled DNA fragment 
of the same length as the sequence marker of the nucleotide 
distal to the label - ie. on a 3* en d-labelle d strand it 
will be equivalent to the 5 f partner, and on a 5 ’ end- 
labelled strand, to the 3* partner. This is illustrated 
diagramatically in the sequence gels shown.
5 1--------- !---------------- p X p G p Y -------------------------3 1
5'- - - - - - - - - - - pXp p Y ----------- 3
5 ’- - - - - - - - - - - pX p G p Y ----------- 3
5 '---------- p X p G  p Y - ---------- 3
»
• • • G G G X C G C G ....
• • • C C C G G C G C ....
o I r I
5 1 3 ’
DNa se  1 . . DNase 1
co 
m
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would generate a labelled fragment of length p Y - 3 ’. DNase I 
digestion at the 3' side of the G residue would produce an 
identical fragment. Thus, by aligning the DNase I dig estion 
pattern with a sequence marker the dinucleotide bond being 
broken can be identified.
Infected cell extracts alter the DNase I digestion pattern 
of the HSV-1 ’a* sequence
The DNase I digestion pattern withi n and the DR^ repeats 
is altered in the presence of infected cell extracts (Figure 
59). Within the DR£ repeat region a repetitive pattern is 
seen, con sisting  of apparently protected regions spanning 
approximately 7 nucleotides (indicated by brackets) flanked 
on either side by two nucleotides showing enhanced cleavage 
(indicated by small arrows). Between each of these repeat ed 
elements is one apparently unaffected nucleotide. This area 
has been termed Region 1. A number of bands within show 
a very marked increase in sensitivity to DNase I. In some 
experiments, but not all, some protection can be seen around 
this region (compare, for example, lanes 1,4 and 7). This 
area has been termed Region 2. Region 1 and Region 2 are 
shown more clearly in Figure 60. There was no evidence to 
suggest that any sequence-specific DNA-protein int eractions 
were occurring within , under our assay conditions (results 
tot shown).
In the exper iment s of Dalziel and Marsden (1984), 21K 
bound to the ’a' sequence in the presence of B2 buffer. 
Therefore, our original DNase I footprinting assays were 
carried out in B2 buffer containing additionally 8mM M g C ^ ,  
Sug/ml calf thymus DNA and O.lmg/ml BSA. However, in sub- 
sequent experiments we altered the conditions in an attempt
FIGURE 59
DNase I footprinting on the HSV-1 fa* sequence. The Eco RI/ 
Hind HI fragment from plasmid pR9, 3* end -labelled at the 
Hind HI site, was subjected to DNase I footprinting as 
described in method section X.3, except that the M g C ^  
concentration used was either 8 mM (lanes 1-7) or varied 
(lanes 8-12). End-labelled DNA was incubated in the absence 
(lane 1) or presence of HSV -l-in fe cted (lanes 2-4, 8-12) 
and H S V - 2 - i n f ected (lanes 5-7) cell extracts. The volume 
of extract added, and the final concen tr ation of M g C ^  in 
the reaction buffer, are indicated. Max am and Gilbert 
sequence reactions (GA, G) are shown for alignment, and 
the relative positions of the DR£ repeat and regions 
are shown. Changes observed in the presence of extract 
within the DR£ repeat region are designated Region 1. Areas 
of protection are indicated by brackets ( ] ) , while 
apparently enhanced bands are indicated by the small 
arrows ( -►). Changes observed within the region are 
designated Region 2. The large arrow ( - ► )  indicates a 
band enhanced only in the presence of 8 mM M g C ^ *  Samples 
were analysed on a 6% sequencing gel.
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FIGURE 60
Altered DNase I digestion pattern in the presence of HSV-1- 
infected cell polypeptides. An HSV-l -infe ct ed cell extract 
was applied to a DE-52 cellulose column in B2 buffer, and 
fractions collected into 0.5 inhibitory units of 
m a c r o g l o b u l i n . After collecting the flow -through (FT), the 
column was washed and bound protein eluted stepwise with 
0.3M, 0. 6M and 2M NaCl. Fractions were dialysed against 
B2 buffer before use.
The Eco RI/Hind III fragment from plasmid pR9, 3 f end- 
labelled at the Hind HE site, was incubated with either 
no protein (lane 6) or 30 ul of the DE-52 purified protein 
fraction indicated. Samples were analysed on a 6% sequencing 
gel. GA and G sequence reactions serve as marker tracks, 
and the position of the D R 2 repeat and regions are 
indicated. The DNA sequences around Region 1 and Region 2 
are shown. Arrows represent nucleotides apparently enhanced 
in cleavage at their 3 f side, while the bracket represents 
nucleotides protected from DNase I digestion.
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to optimise for the effects we had observed (Figure 59, and 
results not shown). These latter experiments showed that the 
reaction is absolutely dependent on the presence of M g ^ + ions, 
being optimal at 2mM M g C ^ .  At concentra tions  much higher 
than lOmM M g C ^  there was a significant loss of rec ov erable 
counts. Neither M n ^ + nor C a ^ + could replace the M g ^ + ions.
Raising the salt con cent ratio n to lOOmM, using either NaCl 
or K C 1 , sig nif icantly inhibited the reaction. The reaction 
also appeared to be dependent on the presence of a red uci ng  
agent, the level of 2- mer capto ethanol being optimal at l-3mM.
The level of competitor calf thymus DNA could be increased 
to a final co ncentra tion of 20ug/ml. This resulted in a 
significant increase in the recovery of counts (ie. p r e c i pi table  
end-labelled DNA) without affecting the DNase I digesti on  
pattern seen. However, at 60ug/ml the reaction was inhibited. 
Incubation for 5 min at 37°C was sufficient for the reaction 
to occur, with longer incubations resulting in signific ant 
degradation of the DNA. The reaction would not occur at 4°C, 
even after 30 min incubation. However, following incubation 
at 37°C samples could be left at 4°C without s ignif ic antly 
affecting the results, for at least 15 min. Thus, 4°C could 
be used as a 'stop* for the DNase I footprinting reactions.
Where possible, extracts were prepared and used while fresh. 
However, samples could be kept at -70°C for up to 6 weeks 
and freeze-thawed at least twice with about only a 50% re duction 
in the level of activity. Incubation at 37°C for 30 min resulted 
ln a significant loss of activity.
Therefore, in all experiments shown, with the excep tio n 
°i Figure 59, the assays were carried out as described in 
Method section X.3. The alterations to the reaction con dit ions 
did not result in a change in the DNase I digestion pattern
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seen, with one minor exception. An additional band within 
Ub (indicated by the heavy arrow in Figure 59) was co nsistently  
found to be enhanced in the presence of 8mM M g C ^ .  However, 
in the presence of 2mM M g C ^  this band wafe no longer enhanced 
(compare lanes 10 and 12). In contrast, with 2mM M g C ^  there 
appeared to be an even greater level of enhancement in Region 2, 
within U^. The reason for this difference in M g C ^  sensi tivit y 
is unknown.
IV,5 Extracts from H S V - 2 - i n f ected cells, but not moc k-in fe cted 
cells, produce the same DNase I footprint as the HSV-1- 
infected cell extracts
Extracts from cells infected with HSV-2 generated an 
identical DNase I digestion pattern to HSV-l-infected cell 
extracts (Figure 59, lanes 5-7), both with respect to the 
protection in the D R 2 repeats and the enhanced cleavage seen 
within U^. In contrast, mock-infecte d cell extracts did not 
induce this change, but instead resulted in a different 
pattern of cleavage in the D R 2 repeats (Figure 61). There 
was no enha nc ement  in Region 2, although some bands within 
appeared to be slightly enhanced in cleavage. This result 
is shown more clearly in Figures 62 and 63. Thus, the reaction 
observed with the infected cell extracts is specific for virus- 
infected c e l I s .
^  Alterations in the DNase I digestion pattern of the 
Ip wer strand
So far, only results for the pR9 insert 3' end-labelled 
at the Hind HE site have been shown. This represents the 
uPper strand with respect to the 5'-3' sequence shown in 
Fig ore 63. Therefore, to investigate interactions on the
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FIGURE 61
DNase I digestion pattern in the presence of mock-infected 
cell extracts. The Eco RI/Hind IH fragment from plasmid 
pR9, end-labelled at the Hind HI site, was incubated with 
15 ul or 30 ul of either moc k-infecte d or HSV-l-infected 
cell extract, as indicated. Samples were analysed on a 6% 
sequencing gel. GA and G sequence reactions serve as markers, 
and the position of the D R 2 repeat and U^ regions are shown. 
Bands within U^ apparently enhanced in cleavage in the 
presence of mock-i nfe cted cell extracts are indicated (• )•
FIGURE 62
Comparison of the DNase I footprint generated by infected 
and mock-in fected cell extracts. The Eco RI/Hind HE fragment 
from pR9, 3' end-labelled at the Hind HE site, was incubated 
with either no protein (-), 30 ul of mock-in fecte d cell 
extract (MI), or 15 ul or 30 ul of HSV-l -in fected cell 
extract (17+ ). Samples were analysed on a 6% sequencing 
gel. GA and G sequence reactions serve as markers, and the 
position of the D R 2 repeat and regions are indicated.
Part of the DNA sequence within U^ and D R 2 is presented - 
alterations in the DNase I digestion pattern generated by 
moc k-i nfected cell extracts are indicated to the left (MI), 
while those generated by infected cell extracts are indicated 
to the right (17+ ). Nucle otides apparently enhanced in 
cleavage to their 3 ! side in the presence of mock-infected 
(■ ,— ►) or infected ( — ► )  cell extracts, are indicated. 
Nucleotides apparently protected from DNase I digestion 
are indicated by brackets (]).
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FIGURE 63
DNase I digestion patterns of mo ck-infected  and infected 
cell extracts. The nucleotide sequence of the D R 2 /U^ region 
of the ’a 1 sequence is shown. This is adapted from, and 
in the opposite orientation to, that shown in Davison and 
Wilkie (1981), and represents the top strand, in a 5 1—3 1 
direction, of the ’a ’ sequence present in plasmid pR9.
Those nucleotides on this strand enhanced in cleavage at 
their 3 ’ side in the presence of infected ( ^  ) or mock- 
infected ( ► )  cell extracts are indicated. The overline 
represents those nucleotides apparently protected from 
DNase I digestion in the presence of infected cell extracts; 
the underline represents those nucleotides apparently 
protected from DNase I digestion in the presence of mock- 
infected cell extracts.
nucleotide enhanced in cleavage at its 3 ’ side only
in the presence of 8 mM M g C ^ .
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lower strand, the plasmid was 5 ’ end-labelled at the Hind HI 
site (Figure 64). DNase I footprinting on 5 ’ end-labe lled 
fragments has proved relatively unsuccessful, due apparently 
to the presence of an endogenous 5 f — 3 ’ exonuclease activity 
within the extracts. However, long exposures of such footprints 
(lanes 7 and 8) suggest that there is little additio nal 
activity on the lower strand. Only one band appears to be 
significantly enhanced (indicated by the heavy arrow) although 
two add itional bands appear to be weakly enhanced (indicated 
by the open circles).
IV.7 DNase activity within the whole cell extract
The high level of nuclease activity within the infected 
cell extracts has been a consistent problem. The question of 
whether the enhanced cleavage seen in Region 2 is due to a 
specific cleavage event generated by a protein, or proteins, 
within the infected cell extract, or whether it is simply 
enhancement of cleavage by DNase I, cannot be answered using 
crude whole cell extracts. Incubation of 3' end- labelle d DNA 
with infected cell extracts produces an identical footprint 
in the presence or absence of DNase I (Figure 65, compare 
lanes 2 and 4, and 5 and 7), suggesting that a DNase I-like 
activity resides within the extract.
^•8 Partial puri ficat ion of the DNase I footprinting activity
To identify the protein(s) involved in this interaction 
and to separate them from the endogenous nuclease activity, 
a number of purifica tion procedures were attempted. Infected 
cell extracts were applied in B2 buffer to DEAE- cellu lose 
(DE-52), pho sphoce ll ulose and hepar in-Seph arose and then 
eluted stepwise with 0.3M, 0 . 6M and 2M NaCl . The activity
FIGURE 64
Alterations in the DNase I dige stion pattern of the lower 
strand in the presence of infected cell extracts. Eco RI/ 
Hind III fragments from plasmid p R 9 , 3 ’ (upper strand) or 
5 ’ (lower strand) end -lab elled  at the Hind IH site, were 
incubated with either no protein (-), or with 30 ul of 
HSV-1 (17+ ) or HSV-2 (HG52) -infect ed cell extracts. 
Samples were analysed on 6% sequenc ing  gels. GA and G 
sequence reactions serve as markers, and the positions of 
the D R 2 and regions are indicated.
a nucleotide on the lower strand apparently enhanced 
in cleavage at its 5' side.
O  nucleotides on the lower strand possibly enhanced 
in cleavage at their 5 ’ side.
Lanes 7 and 8 represent a longer exposure of lanes 4 and 5; 
lane 9 -is the same as lane 6.
protein protein HG52 17
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FIGURE 65
Effect of endogenous DNase I on the pattern of digestion. 
Eco RI/Hind HI fragments, 3 r end-labelled at the Hind HE 
site, were incubated with an HSV-l-in fe cted cell extract 
and then either treated (+) or not treated (-) with DNase I. 
Samples were analysed on a 6% sequence gel. GA and G 
sequence reactions serve as markers. Only a portion of 
the gel is shown - the DR£ repeats occupy approximately 
the top third of the gel, and Region 2 within is 
indicated. Lanes 5-7 represent a longer exposure of lanes 
2-4.
-156-
was recovered entirely within the 0.3M eluate from DE-52 
(Figure 60), appeared to be lost by passage through phospho- 
cellulose, and was recovered pre domin antly in the 0 . 6M eluate 
from h e p a r i n -S epharo se  (Figure 66A). However, the majority 
of proteins eluted in these fractions (results not shown).
An H S V-l -i nfected  cell extract was fra ctionated on DNA 
cellulose, as described in result section H I .3, by Dr Graham 
Hope, and the eluted fractions were then assessed for activity 
in the DNase I footprinting assay (Figure 6 6 B ) . The activity 
was found to spread broadly across the gradient, being most 
predominant in fractions 1 and 9. Fraction 9 was the purest 
fraction with respect to protein content, and had a low level 
of endogenous nuclease activity (Figure 66 and results not 
shown). This fraction was therefore further purified using 
an FPLC mono Q anion exchange column. Despite reasonable 
recovery of most proteins, the DNase I footprinti ng activity 
was lost (results not shown).
Loss of the DNase I footprinting activity could be due 
to a number of factors. Firstly, the assay is relatively  
insensitive and therefore significant dilution of the activity 
would render it undetectable. Secondly, the activity is 
unstable, and may have become denatured or degraded during 
chromatography. Thirdly, the activity may involve more than 
one protein, and these proteins may have become separated 
by the chr omato gr aphic procedures.
IV‘9 Role of the 21K polypeptide in the DNase I footprinting 
Activity
The 21K polypeptide is known to bind to the !a ’ sequence 
and is the refore a potential candidate for the DNase I
footprinting activity. To further investigate which protein
FIGURE 66
Partial purif ication  of the DNase I foo tprinting activity. 
HSV-l -in fected cell extracts were applied to either phospho- 
cellulose (PC), h e p a r i n-Sepha ro se (HEP) or DNA cellulose 
columns. Flo w-th ro ug h (FT) material was collected and 
bound proteins were eluted either stepwise with 0.3M, 0.6M 
and 2M NaCl (1.5 ml fractions being collected into 0.5 
inhibitory units of crt^-macroglobulin), or, for the DNA 
cellulose, with a linear 50-900 mM NaCl gradient. Following 
dialysis against B2 buffer, 30 ul of each fraction was 
incubated with the Eco RI/Hind HI fragment of plasmid pR9,
3 ! end-labelled at the Hind HI site. Only the relevant 
portion of the gel is shown, and GA and G sequence r e a c t i o n s  
serve as mol. w t . markers. Samples were analysed on 6% 
sequencing gels.
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or proteins were involved in this activity, and specifically 
to determine whether the 21K DN A- binding protein played a 
role, we first atte mpt ed to inhibit the int eraction using 
various antisera. The IgG was purified from a general anti- 
HSV-1 a n t i seru m and also from the antisera raised against the 
amino- and carboxy- te rminus of 21K. None of these antibodies 
inhibited the reaction (results not shown).
We next studied the timecourse of app earan ce of the DNase 
I footprin ting activity. The t e m p e ra ture-se ns itive mutant, 
tsK, def ec tive in the IE protein Vmwl75, overproduces IE 
polypeptides but fails to synthesise early and late pol y ­
peptides, at the non-permissive  temperature. This virus did 
not induce the DNase I footprinting activity at the non- 
permissive temperature, although it clearly did so at the 
permissive te mperatu re (Figure 67), suggest ing that, with 
the possible exception  of Vmwl75, this activity does not 
involve an IE polypeptide alone.
Tr eatment of infected cells with phosphon oacetic acid (PAA) 
inhibits viral DNA replication and thus sig nif icantly reduces 
the syn thesis of true late proteins. Figures 67 and 68 show 
that treatment with PAA does not significa ntly inhibit the 
'appearance of the DNase I footprinting activity, reducing 
this activit y by only approximately 2-fold (compare lanes 
3 and 5 in Figure 68), suggesting that this does not require 
a true late function and arguing against the involvement of 
21K. This conclusi on was supported by the observ ation  that, 
as expected, PAA inhibited the synthesis of, among others, 
the 21K polypeptide in this experiment (results not shown).
An HSV-2 mutant has recently been isolated which has a 
large deletion from the right hand end of the short region 
an<J Lacks ' the II gene equivalent; (Brown and Liar land, 1987).
FIGURE 67
Investigation of the temporal class of viral polypeptides 
involved in the DNase I footprinting activity. Eco RI/
Hind III fragments from plasmid pR9, 3 ’ end-labelled at the 
Hind m  site, were incubated with either no protein (lanes 
1 and 11), or with extracts from mock-inf ec ted cells (lane 
2), cells infected with HSV-1 alone (lanes 3 and 4) or in 
the presence of PAA (lanes 5 and 6), or cells infected with 
the temperature sensitive mutant tsK at either the 
permissive (lanes 7 and 8) or non-permissiv e (lanes 9 and 
10) temperature. Samples were analysed on a 6% sequencing 
gel. Only the relevant portion of the gel is shown. GA and 
G sequence reactions serve as markers, and Region 2 is 
i n d i c a t e d .
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FIGURE 68
DNase I digestion pattern with early and late infected 
cell extracts. Eco RI/Hind HI fragments from plasmid pR9, 
3' end -labelled at the Hind HI site, were incubated with 
5, 15 or 30 ul of extracts from cells infected with HSV-1 
in the presence (lanes 1-3) or absence (lanes 4-6) of PAA. 
Samples were analysed on a 6% sequencing gel. GA and G 
sequence reactions serve as markers, and the positions of 
the D R 2 and regions are indicated.
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Extracts were prepared from cells infected with this mutant 
(X12). These produced an identical pattern of cleavage to 
the HSV-2 wild-type virus, HG52 (Figure 69).
In conclusion, the presence of this DNase I footprinting 
activity would not appear to involve the product of gene 
Ugll, or any other true late gene product.
IV, 10 Involvement of the homology region
(a) DNase I footprinting with plasmid pASCU
The HSV-1 and HSV-2 *aT sequences are heterogeneous and 
contain only short stretches of homology (Davison and Wilkie, 
1981). However, the most extensive region of homology lies 
within and overlaps the region (Region 2) in which enhance­
ment of cleavage is evident. Therefore, since both HSV-1 and 
HSV-2-infected cell extracts generate enhancement of cleavage, 
it is possible that the homology region may be involved in the 
interaction. A synthetic oligonucleotide representing the 
homology region was synthesised (see Figure 54). The original 
intention (not subsequently attempted) was to use this oligo­
nucleotide to prepare an affinity column to purify sequence- 
specific binding proteins. Therefore, we attempted to clone 
multimers of the oligonucleotide. One plasmid, termed pASO^, 
contained 3 tandem repeats of this sequence, linked head-to- 
tail (result section I V . 1, Figure 54). Inserts either 3 ’ or 
5 ’ end-labelled at the Hind HI site were isolated and tested 
in DNase I footprinting assays (Figure 70). Incubation with 
HSV-l-infected cell extracts resulted in the enhancement of 
cleavage of certain bands, with no obvious signs of protection. 
Mock-infected cell extracts did not produce this pattern,
Again, enhancement was only visible on one strand. The
FIGURE 69
DNase I digestion pattern with X12-infected cell extracts. 
Eco RI/Hind HE fragments from plasmid pR9, 3* end-labelled 
at the Hind HE site, were incubated with either no protein 
(lane 1), or with 30 ul of extract from cells infected 
with HSV-2 strain HG52 (lane 3), or the HSV-2 mutant X12 
(lane 2), which lacks (among others) gene Ugll. Samples 
were analysed on 6% sequencing gels. GA and G sequence 
reactions were used as markers, and the relative positions 
of the DR^ repeat and U^ regions are indicated.
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FIGURE 70
DNase I footprinting on the synthetic oligonucleotide 
t r i m e r . Eco RI/Hind HE fragments from pASO^, 3 f or 5 ’ end- 
labelled at the Hind III site (as indicated), were incubated 
with either no protein (lanes 1, 12) or with 15 or 30 ul 
of either mock-infected (MI) or HSV-l-i nfected (17+ ) cell 
extracts, for either 5 min, as usual, (lanes 1-5, 9-12), 
or for only 2.5 min (lanes 6-8). Samples were analysed on 
6% sequencing gels. GA and G sequence reactions were used 
as markers. One copy of the oli gonucl eo tide sequence is 
s h o w n .
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sequence tracks for the 3* end-labelled fragment are not very 
clear, and therefore, from this figure, the enhanced bands 
can only be located to within one base. However, by comparison 
with other experiments, the enhanced cleavages were located 
as shown in Figure 71. The pattern did not correlate with 
that seen in the intact 'a' sequence (Figure 71).
(b) DNase I footprinting with the HSV-2 'a* sequence
In addition, very preliminary results have been obtained
with the HSV-2 ?a f sequence. Plasmid pAH2 , obtained from Mr
Martin Murray, contains the HSV-2 'a' sequence derived from
the L-S junction, and about 200 bp of flanking ’bT ' sequence
(materials, Figure 17). The HSV-2 ’a ’ sequence contains an
Eag I restriction enzyme site within the DR^ region which
could be labelled to study interactions occurring in the
region equivalent to U^. Although the DNase I footprint
reaction shown in Figure 72 is poor, it can clearly be seen
that certain bands are markedly enhanced in cleavage in the
presence of HSV-1-infected cell extracts. The sequence tracks
are unclear, partly due to the fact that the Eag I cleavage
site is 5 '-C^GGCCG-3 ' , and therefore 3* end-labelling using 
3 2
[°* P]-dGTP resulted in two populations of molecule differing 
in size by 1 bp. This was a consistent problem with 3 ’ end- 
labelling at restriction enzyme sites of this nature. However, 
from the general pattern of the sequence tracks and by 
comparison with the sequence tracks for the pR9 insert end- 
labelled at the Hind HI site, it would appear that the region 
°f enhancement lies within the homology region - ie. the 
dr2 repeat elements of the pR9 insert start at approximately 
90 bp from the labelled end, while the U ^ homology region 
within the PA H 2 insert Lies between approximately 70-100 bp
FIGURE 71
DNA sequence of a monomer of the synthetic oligonucleotide 
trimer within pASO^. The sequence is shown in the same 
orientation as Figure 63. The U^ homology sequence is 
indicated (i— i) as are those nucleotides forming the linker
sequence (-----), and therefore not present in the intact
’ a ’ s e q u e n c e .
►  dinucleotide bonds enhanced in cleavage when the
pASO^ insert is used as substrate.
» dinucleotide bonds enhanced in cleavage when the
intact ’a* sequence is used as substrate.
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FIGURE 72
DNase I footprinting on the HSV-2 ’a ’ sequence. Plasmid 
p A H 2 contains the HSV-2 ’a ’ sequence. Eco RI/Eag I fragments 
from p A H 2 , 3' end-labelled at the Eag I site (located within 
the DR^ region), were incubated with either no protein 
(lane 1) or 30 ul of an HSV-l-infected cell extract (lane 2). 
Samples were analysed on a 6% sequence gel. GA and G sequence 
reactions on both the Eco RI/Eag I fragment from p A H 2> and 
on an Eco RI/Hind HI fragment from p R 9 , 3 ’ end-labelled at 
the Hind HI site, were used as markers. Between the HSV-2 
and HSV-1 'a* sequence reactions is an empty lane.
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from the labelled end. This result is preliminary and 
obviously requires further study, but it does suggest the 
possible involvement of the homology region in the 
interactions observed.
D I S C U S S I O N
- 161 -
DISCUSSION 
SECTION I : ANTI-PEPT ID E SERA
The aim of this project was to further char acterise the 
21K/22K po lyp ept ides known to spe cifically interact with the 
’a ’ sequence of HSV-1, and to inv estigate in more detail 
their DNA -bi nd in g properties. As discussed in the int roduction 
(section XI), it was thought highly likely that these poly­
peptides were encoded by gene Ugll. Therefore, use was made 
of the available  DNA sequence inf ormation (Rixon and McGeoch, 
1984) to obtain synthetic oligopeptides cor resp onding to 
several regions of the predicted gene product. The original 
intention was to use antisera raised against these o l i g o ­
peptides to purify the 21K/22K proteins. Immunoaffinity 
chromatograph y against anti-peptide antibodie s has the 
advantage that protein specifically bound to the column can 
then, in theory, be eluted using the oligopeptide, thus 
avoiding harsh and denaturing conditions. The re fore this 
procedure is potentially useful for purifying functionally 
active polypeptides.
Five synthetic oligopeptides were obtained over the 
course of this project. These represented amino acids 1-11, 
48-58, 66-76, 132-138 (138-144) and 151-161, res pectively 
(see result section 1.1, Figure 18). All five peptides were 
immunogenic - ie. they induced antisera which reacted against 
the synthetic oligopeptide in a solid phase radioimmunoassay. 
However, only four of the five peptide antise ra reacted 
convincingly with HSV-induced polypeptides. One antiserum, 
ant i-( 132-1 38 ) , failed to react strongly in either immuno- 
blotting or immunoprecipitation reactions, although a very
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weak i nt er actio n was detected. This was the smallest peptide, 
an 8-mer (7 amino acids from the U^ll gene product plus an 
am ino-te rminal tyrosine residue), and internal peptides of 
this size have reportedly a low success rate in inducing 
protein -r ea ctive  antisera (Palfreyman et a l ., 1984b). In 
addition, this peptide represents part of the region within 
the predicted Ugll gene product which contains 24 tandem 
repeats of the sequence X-Pro-Arg. It is possible that this 
repetitive sequence may confer a distinct structure to this 
region of the polypeptide, which the small 8-mer oligopep tide  
may not be able to mimic.
We routinely  coupled synthetic peptides to the carrier 
protein BSA for immunisation. However, it has been reported 
that free, uncou pled peptides can induce strong anti-peptide 
and an ti- p r o t e i n  responses (Young et a l ., 1983), and therefore 
two peptides were tested as immunogens in an uncoupled form.
For both these peptides the anti-peptide and an ti-protein  
responses were considerably weaker than those generated by 
the coupled peptides (see result section I, Table 6 and Figure 
23). However, it must be mentioned that no attempts have been 
made to optimise  the immunisation procedure.
A number of rabbits showed a decline in the RIA and 
immunoblotting reactions, despite continued imm unis ation  
(see result section I, Table 6 and Figure 27), suggesting  
the de velop ment of tolerance to the immunogen. This illust rates  
the importanc e of assessing the immune response to each 
immunisation, to reduce the risk of missing the optimal a n t i ­
protein response. No attempt was made to boost these rabbits 
using peptide coupled to an alternative carrier protein.
There was no apparent correlation between the a n t i ­
peptide titre measured by RIA and the anti-prot ein response
detected by immuno blotting (result section 1.5, Figure 27). 
However, the peak immu no blotting reaction was often found 
to coincide with the initial decline in RIA titre. The RIA 
is an easy and rel atively quick assay to perform (one can 
readily do 500 tests in a day), and could be used to assess 
each consec uti ve bleed with a view to deciding at what point 
to stop immunisa tion and bleed out the animal. However, this 
is obviously a very limited study, and how an ant i-p rotei n 
response assessed by immunoblotti ng correlates with a response 
to native protein is unclear, since in this study no a n t i ­
serum showed a good reaction with native protein by either 
i mmuno pr ec ipita ti on  or immunoaffinity chromatography.
The original intention of this project was to use the 
ant i-p eptide sera to purify the 21K polypeptide. However, 
immun oaf finity ch rom ato graphy proved unsuccessful, the 
synthetic oligo pepti de s failing to specifically elute any 
bound protein from the columns (result section H I .1). A low 
level of 21K was eluted using 3M sodium thiocyanate, but 
this was cont aminate d by a number of other polypeptides. In 
addition, sodium thi ocyanate is a highly denatur ing eluting 
agent, and would be unlikely to be suitable for the p u rif­
ication of a function all y active protein.
It has been demonstr ated that a high proporti on of 
monoclonal antibodies raised against synthetic oligop ep tides 
cross-react with the native protein (Niman et a l ., 1983). 
Therefore, in the hope of selecting an ant i-pe ptide antibody 
with a higher affinity for 21K, we attempted to raise m o n o ­
clonal antibodies against the available oli gopeptides. In 
addition, we attempted to raise monoclonal a nt ib odies against 
the intact 21K polypeptide, by immunising mice with DNA 
cellulose purified material. Both these approac hes failed,
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due, at least in part, to the lack of a reliable assay 
system (result section 1.6).
Therefore, our original intention of pur ifying the 21K/22K 
pol ypeptides by im mun oaffi nity ch romatog raphy against a n t i ­
peptide sera was not achieved. However, this approach 
resulted in the generat ion of some useful antis er a with 
which to further chara ct erise the Ugll gene products.
SECTION H  : C H AR AC TERISAT IO N OF THE Ugll GENE PRO DUCTS
The anti-peptide sera specifica lly recog nised not only 
proteins of apparent mol. w t . 21K and 22K, but also at least 
four lower mol. wt. polyp eptides (17.5K, 15K, 14K and 11K).
The tryptic peptide fingerprints shown in result section H . 2 
(Figure 36) clearly confirm that these pol ypep tides are 
related to 21K and 22K. However, the precise relat io nship 
between these products is unclear. Although the amino acid 
sequence of the predicted Ugll gene product contain s 24 
tandem repeats of the tripeptide X-Pro-Arg, there is no 
extensive reiteration within the DNA sequence, as all the 
potential codons for proline and arginine are used (Rixon 
and McGeoch, 1984). However, there is a short 18 bp sequence 
which is present as three tandem repeats in HSV-1 strain 
17syn+ (Rixon and McGeoch, 1984), but only as two tandem 
repeats in HSV-1 strain Patton (Watson and Vande Woude, 1982). 
It has been suggested (Rixon and McGeoch, 1984) that var iation 
in the number of repeats of this 18 bp sequence may account 
for the interstrain variability in the apparent mol. w t . of 
Vmw21 reported by Lonsdale et a 1. ( 1979). It is also possible 
that this could account for the difference between the 21K 
and 22K polypeptides. However, the fact that the apparent
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mol. wt. of Vmw21, Vmw22 was unaltered in 72 separate plaque 
isolates of HSV-1 strain 17syn+ (Alasdair R iMacLean, personal 
communication), might argue against this possibility.
C a r bo xy-te rm inal antisera recognised products of appar en t 
mol. w t . 17.5K, 14K and 11K which were not recognised by 
am ino-t erminal antisera. Antisera against internal o l i g o ­
peptide 48-58 recogni sed the 17. 5K and possibly the 14K p o l y ­
peptides, but not the 11K polypeptide. This might suggest 
that the 17.5K, 14K and 11K products, while retaining the 
c a r b o x y - t e r m i n u s , lack progressively larger regions from the 
am ino-t erminus of 21K. However, this interpr etation is not 
readily co mpatible  with the dist ribution of the three m e t h i o n i n e  
residues in the predicted U^ll gene product : these are all 
situated in the amino -terminal  region (residues 1, 27 and 41, 
respectively). An alternative in terpretat ion is that the 
amino-t erminus is present in the 17.5K, 14K and 11K p o l y ­
peptides, but ina ccessible to the ami no- te rminal antisera 
in i m m u n oblott in g reactions. It is unlikely that the 11K 
polypeptide is generated without the loss of some amino acids, 
since the predicted mol. w t . of the Ugll gene product is 
17,756 (McGeoch et a l . , 1985) and the in vitro tr ans lation 
product has an apparent mol. wt. of 21K (Rixon and McGeoch, 
1984). Another hypothesis for the observed reactivity of the 
antisera is that the lower mol. w t . polypeptides arise as 
a co nsequence  of splicing within the U^ll gene - however, 
there is no evidence for this (Rixon and McGeoch, 1984;
Frazer J Rixon, personal communication).
The 15K polypeptide is recognised by the a m in o-term in al  
antiserum, anti-(48-58) and possibly by anti-(66-76) sera, 
but not by the car boxy-terminal antisera. The simplest 
interpretation of this result is that this polypeptide lacks
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part of the car boxy-terminus of the Ugll gene product.
Polypep tid es of apparent mol. wt. 21K and 22K, des ignat ed 
Vmw21 and Vmw22, were previously shown to be produced in 
abun dan ce late in infection (Marsden et a l . , 1976) and to 
map to the right hand end of the short region of the virus 
genome (Marsden et a l ., 1978). Timecourse experiments (result 
section IE.1) confirmed that the 21K and 22K Ugll gene 
products are synthesised late in infection, and PAA, an 
inhibitor of viral DNA replication, severely impaired their 
synthesis (approximately 100-fold), in contrast to an a p p r o x ­
imately 5-fold reduction in the synthesis of gD, an early 
(^ Jf ) polypeptide. Thus, it was concluded that the 21K/22K 
polypeptide s encoded by gene Ugll could be defined as true 
late gene products.
One reason for studying the Ugll gene products was to 
determine their relationship with the previously described 
21K and 22K DNA -binding proteins shown to spe cifically 
interact with the ’a ’ sequence of HSV-1 (Dalziel and Marsden, 
1984). Three attempts were made to repeat the competi tion 
experi men ts of Dalziel and Marsden, and these resulted in 
a very high level of non-specific elution of DNA -binding 
proteins. Therefore, we could not obtain the fa' sequence- 
specific DNA -binding proteins for immunoblotting or immuno- 
precipit ati on experiments, and so it was not possible to 
de mon strate una mbiguously that the Ugll gene products i n t e r ­
acted with the ’a f sequence of HSV-1. However, by immuno- 
blotting proteins eluted from DNA cellulose columns we could 
confirm that the 21K and 22K Ugll gene products were DNA- 
binding proteins (result section H . 3, Figure 37). The existen ce 
of a second, completely unrelated, pair of late 21K/22K 
DNA-binding proteins would seem sufficiently unlikely that
- 167 -
it can be concluded with reasonable confidence  that the 
21K/22K proteins which specifically interact with the HSV-1 
fa ! sequence are the products of gene Ugll.
The su bce llular local isa tion of the U^ll gene products 
was d et ermined  by immune electron microscopy. The Ugll gene 
products localis ed within two areas of the infected cell, 
the cy t o p l a s m  and the nucleolus. The cyt oplas mi c labelling 
varied in inten sity between individual cells, but the reason 
for this was not clear. Nor was the function al signific ance 
of this behaviour apparent. Attempts to compare the dis tri butio n 
of 21K wi thin a popu lat ion of infected cells by i m m u n o ­
fluorescence proved unsuccessful, due to high levels of no n­
specific staining of infected cells. In contrast, the immune 
electron m i c r oscopy was highly specific (result section IE. 4) .
The pr edo minant site of lo cal isati on of the Ugll gene 
products was the nuc leolus (result section IE.4). The structure 
and function  of nucleoli has recently been reviewed 
(S o m m e r v i l i e , 1986). The primary, and only described, function
of the nucleo lu s appears to be the gen erati on  and maturatio n 
of rib osomal particles. Nucleoli are therefore generated  
around rib osomal chromatin  and are often su rr ounde d and 
penetrated by so-called ’n u c l eol us -associ at ed c h r o m a t i n ’
(Jordan, 1984). This was clearly seen, for example, in Figures 
40 and 42.
Studies on the effects of HSV inf ection on cellul ar 
metabolism have led to the conclusion that the nucleolus 
dis agg regates  to produce spherical densely staining components 
(dense bodies) and a less densely staining, irregularl y 
shaped, granular component (Sirtori and B o s i s i o - B e s t e t t i ,
1967; Schwartz and Roizman, 1969; Dupuy-Coin et a 1 . , 1978).
In contrast to the granular component, the dense bodies
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contain no DNA or RNA, although  they have been shown to 
contain at least one n u c l e o l u s- specif ic  protein (Puvion- 
Dutilleul et al . , 1985). No asso ci ation was found between
the Ugll gene products and dense bodies.
The predominant as so ciation of the Ugll gene products 
with the granular component of the nucleolus, the site of 
production, process ing and m a t u rati on  of pre-ribosomal 
particles (S o m m e r v i l l e , 1986) resembles that previously 
shown for ribocharin, a protein believed to be involved in 
nucleocytoplasraic transport of ribos omes (Hiigle et a l . , 1985a) 
and SI, a structural component of ribosomal particles (Hiigle 
et al. , 1985b). This might suggest some preferential a s s o c ­
iation of the Ugll gene products with ribosomal RNA or ribo- 
n u cleo pr ot eins in infected cell nuclei, although an a s s o c ­
iation with ribosomal DNA cannot be excluded. Dis aggrega ti on 
of the nucl eol us and inhibition of ribosomal RNA synthesis 
occur early following infection (Schwartz and Roizman, 1969; 
Wagner and Roizman, 1969) and therefore it would seem unlikely 
that the Ugll gene products play a major role in these events.
Uii et a l . (1968) have previously shown localisati on
of virus -i nduced antigens to similar structures using ferritin- 
conjugated antibodies. However, since only general anti-HSV 
antisera were used, the identity of the antigens recognised 
remains unknown. Therefore, whether other viral antigens 
ac cu mulate within these residual nucleoli is unclear.
Although the 21K/22K polypeptides appear to interact 
with the HSV-1 'a' sequence in v i t r o , their nucleolar l o c a l ­
isation suggests that they may not bind to viral DNA in v i v o . 
Viral DNA is located in the nucle op lasm but is specifically 
excluded from nucleoli (Rixon et a 1. , 1983; P u v i o n - D u t i 1leul
et a 1 . . 1985; Randall and Dinwoodie, 1986). Similar nucleolar
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localisa tio n has not been observed for other HS V-specified 
DNA-b ind ing proteins, for example IE Vmwl75, the major DNA- 
binding protein and the DNA polymerase (Randall and Dinwoodie,
1986). In these cases the di stribution reflects that of 
viral DNA, ie. localisation to the n u c l eopl as m and exclusion 
from the nucleolus.
The different patterns of local isa tion of the virus DNA 
and 21K might suggest that 21K plays no direct role in virus 
DNA repl icati on  or maturation. This suggestion is supported 
by the recent isolation of a number of HSV deletion mutants 
which lack gene Ugll and are viable in tissue culture 
(Longnecker and Roizman, 1986; Umene, 1986; Brown and Harland,
1987). In vivo studies with these mutants have not yet been 
reported. Thus, whether the Ugll gene products influence 
the hos t-r an ge dependence of the virus, or whether they play 
a role in latency or pathogenesis in v i v o , remains to be 
d e t e r m i n e d .
SECTION IH : ATTEMPTS TO PURIFY THE 21K PO LY P E P T I D E
Attempts to purify the 21K polypeptide met with limited 
success (result section HI). A major problem was that the 
use of partiall y-pur if ied 21K for subsequent ch ro ma tograph ic  
procedures generally resulted in loss of the protein - it 
was neither recovered significantly in the flow -throu gh  or 
eluate, nor did it remain bound to the column. The presence 
of various protease inhibitors (PMSF, TLCK and <x2-macro- 
globulin) did not significantly influence recovery. However, 
no systematic study of the effect of protease inhibitors  
was carried out, and it is possible that a co mb ination of 
these and/or other protease inhibitors may have helped.
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A two step purification procedure was developed which 
involved ammonium sulphate precipitation followed by c h r o m a ­
tography of the dialysed supernatant against ph os phocel lu lose  
(result section H I .5). Under certain conditions, this 
yielded an apparently homogeneous prepara tion of 21K, as 
assessed by aut oradiography. However, Coomassie blue staining 
revealed several major contaminants and no det ectable  21K 
polypeptide.
One interes ting feature that emerged from these studies 
was the aberrant mi gra tio n of par tiall y- purifie d 21K in 
SDS-PAGE. It often ran as a very diffuse, smeared band, 
frequently with an increased apparent mol. w t . This aberrant 
migra tio n was part icularly apparent as the protein became 
more pure : the cause is not clear, but may represent a 
structural instabil ity of the polypeptide in a purified 
form.
From the purification  attempts described it became 
clear that we were unlikely to achieve a homo ge neous p u r i f ­
ication of signi ficant quantities of 21K for either the 
generation of monos pec ific antisera or for functional studies. 
It was also possible that purification of the 21K polype ptide 
might result in loss of its DNA-binding activity. Therefore, 
since the original intention was to study the inte raction 
between the 21K polypeptide and the HSV-1 ’a' sequence, we 
decided at this point to look instead for eviden ce of DNA- 
protein interactions  occurring within the ’a ’ sequence, and 
then to investigate whether or not these inte rac tions 
involved the 21K polypeptide.
- 171 -
SECTION IV : DNA-PROTEIN INT ERACTIONS WITHIN THE
HSV-1 'a' SEQUENCE
To investigate sequence-s pe cific DNA-protein interactions 
within the 'a' sequence we used a DNase I footprinting assay 
(result section IV). Incubation of end-labelled ' a 1 sequence- 
containing DNA fragments with crude whole cell extracts 
resulted in alt erations in the DNase I digestion pattern which 
were specific for infected cell extracts (Figure 62). For 
ease of discussio n these altera tions have been divided into 
two areas, termed Region 1 and Region 2 (see Figure 60, result 
section IV .4).
Reg ion  1 occurs within the D R 2 repeat elements, and 
comprises a protected region spanning 7 nucleotides, flanked 
on either side by 2 nucleotides at which cleavage is enhanced. 
Between each element is one nucleotide, cleavage of which is 
apparently unaffected. Region 2 occurs within U^ and encompasses 
a number of sites showing a marked ly enhanced sensitivity to 
DNase I digestion. Occasionally, protection was seen within 
this region.
A major dis advantage to the use of whole cell extracts 
was the high level of nuclease activity present. This severely 
limited the amount of protein which could be added to the 
reaction, and significantly impaired the analysis of 5' end- 
labelled fragments. The selective loss of counts seen at the 
top of the gels with 3 ’ end-labelled fragments, and the fact 
that 5' en d-lab elling of a blunt ended fragment did not 
improve recovery of counts (results not shown), would suggest 
that a 5 T — 3 * exonuclease activity, and not a single-strand 
nuclease activity or a phosphatase activity, was responsible.
It is well established that HSV infection induces high levels
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of nuclease activity in infected cells, and one candidate for 
this would be the virus-encoded alkaline exonuclease (Keir 
and Gold, 1963; Morrison and Keir, 1968). However, for reasons 
discussed later, this does not seem likely to be the source 
of the putative 5 * — 3 * ex onucleas e activity.
M o c k - infe ct ed cell extracts also induce changes in DNase 
sensitivity within the D R 2 repeat element. The relationsh ip  
between these changes and those induced by HSV- infec ted cell 
extracts is unclear (see Figure 62, result section I V . 5, for 
a comparison). It is possible that the DNA-binding pro perties 
of a cellular protein could be modified following infection, 
possibly via interaction with viral protein(s). Alternatively, 
however, a virus-encoded or virus-induc ed protein may be 
responsible for the effect seen with infected cell extracts. 
HSV-1 and H S V - 2 - i n f ected cell extracts induce identical DNase I 
digestion patterns in this region. Interestingly, the HSV-2 
’a ’ sequence contains only a single D R 2 homology (Davison and 
Wilkie, 1981).
The enhancement of cleavage seen in Region 2 is also 
virus-specific, and HSV-1 and H S V - 2 - i n f ected cell extracts 
again generate identical DNase I digestion patterns in this 
region. Enhancement has often been reported near or within 
protected regions in DNase footprinting studies (for example, 
Dynan and Tjian, 1983; Wildem an et a l . , 1986), but here the 
enhancement is occurring in the absence of any si gnificant  
protection. Whether enhanced sensitivity to DNase I is 
indicative of a DNA-protein interaction is debatable. However, 
the enhanc eme nt seen in Region 2 is very marked and must at 
least suggest the possibility of some form of DN A-protein  
interaction within or near this region.
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The HSV-1 and HSV-2 'a' sequences share limited homology 
(Davison and Wilkie, 1981; Mocarski and Roizman, 1981; Mocarski 
et a l . , 1985; Varmuza and Smiley, 1985). However, within 
there is a 28 bp region which is highly conserved between 
these 'a* sequences (Davison and Wilkie, 1981). Bands enhanced 
in the presence of HS V-infected cell extracts overlap and 
flank this region (see later, Figure 74), possibly reflecting 
some undetected binding within the homology region. 
Preliminary experime nts suggest that a similar very marked 
enhancement of cleavage occurs in the HSV-2 fa ’ sequence, 
within the homology region. However, the precise nucleo tid es 
affected were not determined. Nevertheless, this observation 
strengthens the possibility that the homology region may 
be involved in the effects seen in Region 2.
A number of mec hanisms could lead to increased cleavage 
between particular dinucleotides. Firstly, a specific cleavage 
event could be generated by protein(s) within the infected 
cell extract. To test this possibility the putative U^-binding 
protein will have to be purified away from the nuclease 
activity present within the extract. Secondly, protein binding 
may induce a conf or matio nal change in the DNA, leading to 
exposure of DNase hyper sensitive  sites. Thirdly, protein- 
protein int eractions could occur between the DNase I enzyme 
and protein bound to DNA, leading to enhanced cleavage nearby. 
Although the latter two mechanisms may explain the enhanced 
cleavage often described near or within protected regions in 
DNase I f o o t p r i n t i n g , the lack of any obvious protection  
within Region 2 may suggest that, alone, they do not s a t i s ­
factorily account for the marked level of enhancement observed 
here .
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Given the endogenous 5 T — 3 T exonuclease activity, an 
al ter native explanation is that these enhanced cleavages mark 
the 5 ’ boundaries of protein binding sites. Exonucl ease  
digestion has previously been used to map sites of protein 
binding within labelled DNA fragments (Wu, 1984). This 
principle is illustrated in Figure 73. Such a me chanism  could 
explain why the markedly enhanced cleavages are only observed 
on the 3 ’ end-labelled strands of either the o l ig onucle ot ide 
representing the homology region, or the intact 'a' sequence, 
and could also explain the dif ferences observed in the patt ern  
of enhance me nt on these two substrates. A composite picture 
of these enhanced cleavages is shown in Figure 74.
The presence of two regions of enhanced cleavage on each 
strand might suggest that two separate binding sites are 
involved. One potential mec hanism by which the enhanced 
cleavages within could have arisen is shown in Figure 74b.
A sequence of 17 bp is present as an imperfect, overlappi ng  
direct repeat within this region. This is shown in Figure 74c.
In the presence of a 5 ’— 3 * exonuclease, protein bound to the 
leftmost sequence (i) could generate the leftmost blocks of 
enhancement on the upper and lower strands, while protein 
bound to the rightmost sequence (ii) could generate the r i g h t ­
most blocks of enhancement on the upper and lower strands 
(Figure 74b). This appears to be the best candidate for a 
conserved sequence to account for the four regions of e n h a n c e ­
ment. However, the possibility that additional unrelated 
binding sites are involved cannot be excluded.
Although the region protected from exonuclease digestio n  
might be expected to extend further than the nucleotides 
directly involved in the DNA-protein interaction, this m e c h a n i s m  
does not explain the very extensive degree of enhancement 
spread over a large number of nucleotides seen in the r i g h t —
FIGURE 73
Exonuclease f o o t p r i n t i n g . This diagram illustr ates a hypo­
thetical interaction between a sequence- sp ecific DNA- 
binding protein and a fragment of DNA. Protein, binding 
to a specific region of the DNA (indicated by the hatched 
area) will protect it from nuclease attack. The number of 
bases in the protected and unprotected regions are indicated. 
Incubation of a 5 f- 3 f exonuclease with the protein-bound 
DNA, 3* end-labelled on either the upper (U) or lower (L) 
strand (a), will lead to the generation of labelled fragments 
terminating at the 5* boundary of the protein binding site 
on that strand (b). Analysis of the products alongside 
sequence markers (c) then allows these bou ndaries to be 
mapped. In a similar manner, a 3 1— 5 ’ ex onuclease  can be 
used to map the 3 ’ boundaries of the protein binding site, 
using 5 ’ end-labelled DNA.
* radioactive label
direction of cleavage by the exonuc lease
5 1—3 * exonuclease 3 ’-5’ exonuclease
c, U U
20 22
FIGURE 74
A possible mech anism  for the enhanced cleavage within U^.
A composite picture of those di nuc leo tide bonds at which 
cleavage'is enhanced when either the intact 'a ’ sequence 
(upper s t r a n d , — ►) or the oli go nucleo ti de sequence from 
pASO^ (lower strand, ►  ) is used as substrate. These groups 
have been termed E1-E4. indicates the relative position
of the nucleotides within the linker sequence at which 
cleavage is enhanced in the latter case. The homology 
region is indicated (i— i) .
One potential mec ha ni sm by which cleavage may appear to 
be enhanced at these sites. Enhanced cleavage has only 
been observed on 3' end-labelled strands. A 5 T — 3 f exo­
nuclease, processively digesting the labelled DNA until 
blocked by bound protein, would result in the o ve r­
represen tat ion of 3' end-labelled fragments terminating 
at the 5 T boundary of the protein binding site. Protein, 
bound to the right of El and E2, and to the left of E3 and 
E 4 , in (a), could therefore generate these apparently 
enhanced cleavages. The presence of two regions of enhance­
ment on each strand would suggest two separate binding 
sites. One possible candidate, a sequence present as an 
imperfect direct repeat, is indicated.
Putative U^- bindi ng site. (I) indicates those nucleotides 
conserved between the two copies of the imperfect direct 
repeat shown in (b).
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FIGURE 75
Schematic rep resentation of functional domains within  the 
'a T sequence. The HSV-1 ’a' sequence is shown in the 
orientation found at the L-S junction. The location of 
the U^ homology region (pac-1) is indicated (■■■), as are 
the putative U^-binding sites proposed in Figure 74 (— ). 
Below are shown the regions within which different 
functional signals have been mapped (see text). The region 
involved in cleavage/packaging corresponds to the Sma I F 
fragment of Varmuza and Smiley (1985).
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mo sL block of enhancement on the upper strand, nor the additional  
enhancement seen within the restriction enzyme linker in the 
o li gon ucl eotide trimer. It is possible that the effects 
observed reflect several different, possibly unrelated, DNA- 
protein interactions. In addition, it should be st ressed  that 
the m e c h an ism post ulate d above is purely speculative, and the 
precise binding site, or sites, have yet to be elu cidated.
Making the as su mp tion that the enhanced c l e a vag es  
represent D N A - pr ot ein int erac tions  within the ’a* sequence, 
then two main questions  arise : (i) what function(s)
are served by such interactions, and (iL) what viral protein(s), 
if any, are involved.
A number of functio nal signals reside wi th in the HSV fa* 
sequence (see i ntr od uction section X). These are summ ar ised in 
Figure 75. Chou and Roizman (1985) mapped the s e q u ences  required 
for sit e-s pe ci fic in version to the repeat ele ments of the HSV-1 
(F) ’a* sequence (DR£ and DR^), and dem ons trate d that the and
regions were not required. Varmuza and Smiley (1985) mapped 
sequences suf ficient for cleavage and packaging of viral DNA to 
the Sma I F fragment of HSV-1 (KOS). It was co nc luded that there 
are two c l e a v a g e / p a c k a g i n g  signals, one within and one wi thin  
, and it has been suggested that the U^- deriv ed  signal involves, 
at least in part, the 28 bp homology region (Varmuza and 
Smiley, 1985; Deiss et a l . , 1986). In addition, the ’a 1 
sequence contains the p r o m oter- re gulator y domain and t r a n s ­
cription initiat ion site of a gene within the 'b' sequenc e 
of the long repeat region (Chou and Roizman, 1986). Two 
transcription init iation sites were mapped in the HSV-1 (F)
’a' sequence, one within DR^ and the other 15 bp up s t r e a m  
at the edge of a TTTAAA  run within U^, suggested to be the
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nearest equivalent to a 'TATA' box. The authors claimed to 
have preliminary evidence that the promoter resides within 
the U^/Df^ repeat region of the Ta* sequence.
Thus, sequences within are involved in the cleavage 
and packaging of the viral genome, contain promoter elements 
for a gene within the adjacent ’ b ' sequence, and serve as 
transcription initiat ion  sites. Sequences within DI^ may also 
have a p r o m ot er /regu la tory function, and are involved in 
site-specific inv ersion events. Whether the DI^ repeat region 
is involved in packaging is unknown.
The change in the DNase I digestion patterns within 
and D R 2 occurred simultane ous ly - neither was observed in 
the absence of the other. These act ivities c op urifie d through 
the limited ch roma to graphic  procedures used. Therefore, it 
would be interesting to use the synthetic oligon u c l e o t i d e  
representing the homology region to compete with the binding 
of proteins to the intact ’a' sequence, to determine  whether 
binding to the region influences the binding in the Df^ 
repeats, and indeed whether the same protein(s) are involved. 
The sequence within DI^, however, shares limited homology 
with the putative binding sites - two possible alig nments 
are shown in Figure 76. The intensity of the clea va ges seen 
within would suggest that, if the same protein(s) are 
involved, then the affinity for the region is much stronger 
than the affinity for the DI^ repeat elements.
The proteins involved in these int erac tions  are unknown. 
The 21K/22K DN A-bin ding proteins previously shown to interact 
spe cifically with the ’a ’ sequence of HSV-1 (Dalziel and 
Marsden, 1984) are late polypeptides and the products of gene 
Ugll. Extracts from cells infected in the presence of PAA
FIGURE 76
Possible homolog y between D R 2 and the putative U^-binding
s i t e s .
(a) Nucleotide s showing enhanced cleavages in D R 2 . The sequence 
is drawn in the 5 ’- 3 f direction for the upper strand, and 
shows a rep etitive  pattern of enhanced cleavages (arrows). 
The groups of enhancement are labelled 1 and 2 for ease of 
reference. Prot ectio n is indicated by the solid bar.
(b) Sequence of the two putative U^-binding sites, and a 
consensus sequence derived from these. This is shown in 
the 5 f — 3' di rection for the lower strand (compare Figure 
74).
(c) Two possible alignments of the D R 2 repeat sequence with 
the putative U^ -binding site consensus. One possible 
me chani sm  by which apparently enhanced cleavages at sites 
1 and 2 might be generated, in the presence of a 5 1 — 3 f 
exonuclease, is if protein bound to alignm ents (i) and (ii)» 
respective ly  (cleavage would take place on the 5 ’ side, 
close to the binding site). An alterna tive possibility is 
that the enha nceme nt  within D R 2 rep resents true enhancement 
of DNase I cleavage, possible via protein binding within 
the sequence GGGGAGG, the region protected in the DNase I 
footprints (see (a)).
* repre sents those bases shared with the consensus 
sequence in (b ) .
GTGTG G G G A G G AG C G G G G G G A G G A G C
1 2 1 2
-te i G G G G G G 1 G 1 G I T 1 I G G G
-te 2 G G G G G G C C C G I T T I C G G
con se ns us G G G G G G Y ^ Y G T T T I ^ G G
■»U «A» sU <X> «A» <JU j. *JU
'T* "T “T* T  *T* T  ■’T* -T* 'J'
<*> G G G A G G A G C G G G G G G A G
£ # # # sjs sj« sje s}c
<*> G G G G G G A G G A G C G G G G G
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produced an identical DNase I digestion pattern to untreated 
infected cell extracts, as did extracts from cells infected 
with the HSV-2 del eti on mutant, X12, which lacks gene Ugll 
(result section IV . 9 ) . This would rather strongly suggest 
that the 21K/22K ’a ’ seque nc e-spe cific DNA-bi nding proteins 
are not involved in these interactions.
The presence of this activity in the PA A-treat ed extracts 
suggests that the intera ctions involve an IE or early poly ­
peptide. The tem pe ratur e - s e n s i t i v e  mutant, tsK, failed to 
induce this activity when grown at the non-pe rmissi ve  tem p ­
erature, suggest ing that IE polypeptides, with the possible 
ex cep tion of Vmwl75, are not involved alone.
The poly pepti des involved in cleavage and packaging of 
viral DNA and in the inversion of the viral genome are 
unknown. The presence of a pro mot er -r egulat or y domain and 
tra nscri pt io n initiat ion  site within the DJ^/U^ region of 
the ’a ’ sequence could result in the presence of a number of 
potential binding sites for either cellular or viral t ra n­
scription factors. Viral transc rip tion factors include Vmwl75, 
Vmw65 and the major DNA-bin ding protein (introduction, section 
IV.3). Chou and Roizman (1986) classif ied the 'a* sequence 
promoter as a ^  promoter, due to its slight sens itivit y to 
PAA. Vmw65 plays a role in IE transcription, and is therefore 
an unlikely candidate. In contrast, the major DNA -bind in g  
protein is involved in IE, early and late gene expression.
The use of _ts mutants should help to elucidate the role, if 
any, of this polypeptide. Vmwl75 appears to bind, either 
directly or indirectly, to a number of p r o m ot er-regu la tory 
sequences, and a conse nsus sequence 5'-A T C G T C N N N N Y C G R C - 3 1 
was proposed (Faber and Wilcox, 1986). There is no obvious 
homology with this sequence within either the or D R 2 repeat
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region. However, Vmwl75 may interact with sites other than 
this co nsensus sequence (introduction, section VI.6a). The 
use of extracts prepared from cells infected with wi ld-type  
virus under conditions which allow the synthesis of only the 
IE gene products, should help to clarify this point.
Al thoug h the enhanced cleavages within are generated
only by infected cell extracts, this does not exclude the
p os si bil ity that cellular trans cription factors are involved.
The homolo gy region, and flanking sequences, were compared
with known binding sites for a number of cellular t r a n s cript io n
factors, including nuclear factor I, nuclear factor HI, fTATA'~
bo x-bind ing protein, and the tra nsc ript io n factor Spl (Table 10)
Only one apparent homology was found (Figure 77). The sequence
5 ’- T G G G G G G G G C - 3 ’ , present on the lower strand shown in
Figure 74, correlates at 9/10 nucleotid es with the Spl
C CCC
cons ens us sequence 5 ?-^.GGGCGG^^rp-3 ' (Kadonaga e t a l . , 1986). 
Within  the Spl consensus, the hexam eric sequence ’GGGCGG' is 
very highly conserved and has been found, with only two 
exceptions, in all known Spl-bi nding sites to date (Jones 
et a l . , 1986; Kadonaga et a l . , 1986). The two exceptio ns are
S pl -b inding  sites within the HIV promoter, containin g the 
sequ enc es 5 1 -GGGACTT-3 ’ , and 5 ’-AGGCGT?-3 ' , respectively. The 
affinity of Spl for different binding sites appears to 
corr ela te with the degree of homology with the conse nsus 
sequence (Kadonaga et a l . , 1986), and it remains to be 
det erm ined whether the sequence 5' - G G G G G G - 3 ' is an S p l - bi nd ing 
site.
The D R 2  repeat element also shows homology to the Spl 
consensus. The sequence 5'- G G G G A G G A G C - 3 ’ differs only at the 
A at position 5 (GGGAGG) and in this regard resembles one of 
the Sp l-bin ding sites within the HIV promoter (GGG_AGT).
Table 10 i DNA sequence elements believed to interact— with 
t r ansc ri ption factors.
N any nucl eo tide
References
1. Pruijn et a l . , 1986
2. Bohmann et a l . , 1987
3. Jones et a l . , 1987
4. Kad ona ga et a l . , 1986
5. Schlokat et a l . , 1986
6. Singh et a l . , 1986
7. Karin et a l . , 1984
8. Topol et a l . , 1985
9. Sawadogo and R o e d e r , 1985
10. Siva raman et a l . » 1986
11. Zenke et a l . , 1986
Table 10 : Transcription factor binding sites
A. General transc ripti on factor binding sites
Reference
NF HI TATG ATA ATGAG 
(A T G C A A A T A G )
NF I / CTF 
Spl
T G G q NN NNNGCCAA
B. Specific regulatory elements
Ig enhancer elements
Ig NF-A
CAGGTGGC
TGTGGCAA
ATTTGCAT
5
5
5 , 6
Heavy metal ion 
response element (MRE)
G l u c o cort ic oi d receptor 
element (GRE)
Heat shock element
C T C G - C C C G G - C c C
T A AA T cGGT-fCAcT-TGTcCT
C N NG AANNTT CN NG
AdV major late promoter 
USF
AdV E2A promoter
GGC CAC GTGA CC
T G G A G A T G A C G T A G T T T
9
10
SV40 enhancer motifs 
Sph motif
TC motif
GT motif 
P motif
11
a a g J a t g c a
TCCCCAG
G g T G T G G A A t GT
TCAA TTA GTCA
FIGURE 77
Sequences wit h i n  the U^ and D R 2  repeat regions which share 
homology with the Spl consensus sequence.
* indicates con served bases.
§ g g g c g g 5 $ £T A A T
vU »x* «ju \t»✓ js ^ r*  ^  / js  +g%
TGGGGGGGGC
GGGGAGGAGC
^  \ t *  \U  \t»  st«  «x# «ju^  ^  «>p #*(> 'P
^ G G G C G G ^ ^  T A A T
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The significance of the Spl-like elements within these 
two regions is unclear. Only a single Spl-like sequence is 
present within the region, a fact difficult to reconcile 
with the pattern of enhancement seen. The Spl-like sequence 
also overlap s the predominant region of enhancement on the 
top strand. These features, together with the fact that the 
enhanced cleavages are specific for virus-infect ed cell 
extracts, would argue against a role for Spl, at least with 
respect to the enhanced cleavages within . It is possible 
that Spl could be involved in the effects seen with mock- 
infecte d cell extracts within the DI^ repeat region. C o m p e t ­
ition experiments, using DNA containing a known Spl-bi nding  
site (or alternatively, the use of purified Spl) would help 
to eluci date the role of the Spl tra nscr iption factor.
Another question which arises is the nature of the 
apparen t exo nuclease activity. If a 5 T — 3 * exo nuclease is 
indeed responsible for the apparent increase in sensitivity 
to DNase I, by the production of an exonucleas e footprint, 
then it must copurify with the 'a T seque nc e-bindi ng  protein(s) 
through the limited chromat ographic procedures used. Two 
procedures however, phosphocell ulose chroma tograp hy  and FPLC, 
resulted in loss of the footprin ting activity, and this could 
have arisen had the exonuclease and fa ’ seq uence -b inding 
proteins become separated. Equally, the footprint ing activity 
could simply have become inactivated by these procedures. It 
would be interesting to carry out exonucleas e footprint 
experiments, using the extracts and, especially, the partially - 
purified material, to determine whether a known 5 * — 3 f e x o ­
nuclease could generate a similar pattern of cleavage, and 
also whether a 3 * — 5 ? exonuclease could produce a c or re spondi ng  
pattern on the opposite strand. Ideally, this would require
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the partial purification of the 'a’ sequence-b inding proteins 
away from the endogenous exonuclease activity.
The possibilit y that the exonuclease and ’a ’ sequence- 
binding proteins are more directly related must also be 
considered. It has not been excluded that a specific cleavage 
event is resp on sible for the enhanced cleavages within . 
P u r i f icat io n of the 'a’ seque nce-bindi ng protein(s) will be 
required to directly test this possibility. The HS V-enc oded 
alkali ne exon ucl ease possesses both exonuclease and e n d o ­
nuclea se acti vi ties (Hoffmann and Cheng, 1979; Hoffmann, 1981). 
The e x o n uc le as e activity appears to digest both strands of 
DNA at an equal rate, to produce flush ends of digested DNA 
(Hoffmann, 1981), suggesting that the alkaline ex onuclease 
is not respon sible for the 5 ’-3* exonu clease activity observed 
here. However, this does not exclude a possible role for the 
end on uc lease activity in generating these cleavages. The use 
of a t_s mutan.t within the alkaline exonu clease gene (Francke 
et a l . , 1978) would help to more directly address this point.
Exonucle as es have been reported to be involved in the 
process of rec omb ination (Sadowski, 1982). However, the 
region does not appear to be essential for the si te-sp ecific 
re c o m bi na tion events which generate segment inversion. T h e r e ­
fore, it might seem unlikely that an exonu clease activit y 
would sp eci fic ally interact with the region of the ’a' 
sequence. In addition, if the enhancement observed does 
represent a specific cleavage event it would seem unlikely 
that this is directly related to the cleavage events which 
generate the normal genomic termini, since the termini are 
located within DR^, some distance do wnstream from the enhanced 
cleavages within U^. The presence of multiple enhanced bands 
would suggest considerable flexibility in the ’specific*
The anti-peptide antisera used in this study appeared to have 
a low affinity for 21K. Fusion proteins, expressing either
sub-regions of, or the intact, Ugll coding sequences, could 
be used as immunogens to generate higher affinity antisera 
against the products of gene Ugll.
cleavage reaction.
In conclusion, we have demonstrated a DNA-p rot ein i n t e r ­
action occurring within the 'a* sequence which does not 
involve the ’a' sequence-specific 21K/22K DNA-binding proteins. 
This in teraction  appears to involve, at least in part, a region 
within which is highly conserved between different herpes 
viruses. However, much remains to be done to clarify the 
nature of this interaction and its possible signifi cance with 
respect to the many functions associated with the HSV fa ’ 
s e q u e n c e .
Future work
The intense localisation of the 21K polyp eptide to the 
nucleolus of infected cells raises a number of questions 
concerning its function. This loc alisation  would not be 
predicted for an ’a ’ sequence-specific DN A-b inding protein, 
since viral DNA is not present within the nucleolus. The fact 
that the 21K polypeptide binds to the ’a ’ sequence in vitro 
need not necessarily imply that it does so in v i v o . N e v e r t h e ­
less, it would be important to investigate in more detail the 
specific interaction  between the ’a' sequence and 21K. It 
would also be of interest to determine whether 21K binds to 
RNA. Since 21K is non-essential in tissue culture, it should 
be possible to construct deletion mutants in gene Ugll with 
a view to de termining  whether specific sequences are important 
for its nucleolar localisation. In addition, it would be 
interesting to determine whether this polypeptide, in the 
absence of other viral products, would localise to nucleoli 
of uninfected cells. Jfr
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The DNase I footprinting experiments employed crude 
whole cell extracts. It is now imp ortant to use more highly 
purified preparations of protein, to reduce the problem of 
endogen ous  nuclease activity and to increase the sensitivity 
of the assay. This would also esta bl ish whether a specific 
cleavage event is generating the enhanced cleavag es observed, 
or whether an exonuclease footprint is responsible. The 
re la tion sh ip  between the apparent binding within and the 
D R 2  repeats remains to be established. The use of synthetic 
o li go nu c l e o t i d e s  rep resenting these two regions in competit ion 
e xpe riments  should clarify this point. Similarly, competition 
e xp er ime nts could also help to el uci dat e the role of the 
cellular transc ripti on  factor, Spl. In addition, the use of 
temper atu re sensitive mutants may help to determine  which 
viral polypeptides, if any, are involved in the interactions 
o b s e r v e d .
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